<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Nanobiotechnology</journal-id><journal-id journal-id-type="iso-abbrev">J Nanobiotechnology</journal-id><journal-id journal-id-type="pmc-domain-id">142</journal-id><journal-id journal-id-type="pmc-domain">nanobio</journal-id><journal-title-group><journal-title>Journal of Nanobiotechnology</journal-title></journal-title-group><issn pub-type="epub">1477-3155</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12103788</article-id><article-id pub-id-type="pmcid-ver">PMC12103788.1</article-id><article-id pub-id-type="pmcaid">12103788</article-id><article-id pub-id-type="pmcaiid">12103788</article-id><article-id pub-id-type="pmid">40414838</article-id><article-id pub-id-type="doi">10.1186/s12951-025-03461-4</article-id><article-id pub-id-type="publisher-id">3461</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>From bench to bedside: the research status and application opportunity of extracellular vesicles and their engineering strategies in the treatment of skin defects</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Cui</surname><given-names initials="L">Longwei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Song</surname><given-names initials="Y">Yantao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hou</surname><given-names initials="Z">Zhipeng</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Yang</surname><given-names initials="L">Liqun</given-names></name><address><email>yangliqun@sj-hospital.org</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Guo</surname><given-names initials="S">Shu</given-names></name><address><email>sguo@cmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wang</surname><given-names initials="C">Chenchao</given-names></name><address><email>ccwang@cmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04wjghj95</institution-id><institution-id institution-id-type="GRID">grid.412636.4</institution-id><institution>Department of Plastic Surgery, </institution><institution>The First Hospital of China Medical University, </institution></institution-wrap>Shenyang, Liaoning 110002 People&#8217;s Republic of China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04wjghj95</institution-id><institution-id institution-id-type="GRID">grid.412636.4</institution-id><institution>Research Center for Biomedical Materials, Shenyang Key Laboratory of Biomedical Polymers, Engineering Research Center of Ministry of Education for Minimally Invasive Gastrointestinal Endoscopic Techniques, </institution><institution>Shengjing Hospital of China Medical University, </institution></institution-wrap>Shenyang, Liaoning 110004 People&#8217;s Republic of China </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">478190</issue-id><elocation-id>375</elocation-id><history><date date-type="received"><day>3</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>11</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>25</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>25</day><month>05</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-27 06:25:24.840"><day>27</day><month>05</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12951_2025_Article_3461.pdf"/><abstract id="Abs1"><p id="Par1">Engineered extracellular vesicles (EVs), which are EVs modified to enhance certain biological properties, offer a promising therapeutic strategy for the treatment of skin defects. Conventional nanomaterials often encounter clinical translation challenges due to potential toxicity and limited targeting. Engineered EVs, utilizing inherent biocompatibility and effective physiological barrier traversal, can ameliorate the limitations of conventional EV therapies to some extent, including detection, isolation, purification, and therapeutic validation. Recent advances in EV engineering, such as genetic modification of production cells to control cargo, surface engineering for targeted delivery, and pre-treatment of parental cells to optimize production and bioactivity, have improved therapeutic efficacy in laboratory studies through enhanced targeting, prolonged retention time, and increased yield. Many studies have suggested the potential ability of engineered EVs to treat a variety of skin defects, including diabetic wounds, burns, and hypertrophic scars, providing a promising avenue for their clinical translation in this area. This paper reviews the therapeutic potential of engineered EVs in skin regeneration, highlighting their role in promoting cell migration and angiogenesis, modulating inflammation and reducing scar formation during wound healing. In addition, given the investment in this rapidly evolving field and the growing clinical trial activity, this review also explores recent global advances and provides an outlook on future application opportunities for EVs in the treatment of skin defects.</p><sec><title>Graphical abstract</title><p id="Par2">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="MO1" orientation="portrait" xlink:href="12951_2025_3461_Figa_HTML.jpg"/>
</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Nanomedicine</kwd><kwd>Extracellular vesicle</kwd><kwd>Extracellular vesicle engineering</kwd><kwd>Skin defect</kwd><kwd>Therapeutic effect</kwd><kwd>Clinical application</kwd></kwd-group><funding-group><award-group><funding-source><institution>the National Natural Science Foundation of China</institution></funding-source><award-id>51872332</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>Basic Research Project of the Education Department of Liaoning Province</institution></funding-source><award-id>LJKZ0740</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par3">In recent decades, advancements in nanoscale technologies and tools have facilitated the development of a diverse array of nanomaterials. Within the field of biomedicine, a variety of engineered nanoplatforms have been employed for the diagnosis and treatment of various diseases [<xref ref-type="bibr" rid="CR1">1</xref>]. Nevertheless, the potential for adverse systemic effects and immunogenicity of foreign synthetic nanomaterials may act as a barrier to their progression towards clinical application and commercial viability [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Extracellular vesicles (EVs) represent naturally occurring nanocarriers that encapsulate functional cargoes, presenting an intriguing option from a materials standpoint. These entities have attracted significant attention in the biomedical field owing to their potential to surmount the limitations associated with alternative nanoparticle-based approaches [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par4">Exosomes (Exos) are a type of EVs that have a bilayer lipid membrane structure and are ubiquitously distributed throughout various bodily fluids such as serum, saliva, and cerebrospinal fluid [<xref ref-type="bibr" rid="CR5">5</xref>], with sizes ranging from 30&#8211;150&#160;nm [<xref ref-type="bibr" rid="CR6">6</xref>]. The structural properties of exosomes enable them to shield their internal components from degradation by the external environment [<xref ref-type="bibr" rid="CR7">7</xref>]. Since their initial discovery in the 1980s, exosomes had remained largely unrecognized until their function as mediators of intercellular communication was recognized in the early twenty-first century [<xref ref-type="bibr" rid="CR8">8</xref>&#8211;<xref ref-type="bibr" rid="CR13">13</xref>]. Numerous studies have demonstrated the therapeutic potential and safety of exosomes for a variety of diseases in the context of cellular and cell-free therapeutic methods [<xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par5">EVs, especially exosomes, exhibit excellent biocompatibility and biological action potential due to their nanoscale size structure, the presence of ligands on the membrane surface, and their contents [<xref ref-type="bibr" rid="CR18">18</xref>]. This is evidenced by their ability to transcend physiological barriers and penetrate recipient cells through direct fusion, phagocytosis, and endocytosis [<xref ref-type="bibr" rid="CR19">19</xref>]. Once internalization, they discharge their cargo, thereby initiating a cascade of downstream cellular responses [<xref ref-type="bibr" rid="CR20">20</xref>]. In contrast to stem cells, exosomes are safer and have a reduced risk of embolization and tumorigenesis [<xref ref-type="bibr" rid="CR21">21</xref>]. Additionally, their inherent stability and ease of storage render them increasingly favored in the realms of research and practical applications, particularly in the context of tissue repair and regeneration [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par6">In specific cases, such as burns, mechanical injuries, diabetic ulcers, and conditions of prolonged stress, the endogenous capacity of human skin to self-repair falls short of being effective [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. This inadequacy results in a compromised skin barrier that is difficult to repair and makes it challenging to maintain the body&#8217;s homeostasis [<xref ref-type="bibr" rid="CR25">25</xref>]. In such scenarios, interventions such as skin grafts may be necessary [<xref ref-type="bibr" rid="CR26">26</xref>]. Difficult-to-heal skin injuries can lead to prolonged hospitalization, thereby exerting a substantial burden on the healthcare infrastructure through the consumption of surgical and wound care supplies, as well as the demand for physician and nursing resources [<xref ref-type="bibr" rid="CR27">27</xref>]. Moreover, the healthcare system is currently under considerable stress due to the ongoing challenges posed by other health crises, such as the Corona Virus Disease-2019 (COVID-19) pandemic, emphasizing the urgent need for low-risk wound management strategies [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>].</p><p id="Par7">EV therapy is thought to have the potential to ameliorate the problem of delayed healing to some extent. However, the practical and widespread use of EVs in clinical settings has been hampered by several challenges, including extraction and isolation, purification and identification [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], and low yields of production [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. To overcome these obstacles, researchers have investigated EV engineering strategies as new approaches to modify them. Modified EVs have the potential to improve yield, therapeutic efficiency, and targeting ability, making them applicable across a broad spectrum of prospective clinical interventions in disease management [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par8">This review aims to elucidate the biological characteristics of exosomes, the most representative entities among EVs, along with their biogenesis processes and isolation methodologies. It will also discuss the strategies employed for EV engineering and highlight the various biological effects of both conventional EVs and those modified through engineering techniques in wound healing. Furthermore, the current state of research in this field and the potential clinical applications of EVs will be analyzed. It is noteworthy that some studies do not rigorously distinguish between &#8220;exosomes&#8221; and &#8220;EVs&#8221;. Therefore, unless explicitly specified, the term &#8220;extracellular vesicles&#8221; will be used throughout this article.</p></sec><sec id="Sec2"><title>Exosome biogenesis, secretion, cellular up-taking and in vitro production</title><sec id="Sec3"><title>Biogenesis, secretion, and cellular up-taking of exosomes</title><p id="Par9">Exosomes, identified as nanoscale lipid bilayer vesicles of biological origin [<xref ref-type="bibr" rid="CR34">34</xref>], can be secreted by a broad spectrum of cell types and are prevalently present in various bodily fluids as well as cell culture supernatants [<xref ref-type="bibr" rid="CR35">35</xref>]. Being a representative vesicle of cellular origin, the exosome&#8217;s architecture and surface-associated molecules possess unique properties. Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>a illustrates the diverse array of molecules localized on the surface of exosomes, including lipids, cell-specific proteins, adhesion molecules, tetraspanins, and some glycoproteins. These molecules are pivotal in the biogenesis, transportation, and functionality of exosomes. The internal composition of exosomes includes an assortment of enzymes, cytokines, nucleic acids, and other bioactive molecules, which enable exosomes to mediate a wide array of cellular functions such as targeting, adhesion, metabolic processes, and the modulation of inflammation.<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Overview of exosome characteristics. <bold>a</bold> Illustrative representation of exosomes, depicting surface molecules and internal constituents. <bold>b</bold> Depiction of the processes involved in the intracellular biogenesis and outward secretion of exosomes. The content within the illustrations is based on the current state of scientific understanding</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12951_2025_3461_Fig1_HTML.jpg"/></fig></p><p id="Par10">The fundamental principles of exosome biogenesis are relatively well-established. Exosomes originate from endosomes through a series of processes including generation, circulation, degradation, and eventual release [<xref ref-type="bibr" rid="CR36">36</xref>]. As depicted in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>b, this process initiates with the inward budding of the cytomembrane, culminating in the creation of early endosomes. Extracellular substances undergo fusion with early sorting endosomes via the processes of plasma membrane invagination and endocytosis. Subsequently, these endosomes evolve into late sorting endosomes, within which intraluminal vesicles are formed through further invagination. These vesicles are integral to the formation of multivesicular bodies (MVBs) [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] or act as a part of the endomembrane system [<xref ref-type="bibr" rid="CR38">38</xref>]. MVBs may either be directed toward lysosomes for degradation or proceed to exocytosis, merging with the plasma membrane to discharge exosomes into extracellular space [<xref ref-type="bibr" rid="CR39">39</xref>]. Once in the extracellular milieu, exosomes serve as facilitators of intercellular communication, transferring bioactive molecules to recipient cells via mechanisms such as direct fusion, endocytosis, and receptor-ligand interactions [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. This exchange triggers downstream cascade reactions that affect cellular operations and participate in the physiological and dysfunctional activities of the organic living system [<xref ref-type="bibr" rid="CR42">42</xref>].</p><p id="Par11">Studies have demonstrated that the endosomal sorting complex required for transport (ESCRT) family is critical in the process of exosomes&#8217; biogenesis [<xref ref-type="bibr" rid="CR43">43</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref>]. Besides, heat shock protein 90 (HSP90) and the mechanistic target of rapamycin complex 1 (mTORC1) can also exert an impact on the secretion of exosomes [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. In addition to the ESCRT-dependent exosome pathway, investigations have also revealed the ESCRT-independent pathway that is involved in exosome biogenesis and can also load substances into exosomes with the assistance of exosomal proteins [<xref ref-type="bibr" rid="CR48">48</xref>].</p></sec><sec id="Sec4"><title>Methods for obtaining exosomes</title><p id="Par12">The distinctive features of exosomal architecture and composition suggest specific facets of their physiological impact. Achieving high yield and purity in exosome isolation is a critical foundational step for both research and practical applications. Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref> detailing exosome processing and characterization is presented below. A multitude of techniques has been employed to isolate exosomes, including centrifugation, ultrafiltration, size-exclusion chromatography (SEC), immunoaffinity separation, polymer precipitation, and microfluidic technology. The pros and cons of commonly used isolation techniques for exosomes are listed in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>.<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Flowchart depicting exosome processing and characterization. Exosomes can be extracted from various sources through many techniques. The section on exosome characterization includes quantitative and qualitative assessments, and other examinations, such as their structures, sizes, topology and so on</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="12951_2025_3461_Fig2_HTML.jpg"/></fig><table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Comparison of commonly used exosome isolation techniques and their benefits and limitations</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Techniques</th><th align="left" colspan="1" rowspan="1">Principles</th><th align="left" colspan="1" rowspan="1">Advantages</th><th align="left" colspan="1" rowspan="1">Limitations</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Differential ultracentrifugation</td><td align="left" colspan="1" rowspan="1">Separate by density, size, and shape</td><td align="left" colspan="1" rowspan="1"><p>Low cost</p><p>High productivity</p><p>Easy to apply</p></td><td align="left" colspan="1" rowspan="1"><p>Large sample volume</p><p>Time consuming</p><p>Relatively low purity</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Density-gradient centrifugation</td><td align="left" colspan="1" rowspan="1">Separate by buoyant density</td><td align="left" colspan="1" rowspan="1">More purified</td><td align="left" colspan="1" rowspan="1"><p>Contamination of extracellular microvesicles</p><p>Negatively affects structures and biological functions of isolated exosomes</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Ultrafiltration</td><td align="left" colspan="1" rowspan="1">Molecular size or molecular weight recognition by ultrafine nanomembranes</td><td align="left" colspan="1" rowspan="1"><p>Quick</p><p>Easy to operate</p></td><td align="left" colspan="1" rowspan="1"><p>Low yield</p><p>Co-existence of nanoparticles of comparable sizes to exosomes</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Size-exclusion chromatography</td><td align="left" colspan="1" rowspan="1">Separate by different molecular weights</td><td align="left" colspan="1" rowspan="1"><p>Preservation of the natural bioactivity of exosomes</p><p>High-throughput preparation</p></td><td align="left" colspan="1" rowspan="1">Contaminants of protein aggregates and lipoproteins</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunoaffinity isolation</td><td align="left" colspan="1" rowspan="1">Interaction of exosomal antigen and antibody</td><td align="left" colspan="1" rowspan="1"><p>High yield</p><p>More purified</p><p>Low sample volume</p></td><td align="left" colspan="1" rowspan="1"><p>High cost</p><p>Potential disruption of the structural and functional integrity</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Polymer precipitation</td><td align="left" colspan="1" rowspan="1">Solubility and isoelectric point</td><td align="left" colspan="1" rowspan="1"><p>Easy to apply</p><p>High yield</p></td><td align="left" colspan="1" rowspan="1">Contamination of nucleic acids, lipoproteins, proteins, and viruses</td></tr><tr><td align="left" colspan="1" rowspan="1">Microfluidic technique</td><td align="left" colspan="1" rowspan="1">Physical and biochemical properties</td><td align="left" colspan="1" rowspan="1"><p>Quick</p><p>Small volume samples</p><p>Automatic operation</p></td><td align="left" colspan="1" rowspan="1"><p>Relatively complex equipment</p><p>No standardized protocol</p></td></tr></tbody></table></table-wrap></p><sec id="Sec5"><title>Centrifugation</title><p id="Par13">Centrifugation is an extensively utilized approach for the fractionation of small particles, like microorganisms and cellular organelles, based on the application of centrifugal forces. For the isolation of exosomes, forces typically within the range of 100,000 to 150,000&#8201;&#215;&#8201;g are employed, offering a cost-effective means of exosome extraction [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. In general, centrifugation methods can be categorized into two main types: differential ultracentrifugation and density gradient centrifugation.</p><p id="Par14">Differential ultracentrifugation, alternatively known as simple ultracentrifugation or pelleting technique, is a centrifugal-force-based method used to separate components of fluid samples according to their density, size, and shape [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Initially reported by Johnston in 1989 [<xref ref-type="bibr" rid="CR53">53</xref>] and afterwards refined by Th&#233;ry and colleagues [<xref ref-type="bibr" rid="CR54">54</xref>] in 2006, this methodology has been a favored approach for the extraction of exosomes from diverse origins over several decades [<xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR57">57</xref>]. This is due to its straightforwardness and ability to produce large quantities. However, the method is based on a principle that allows for the co-separation of all components sharing similar buoyant density, size, and mass by precipitation under a chosen centrifugal force [<xref ref-type="bibr" rid="CR58">58</xref>]. Exosome samples isolated by differential ultracentrifugation are of suboptimal purity, which may adversely affect downstream both quantitative and functional analytical studies related to exosomes [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>].</p><p id="Par15">To enhance the effectiveness of the classical centrifugal-force-based separation technique, density gradient centrifugation was introduced and widely adopted as a representative improvement [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. This method has proven effective for obtaining purer exosome samples by exploiting the density disparities among various extracellular constituents [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Although the method was effective in separating exosomes from protein aggregates, the method has not been entirely successful in eliminating contamination by extracellular microvesicles, attributed to the buoyancy density factor [<xref ref-type="bibr" rid="CR65">65</xref>].</p></sec><sec id="Sec6"><title>Ultrafiltration</title><p id="Par16">Ultrafiltration is a method for separating extracellular vesicles from collected specimens or culture media, utilizing ultrafine nanomembranes with varying molecular weight cut-offs to differentiate EVs based on size [<xref ref-type="bibr" rid="CR66">66</xref>]. Remarkably, this process can be completed in a mere 16&#160;min and does not necessitate specialized equipment, presenting itself as a preferable substitute for ultracentrifugation methods [<xref ref-type="bibr" rid="CR67">67</xref>]. It is noteworthy that by adjusting the pore size of the filtration membrane, ultrafiltration enables the classification of extracellular vesicles based on specific size criteria [<xref ref-type="bibr" rid="CR68">68</xref>].</p><p id="Par17">However, the employment of ultrafine nanomembranes during the separation process may result in the entrapment of larger vesicles within the membrane pores, leading to the aggregation of exosomes and clogging of the pores. This phenomenon can significantly reduce the yield of isolated exosomes and contribute to the deterioration of the ultrafiltration membranes [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. In addition, the concurrent presence of nanoparticles of a size similar to that of exosomes, coupled with the potential for exosome deformation induced by transmembrane pressure, represent additional limitations of the ultrafiltration technique [<xref ref-type="bibr" rid="CR49">49</xref>].</p></sec><sec id="Sec7"><title>Size-exclusion chromatography</title><p id="Par18">SEC, first invented by Grant and Colin in the 1950s, represents a separation technique predicated on the differential molecular weights of substances as they traverse a chromatographic column [<xref ref-type="bibr" rid="CR70">70</xref>]. Following the introduction of a variety of finely porous materials such as dextran polymers, agarose, and polyacrylamide, the utility of this technique has seen a gradual expansion [<xref ref-type="bibr" rid="CR71">71</xref>]. In the context of exosome research applications, SEC facilitates the separation of exosomes through passive gravity flow, offering the distinct advantage of precise isolation of the target exosomes while maintaining the vesicles&#8217; structural and functional integrity [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. Importantly, the method is applicable not only for the isolation of trace samples but also supports scalability and automation for high-throughput exosome production.</p><p id="Par19">Notwithstanding its advantages, the SEC method also encounters some challenges, including the presence of contaminants like protein aggregates and lipoproteins within the smaller size fraction. It has been documented that amalgamating SEC with the immunoaffinity capture isolation technique presents a viable solution to mitigate this challenge [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR74">74</xref>].</p></sec><sec id="Sec8"><title>Other techniques</title><p id="Par20">In addition to the methods mentioned above, techniques such as immunocapture, polymer precipitation and microfluidics have also been applied and investigated for obtaining exosomes.</p><p id="Par21">Theoretically, any protein or cellular membrane component that is either exclusively or predominantly located on the exosome membrane, and absent in the extracellular fluid, could serve as a target for immunoaffinity-based exosome capture. Several exosome markers like cluster of differentiation 9 (CD9), CD63, and CD81 have been widely utilized for the targeted isolation of exosomes [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. While immunoaffinity enables the attainment of a high yield of more pure exosomes from comparatively minimal sample volumes, this technique&#8217;s drawbacks include the elevated cost associated with isolation and the possible compromise of exosome integrity and biological functionality [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>].</p><p id="Par22">Polymer-induced precipitation capitalizes on the interaction between highly hydrophilic polymer molecules and the water molecules enveloping the exosomes, thereby generating a hydrophobic environment that induces the precipitation of exosomes. Typically, researchers have used hydrophilic polyethylene glycol (PEG) of a certain molecular weight to interact with the cell culture medium of cells or body fluids, subsequently utilizing centrifugation to isolate exosomes. The polymer precipitation technique is straightforward, does not demand elaborate apparatus, and can be readily scaled up to generate large volumes of exosomes. However, polymers do not exclusively precipitate exosomes but also co-precipitate a variety of water-soluble entities, thereby elevating the risk of contamination with other extracellular materials in comparison to the methods previously described [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>].</p><p id="Par23">Microfluidic separation technology enables the rapid extraction of exosomes from minimal volumes of liquid samples and enables the analysis of exosomal properties at a microscopic scale, thereby permitting the real-time characterization and potential on-site diagnostic evaluation of exosomes. This technique was first introduced for the isolation of exosomes by Chen and colleagues using anti-CD63 antibodies [<xref ref-type="bibr" rid="CR79">79</xref>]. Fundamentally, microfluidics has revolutionized the conventional biphasic process&#8212;comprising exosome isolation followed by characterization&#8212;into a streamlined, singular procedure [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. However, some critical parameters of the analytical system, like selectivity and affinity of the deployed antibodies, need to be meticulously assessed when designing microfluidic devices for real-time analysis.</p></sec></sec></sec><sec id="Sec9"><title>Methodologies for EV engineering</title><p id="Par24">As previously mentioned, traditional EV therapy is encumbered by issues such as diminished effectiveness, low production yields, limited local persistence, and inadequate targeting capabilities. These limitations have catalyzed numerous investigations, leading to the development of the emerging field of EV engineering [<xref ref-type="bibr" rid="CR82">82</xref>].</p><p id="Par25">Engineered EVs are EVs that have undergone modifications and optimizations through bioengineering methods or physical or chemical interventions, which are designed to fulfill particular functions or augment their inherent characteristics to satisfy clinical or other specific requirements. Typically, these engineered EVs preserve the fundamental structural and physicochemical attributes of natural EVs, including nanoscale dimensions, lipid bilayer configuration, and distinct protein profiles. Besides, engineered EVs exhibit enhanced properties in comparison to natural EVs including functional contents, ligands, and receptors [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. Broadly speaking, methodologies within EV engineering can be categorized into three principal strategies: adapting the culture environment of the cells, directly treating the parent cells, and modifying the isolated EVs (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). A comprehensive understanding of these methods is essential for comprehending the engineering pathway of EVs, thereby establishing the technical foundation for their application in skin regeneration.<fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p>Methodologies for extracellular vesicle engineering. Diverse approaches can be utilized to produce engineered EVs during different stages of the extraction procedure. These techniques can be applied to the cell culture environment, parental cells, or directly on the EVs. The figure depicts an array of technical approaches for EV engineering, grounded in the current knowledge</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="12951_2025_3461_Fig3_HTML.jpg"/></fig></p><sec id="Sec10"><title>Adjustment of the culture environment</title><sec id="Sec11"><title>Hypoxia microenvironment</title><p id="Par26">It is well known that oxygen is essential for life. As oxygen is involved in many biochemical reactions such as glycolysis, it is necessary to maintain the oxygen balance in the cell culture environment [<xref ref-type="bibr" rid="CR85">85</xref>]. The level of oxygen, or oxygen tension is regarded as a crucial factor that impacts the biological characteristics of stem cells in vitro culturing. Intriguingly, research by Cooper et al. in 1958 revealed that hypoxic conditions could augment the proliferation rates of certain cell types [<xref ref-type="bibr" rid="CR86">86</xref>]. This proliferative enhancement under hypoxic conditions has similarly been observed in mesenchymal stem cells (MSCs) [<xref ref-type="bibr" rid="CR87">87</xref>]. It has been suggested that oxygen levels can potentially induce DNA damage within cells [<xref ref-type="bibr" rid="CR88">88</xref>]. As a result, the cultivation of MSCs in a hypoxic environment is believed to potentially improve their condition and, in certain instances, lead to more efficacious therapeutic outcomes.</p><p id="Par27">In conditions of hypoxia, cells trigger a series of complex reactions, including those involved in autophagy, cellular stress responses, and pathways related to energy metabolism [<xref ref-type="bibr" rid="CR89">89</xref>]. For example, hypoxia-inducible factors (HIFs) play a crucial role in the transcriptional regulation of genes that are pivotal in various biological processes, like cell proliferation, apoptosis, metabolic regulation, immune responses, and the mechanisms of tumorigenesis and metastasis [<xref ref-type="bibr" rid="CR90">90</xref>]. When exposed to low oxygen levels, MSCs exhibit an upregulation of HIF-1&#945; [<xref ref-type="bibr" rid="CR91">91</xref>]. Additionally, evidence suggests it has been shown that pre-exposure to hypoxic conditions can amplify the secretion capabilities of exosomes [<xref ref-type="bibr" rid="CR92">92</xref>]. It is important to note that hypoxia is one of the pathological microenvironment characteristics of diabetic ulcer [<xref ref-type="bibr" rid="CR93">93</xref>]. Therefore, from this standpoint, the engineered EVs obtained by this method have the potential to be applied to diabetic wounds.</p><p id="Par28">However, in such culture conditions, evidence suggests that hypoxia exerts a limited influence on the miRNA composition of EVs from bone marrow derived mesenchymal stem cells (BMSC-EVs) [<xref ref-type="bibr" rid="CR94">94</xref>]. The discrepancy in findings raises questions regarding the potential impact of variability in cell sources or the techniques employed for EV engineering. Furthermore, the feasibility of scaling up hypoxia, a culture condition that may not be conducive to cell viability, warrants further investigation.</p></sec><sec id="Sec12"><title>Stereoscopic culture environment</title><p id="Par29">To date, the majority of traditional cell culture methodologies have been conducted within a two-dimensional setting, typically utilizing static adherent wall cultures. However, it is essential to recognize that there are significant differences that exist between the two-dimensional (2D) culture conditions and the three-dimensional (3D) microenvironment encountered in vivo, particularly concerning biological functionality and the structure of the medium. Within a two-dimensional culture environment, there is a tendency for cells to progressively deviate from their native morphology, structural integrity, and functional capacities as observed in vivo. Such alterations may lead to disruptions in a range of cellular biogenesis activities, which, in turn, may impact the EV produced [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. Table <xref rid="Tab2" ref-type="table">2</xref> compares the advantages and drawbacks of planar versus spatial cell culture techniques.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Comparison of 2D and 3D cell culture techniques</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">2D cell culture</th><th align="left" colspan="1" rowspan="1">3D cell culture</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Cellular morphology</td><td align="left" colspan="1" rowspan="1">Elongated and flat, growing in a single layer</td><td align="left" colspan="1" rowspan="1">Maintain natural shape and growth pattern, forming 3D aggregates or spheres, or growing stereoscopic along 3D scaffolds</td></tr><tr><td align="left" colspan="1" rowspan="1">Cell attachment</td><td align="left" colspan="1" rowspan="1">Rare to be seen</td><td align="left" colspan="1" rowspan="1">Common and easily generated communication</td></tr><tr><td align="left" colspan="1" rowspan="1">Cell differentiation</td><td align="left" colspan="1" rowspan="1">Relatively poor</td><td align="left" colspan="1" rowspan="1">Relatively well</td></tr><tr><td align="left" colspan="1" rowspan="1">Cell proliferation</td><td align="left" colspan="1" rowspan="1">Unnaturally rapid rate</td><td align="left" colspan="1" rowspan="1">Closer to the real situation, depending on the techniques and cell types</td></tr><tr><td align="left" colspan="1" rowspan="1">Influences on EV production</td><td align="left" colspan="1" rowspan="1"><p>Lower yields</p><p>Lower bioactivity</p><p>Potentially leading to discrepancies in the compositions and functions</p></td><td align="left" colspan="1" rowspan="1"><p>Relatively higher yields</p><p>More effective bioactivity</p><p>Better represent in vivo conditions</p></td></tr><tr><td align="left" rowspan="2" colspan="1">Evaluation</td><td align="left" colspan="1" rowspan="1">Lower cost, suitable for long-term, large-scale studies</td><td align="left" colspan="1" rowspan="1">More costly, more time-consuming, and relatively difficult to reproduce</td></tr><tr><td align="left" colspan="1" rowspan="1">Does not accurately reflect mechanical stimulation of cells and the effects of gravity</td><td align="left" colspan="1" rowspan="1">Can accurately reflect cellular responses to mechanical stimuli, and gravity</td></tr></tbody></table></table-wrap></p><p id="Par30">Currently, three-dimensional culture techniques can be broadly divided into two directions: those that do not rely on materials and those that do. Material-independent three-dimensional culture methods mainly include stirred culture conditions [<xref ref-type="bibr" rid="CR97">97</xref>], scaffold-free suspension culture [<xref ref-type="bibr" rid="CR98">98</xref>], and so on. Material-reliant cell culture techniques have garnered extensive investigation in recent times, particularly within the realm of tissue engineering. This includes cell scaffolds [<xref ref-type="bibr" rid="CR99">99</xref>], bioreactors [<xref ref-type="bibr" rid="CR100">100</xref>], quantum cell expansion systems [<xref ref-type="bibr" rid="CR101">101</xref>], etc. Biomaterials, recognized for their superior biocompatibility, are a distinct category of materials whose properties and biodegradation characteristics can be tuned with minimal alterations to their chemical structure [<xref ref-type="bibr" rid="CR102">102</xref>]. This adaptability facilitates the development of materials that support cell culture, offering porosity, bioactivity, and mechanical robustness to satisfy the requirements of diverse cellular types. 3D culture systems have been developed to expedite the generation of mesenchymal stem cells [<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR103">103</xref>] and their exosomes [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR104">104</xref>], achieving greater yields within shorter time spans or utilizing lesser volumes. Recent evidence indicates that hollow bioreactor-based 3D culture systems have enhanced the overall yield of MSC-exosomes, achieving an approximate increase of 19.4-fold in comparison to traditional 2D cultures [<xref ref-type="bibr" rid="CR100">100</xref>]. Moreover, it has been observed that 3D-exos from space-based culture systems confer unique benefits in terms of enhancing the ability of proliferation and migration of endothelial cells, angiogenic capabilities, and the repair of various forms of damage compared with 2D-exos [<xref ref-type="bibr" rid="CR105">105</xref>]. Therefore, these findings offer a preliminary foundation for the utilization of this method in producing engineered EVs to promote wound healing.</p></sec></sec><sec id="Sec13"><title>Treatment of EV-producing cells</title><p id="Par31">Pretreatment of source cells represents an alternative strategic approach capable of modifying cellular characteristics. Studies have shown that these techniques are effective in augmenting the efficiency and output of EVs [<xref ref-type="bibr" rid="CR106">106</xref>]. In this section, we will discuss treatment strategies encompassing physical stimulation, pre-application of chemicals or cytokines, and the implementation of genetic engineering.</p><sec id="Sec14"><title>Physical stimulation</title><p id="Par32">Investigations have revealed that low-intensity ultrasound stimulation enhances the proliferation of MSCs, modifies their physiological activity responses, and directs their developmental pathways [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. In a study by Zheng et al. [<xref ref-type="bibr" rid="CR109">109</xref>], an approach utilizing low-intensity ultrasound stimulation (US) on adipose-derived stem cells (ADSCs) was devised to increase the secretion of EVs for potential clinical application. In this investigation, an appropriate ultrasound setting was determined, which in turn increased the production of ADSC-EVs. In addition, US-EVs have been demonstrated to enhance the biological functions of fibroblasts, keratinocytes, and endothelial cells in vitro experiments, and to facilitate the healing of diabetic wound animal model in vivo through mechanisms including supporting re-epithelialization, enhancing collagen production, promoting cell proliferation, facilitating keratinocyte differentiation and migration, and inducing angiogenesis [<xref ref-type="bibr" rid="CR109">109</xref>].</p></sec><sec id="Sec15"><title>Chemical treatment</title><p id="Par33">Many cells, including MSCs, are capable of reacting to a diversity of chemical agents, such as metformin, and melatonin, among others, which can profoundly modify their phenotypic characteristics. These modifications consequently influence both the volume and composition of EVs released, offering a method for EV engineering.</p><p id="Par34">N, N-dimethylbiguanide, serves as an oral antihyperglycemic agent prevalently employed in diabetes therapy [<xref ref-type="bibr" rid="CR110">110</xref>]. It is known to activate adenosine 5&#8217;-monophosphate-activated protein kinase (AMPK) and has been observed to influence the secretion of EVs from MSCs [<xref ref-type="bibr" rid="CR111">111</xref>]. Detailed mechanistic studies have shown that metformin induces the integration of the &#945;-trypsin inhibitor heavy chain H4 (ITIH4) into MVBs, leading to an enrichment of ITIH4 in the exosomes. The MSC-derived exosomes were demonstrated to mitigate senescence in nucleus pulposus cells, thus enhancing their therapeutic application value intervertebral disc degeneration (IDD) [<xref ref-type="bibr" rid="CR112">112</xref>]. However, although metformin is a first-line treatment for type 2 diabetes [<xref ref-type="bibr" rid="CR113">113</xref>], there has been no exploration of preconditioning with metformin to obtain engineered EVs suitable for the treatment of diabetic ulcers as the time of writing.</p><p id="Par35">Melatonin (MT), a free radical scavenger and broad-spectrum antioxidant, was originally isolated from the pineal gland and is widely distributed throughout the body. It has been shown to promote M2-like polarization of macrophages [<xref ref-type="bibr" rid="CR114">114</xref>] and has been effectively employed in the therapy of diverse illnesses [<xref ref-type="bibr" rid="CR115">115</xref>&#8211;<xref ref-type="bibr" rid="CR118">118</xref>]. Recent studies have revealed that MT-pretreated extracellular vesicles exert advantageous impacts on conditions such as renal ischemia&#8211;reperfusion injury and cerebral ischemia, among others. Furthermore, in the context of diabetic wound healing, MT has been indicated to exhibit beneficial outcomes [<xref ref-type="bibr" rid="CR119">119</xref>&#8211;<xref ref-type="bibr" rid="CR122">122</xref>].</p><p id="Par36">Treatment with other chemical factors was also investigated, such as glycyrrhizin acid [<xref ref-type="bibr" rid="CR123">123</xref>], kartogenin [<xref ref-type="bibr" rid="CR124">124</xref>], thrombin [<xref ref-type="bibr" rid="CR125">125</xref>], oridonin [<xref ref-type="bibr" rid="CR126">126</xref>], and atorvastatin [<xref ref-type="bibr" rid="CR127">127</xref>]. The collective evidence from these studies indicates that different chemical compounds can augment the restorative or immunosuppressive capacity of EVs by altering the secretome of mesenchymal stem cells. However, further research is required to ascertain the types of chemicals utilized, in addition to the optimal concentrations and pretreatment times, with a view to producing engineered EVs that facilitate wound healing.</p></sec><sec id="Sec16"><title>Cytokine preconditioning</title><p id="Par37">The approach of cytokine pretreatment is similar to that of chemical interventions, with the distinct characteristic being that the biological effects of cytokines can typically be detected. EVs mediate paracrine secretion, serving as a mechanism for cellular communication [<xref ref-type="bibr" rid="CR128">128</xref>]. Cytokine-induced stimulation has been recognized for its ability to increase the efficiency of paracrine communication and control the expression and release of various therapeutic substances within EVs [<xref ref-type="bibr" rid="CR87">87</xref>]. Studies have also demonstrated that cytokine pretreatment of MSC-exos can modulate immune responses. This adjustment involves nudging MSCs toward a less inflammatory phenotype and aiding in the shift of macrophages from the inflammatory M1 type to the anti- inflammatory M2 type [<xref ref-type="bibr" rid="CR129">129</xref>&#8211;<xref ref-type="bibr" rid="CR132">132</xref>]. These M2 macrophages, noted for their anti-inflammatory functions, are crucial in aiding the healing process during the inflammation phase of wound recovery [<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR134">134</xref>].</p><p id="Par38">Inflammatory stimuli, for example, like tumor necrosis factor-&#945; (TNF-&#945;), interleukin-1&#946; (IL-1&#946;), and interferon-&#947; (IFN-&#947;), have been shown to enhance the regenerative potential and anti-inflammatory ability of MSC-exos. TNF-&#945; has been found to elevate miRNAs linked to the suppression of inflammation, thereby increasing the release of anti-inflammatory exos from MSCs, leading to the secretion of more anti-inflammatory MSC exosomes [<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR131">131</xref>]. IL-1&#946; promotes the anti-inflammatory functions of MSC exosomes in osteoarthritis by upregulating miRNA-147b expression [<xref ref-type="bibr" rid="CR135">135</xref>]. Additionally, Yang et al. [<xref ref-type="bibr" rid="CR136">136</xref>] reported that IFN-&#947; also improved the ability of MSC-exos to suppress Th17 cell differentiation and alleviate colitis. Li et al. [<xref ref-type="bibr" rid="CR137">137</xref>] used engineered macrophage-derived extracellular vesicles to create a bioactive hydrogel ink, aimed at enhancing wound healing. The EVs were obtained from M2 macrophages stimulated with interleukin-4 (IL-4), which promotes their anti-inflammatory properties. These EVs were incorporated into sodium alginate hydrogel precursors, resulting in a hydrogel that exhibits angiogenic effects, promotes endothelial cell migration, and facilitates the polarization of macrophages towards the M2 phenotype, providing a promising strategy for effective and personalized wound management.</p></sec><sec id="Sec17"><title>Genetic engineering</title><sec id="Sec18"><title>For targeted transportation</title><p id="Par39">EVs possess the ability to traverse the bloodstream and penetrate tissues, including crossing the blood&#8211;brain barrier (BBB). Therefore, enhancing their tissue-specific targeting capabilities is crucial for improving their therapeutic outcomes. Strategies have been employed to improve their targeting ability. Surface modifications directly alter EV surface molecules, augmenting their therapeutic effects and enhancing their targeting capabilities [<xref ref-type="bibr" rid="CR138">138</xref>]. Genetic engineering of the source cells allows for the incorporation of targeted signaling molecules, enabling the precise engineering of EVs for optimized delivery to targeted tissues and lesions.</p><p id="Par40">Genetic engineering techniques, including molecular cloning and lentiviral vector assembly, can be utilized to produce engineered EVs with tailored characteristics [<xref ref-type="bibr" rid="CR139">139</xref>]. This procedure entails linking the genetical sequence of a guide protein or peptide to the genetical sequence of a chosen EV membrane protein, leading to the assembly of specific signaling proteins on the EV surface. Then, the parental donor cells are transfected with a plasmid that encodes the fusion protein, resulting in the displaying of the desired ligand on their surface. For example, Zhang et al. [<xref ref-type="bibr" rid="CR140">140</xref>] induced the differentiation of human induced pluripotent stem cells (iPSCs) into endothelial cells (iPS-ECs) utilizing genetic engineering methodologies. These iPS-ECs inherently exhibit elevated expression of C-X-C chemokine receptor type 4 (CXCR4), a chemokine receptor instrumental in enabling precise delivery to endothelial cell populations. Employing a sequential extrusion protocol, the membrane-associated proteins of iPS-ECs, notably CXCR4, were effectively retained within the resultant nanovesicles (NVs). These engineered NVs emulate the intrinsic characteristics of natural EVs and were subsequently modified to incorporate dapagliflozin (DA) as a therapeutic payload. The strategic delivery of DA via CXCR4-enriched NVs markedly enhanced angiogenesis and expedited the healing process in diabetic wounds. This innovative strategy underscores the potential of genetic engineering in crafting EVs with tailored targeting and therapeutic properties, thereby advancing tissue regeneration in chronic wounds.</p></sec><sec id="Sec19"><title>For cargo packaging</title><p id="Par41">EVs can be loaded with many diverse cargo molecules to elicit different biological functions, including DNAs, RNAs, lipids, metabolites, and proteins. As of May 2024, the ExoCarta online database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.exocarta.org">http://www.exocarta.org</ext-link>) has cataloged 9769 proteins, 3408 mRNAs, 2838 miRNAs, and 1116 lipids identified in exosomes from different types of cells and organisms. Cargo loading into EVs can be categorized into endogenous and exogenous pathways [<xref ref-type="bibr" rid="CR106">106</xref>]. This section will focus on endogenous pathways, while exogenous methods will be discussed subsequently.</p><p id="Par42">Endogenous carriers, like viral vectors and plasmids [<xref ref-type="bibr" rid="CR106">106</xref>], are genetically engineered to modify the source cells. These carriers are commonly employed to load endogenous molecules with therapeutic effects [<xref ref-type="bibr" rid="CR138">138</xref>]. MiRNAs have important functions in many disease models and have been extensively studied [<xref ref-type="bibr" rid="CR141">141</xref>&#8211;<xref ref-type="bibr" rid="CR145">145</xref>]. Mounting evidence suggests that packaging endogenous proteins can augment the therapeutic efficacy of EVs in a variety of diseases [<xref ref-type="bibr" rid="CR146">146</xref>&#8211;<xref ref-type="bibr" rid="CR148">148</xref>].</p><p id="Par43">For example, You et al. [<xref ref-type="bibr" rid="CR149">149</xref>] found that encapsulated mesenchymal stem cells-EVs (EVs-L-PGDS) inhibited the progression of gastric cancer through the delivery of lipocalin-type prostaglandin D2 synthase (L-PGDS). For the therapy of chronic wounds, Huang et al. [<xref ref-type="bibr" rid="CR150">150</xref>] investigated the construction of engineered small extracellular vesicles (sEVs) derived from MSCs that overexpress circular RNA derived from cyclin-dependent kinase 13 gene (circCDK13), which is downregulated in diabetic wounds. These engineered vesicles demonstrated a significant ability to promote the proliferation and migration of human dermal fibroblasts and human epidermal keratinocytes, thereby accelerating wound healing in diabetic models.</p></sec></sec></sec><sec id="Sec20"><title>Modification of isolated-EVs</title><p id="Par44">A more direct approach to modifying EVs involves processing them immediately following isolation, extraction, and purification to alter their contents (i.e. the exogenous pathways mentioned previously) to improve their biological functionality or confer them the ability to target transport. Overall, such approaches generally include incubation, physical or chemical treatment, and membrane fusion techniques.</p><sec id="Sec21"><title>Incubation</title><p id="Par45">Co-incubation is a straightforward and facile way to load EVs with substances that have therapeutic effects. When EVs are co-incubated with a drug, the concentration gradient between the interior and exterior of the EV membrane drives the diffusion of the therapeutic molecules into the lumen [<xref ref-type="bibr" rid="CR151">151</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]. EVs loaded with the drug will then be obtained by purification and isolation [<xref ref-type="bibr" rid="CR153">153</xref>]. For example, Salarpour et al. conducted a study wherein paclitaxel (PTX) was successfully loaded into exosomes derived from human glioblastoma U-87 cells for drug delivery purposes through the application of incubation techniques [<xref ref-type="bibr" rid="CR154">154</xref>].</p><p id="Par46">However, drug loading efficiency is often constrained when employing this technique for drug encapsulation, attributable to the lipid bilayer membrane of EVs and the physicochemical properties of the drug [<xref ref-type="bibr" rid="CR155">155</xref>]. The interaction of the lipid membrane surface of the EV with the loading molecule, the hydrophobic properties of the target cargo, and the concentration gradient within and outside the EV will significantly affect the loading efficiency [<xref ref-type="bibr" rid="CR156">156</xref>]. Therefore, it is challenging to control the loading inside the actual EV for cargo loading performed under this method.</p></sec><sec id="Sec22"><title>Physical treatment</title><sec id="Sec23"><title>Extrusion</title><p id="Par47">Extrusion represents another widely used technique [<xref ref-type="bibr" rid="CR157">157</xref>&#8211;<xref ref-type="bibr" rid="CR160">160</xref>]. This method involves isolating and assembling EV-like nanoparticles from the cytomembrane of the parental cell via a compression process utilizing polycarbonate membranes with sequentially decreasing pore sizes. Such EV-like nanovesicles exhibit similar properties as cell-secreted extracellular vesicles, such as size, shape, biology functions, and so on [<xref ref-type="bibr" rid="CR161">161</xref>], thus circumventing the limitation of low yield and providing a method for relatively substantial scale production of extracellular vesicles.</p><p id="Par48">For example, Yu et al. [<xref ref-type="bibr" rid="CR162">162</xref>] utilized the extrusion technique to generate exosome mimetics (EM) from polymorphonuclear neutrophils (PMNs). This method markedly improved both the production and purity of these mimetics, with a notable focus on activated neutrophil-derived exosome mimetics (aPMNEM) that preserved the antimicrobial properties of PMNs. By integrating aPMNEM into an extracellular matrix hydrogel, they achieved a substantial enhancement in wound healing for diabetic rats, driven by increased collagen deposition, angiogenesis, and a reduction in bacterial infections. Recently, Liu et al. [<xref ref-type="bibr" rid="CR163">163</xref>] employed the extrusion method to prepare biomimetic NVs from endothelial progenitor cells (EPCs), which exhibited high yield, rapid production, and inheritance of parental cell phenotypes. Furthermore, a multifunctional hydrogel was developed to enable sustained release of cyclic arginine-glycine-aspartic acid (RGD) peptide modified NVs while providing antioxidant and antibacterial properties. The hydrogel demonstrated excellent biocompatibility and effectively promoted diabetic wound healing by enhancing angiogenesis, scavenging reactive oxygen species (ROS), and inhibiting bacterial infection in a synergistic manner.</p></sec><sec id="Sec24"><title>Electroporation</title><p id="Par49">Electroporation is an extensively applied method for introducing exogenous cargoes into EVs [<xref ref-type="bibr" rid="CR164">164</xref>]. By applying an electric field, it is possible to induce the formation of tiny pores within the phospholipid bilayer of nanovesicles, facilitating the entry of various small molecule substances into EVs through the force from the electric field, thereby enabling drug encapsulation. Additionally, these small pores are reparable, mitigating the risk of drug leakage or premature release. For example, a recent study employed electroporation to load small interfering RNA (si-TNF-&#945;) into EVs, thereby generating engineered EVs (si-TNF-&#945;-EVs). Following in vitro and in vivo experiments demonstrated that si-TNF-&#945;-EVs significantly promoted macrophage polarization toward the M2 phenotype, markedly suppressed TNF-&#945; secretion in wound exudates, and accelerated wound closure [<xref ref-type="bibr" rid="CR165">165</xref>].</p></sec><sec id="Sec25"><title>Acoustical method</title><p id="Par50">Sonication, an acoustic-based technique, momentarily disrupts the structural stability of the EV membrane, thereby permitting therapeutic drugs to permeate into the vesicle interior [<xref ref-type="bibr" rid="CR166">166</xref>, <xref ref-type="bibr" rid="CR167">167</xref>]. This method can restore membrane structure, and the shear forces generated by sound waves do not permanently affect the membrane contents [<xref ref-type="bibr" rid="CR155">155</xref>]. Compared to simple incubation methods, utilizing this method for the delivery of stable molecules into EVs demonstrates increased loading efficiency [<xref ref-type="bibr" rid="CR153">153</xref>]. However, it may not be optimal for the conveyance of specific therapeutic RNAs due to sonication-induced aggregation and degradation. Additionally, the drug may stick to the exterior surface EV or be incorporated into its interior, resulting in uneven loading and a biphasic drug release pattern. The drug is first released in rapid bursts from the surface, succeeded by a gradual release from the interior core [<xref ref-type="bibr" rid="CR155">155</xref>].</p><p id="Par51">Guo et al. [<xref ref-type="bibr" rid="CR168">168</xref>] innovatively utilized ultrasound irradiation to controllably remove PEG by cleaving thioketal (TK) through ROS generated by Chlorin e6 (Ce6). They developed a variable stealth coating, CD63-penetrating 05 peptide-TK- methoxy PEG (CP05-TK-mPEG), which was tethered to exosomes via the binding of the CP05 peptide to the exosomal surface marker CD63. Under sonication, ROS produced by Ce6 enabled the controlled removal of PEG, followed by the encapsulation of bone morphogenetic protein 7 (Bmp7) mRNA into exosomes for targeted delivery to the omental adipose tissue (OAT) of obese C57BL/6 mice, successfully inducing browning and demonstrating therapeutic efficacy. This study provides significant technical insights into the development of an intelligent exosome-based drug delivery system. Its capabilities in controlled release and targeted delivery hold substantial potential for applications in skin wound healing, such as the precise regulation of the wound microenvironment through the delivery of pro-healing factors (e.g., growth factors or anti-inflammatory molecules), thereby accelerating tissue repair and regeneration.</p></sec><sec id="Sec26"><title>Freeze&#8211;thaw cycles</title><p id="Par52">In earlier studies, rapid freeze&#8211;thaw cycles were used as a liposome-forming reconstitution procedure [<xref ref-type="bibr" rid="CR169">169</xref>, <xref ref-type="bibr" rid="CR170">170</xref>]. However, subsequent research has identified this approach as a mechanical strategy for the incorporation of cargo into EVs [<xref ref-type="bibr" rid="CR171">171</xref>]. This procedure involves the cyclical heating of a blend containing EVs and the intended cargo from ambient temperature or 37&#160;&#176;C to conditions achieved with liquid nitrogen. A study by Hettich et al. investigated several drug-loading techniques targeting extracellular vesicles. Their findings indicated that the freeze&#8211;thaw technique was efficacious, yielding a satisfactory rate of drug encapsulation and concurrently maintaining the structural integrity status and biological functions of the small vesicles [<xref ref-type="bibr" rid="CR172">172</xref>].</p><p id="Par53">Hajipour et al. [<xref ref-type="bibr" rid="CR173">173</xref>] loaded human chorionic gonadotropin (hCG) into exosomes using freeze&#8211;thaw cycles and sonication methods. The results showed that hCG-loaded exosomes had a greater influence on endometrial tolerance than hCG or exosomes used alone. Their findings imply that uterine fluid-derived exosomes could serve as efficient carriers for the therapeutic substances to the target cite. Nevertheless, despite its simplicity of execution, the freeze&#8211;thaw technique exhibits lower efficacy in drug encapsulation compared to sonication or extrusion methods [<xref ref-type="bibr" rid="CR153">153</xref>, <xref ref-type="bibr" rid="CR155">155</xref>]. Additionally, it has been noticed that the freeze&#8211;thaw cycle may induce protein denaturation and EV aggregation, culminating in an increased heterogeneity in particle size distribution [<xref ref-type="bibr" rid="CR174">174</xref>].</p></sec></sec><sec id="Sec27"><title>Chemical modification</title><p id="Par54">Chemical modifications utilize various methods to display an array of native or artificial ligand receptors on the EV exterior. The chemical composition of EVs allows for the direct and rapid formation of covalent chemical bonds with different functional groups due to the existence of amine groups and carboxyl-terminated phospholipids on their surface [<xref ref-type="bibr" rid="CR175">175</xref>].</p><p id="Par55">The copper-catalyzed azidoalkane cycloaddition, commonly known as click chemistry, is an efficacious reaction for forming triazole linkages between alkanes and azides [<xref ref-type="bibr" rid="CR176">176</xref>]. The presence of a catalyst markedly enhances the reaction rate of click chemistry, enabling its execution in diverse solvents such as water, alcohol, and dimethyl sulfoxide (DMSO) [<xref ref-type="bibr" rid="CR177">177</xref>]. Zeng et al. [<xref ref-type="bibr" rid="CR178">178</xref>] developed a novel nanoreagent for spinal cord injury (SCI) therapy by attaching biologically active Ile-Lys-Val-Ala-Val (IKVAV) peptides to the surface of M2-type macrophage-derived exosomes via click chemistry. These engineered exosomes specifically target the SCI site in vivo and enhance motor function recovery. Hao and colleagues [<xref ref-type="bibr" rid="CR179">179</xref>] employed click chemistry to attach the collagen-binding peptide (SILY) to EVs derived from MSCs, substantially improving the retention and therapeutic effectiveness of EVs in injured tissue. The resulting SILY-EVs exhibited enhanced binding to collagen, effectively reduced inflammation, and stimulated muscle regeneration and blood vessel formation, underscoring their promise in tissue repair applications.</p><p id="Par56">Apart from covalent bonding strategies, noncovalent modification approaches, including ligand-receptor binding [<xref ref-type="bibr" rid="CR180">180</xref>], hydrophobic insertion [<xref ref-type="bibr" rid="CR181">181</xref>], electrostatic binding [<xref ref-type="bibr" rid="CR182">182</xref>], and anchoring peptides [<xref ref-type="bibr" rid="CR183">183</xref>], have also been applied to the customization of EV membrane surfaces.</p></sec><sec id="Sec28"><title>Membrane fusion technique</title><p id="Par57">Membrane fusion technology leverages the inherent characteristic whereby the lipid bilayer membrane of EVs is capable of spontaneously merging with other membrane structures. This process allows for the alteration of the contents or structural arrangement of EVs, providing new possibilities for improving their cell-targeted therapeutic efficiency. As targeted drug delivery vehicles, liposomes are the most extensively employed nanoparticulate systems. They are vesicles with a bilayer membrane structure formed spontaneously from phospholipids dispersed in an aqueous medium [<xref ref-type="bibr" rid="CR184">184</xref>]. The development of embrane Fusion Hybrid Exosomes (MFHE) introduces a novel potential for drug delivery systems by amalgamating liposomes and exosomes through diverse membrane fusion techniques [<xref ref-type="bibr" rid="CR185">185</xref>].</p><p id="Par58">Liang et al. [<xref ref-type="bibr" rid="CR186">186</xref>] constructed a hybrid CAP-exo by fusing chondrocyte affinity peptide (CAP) with an exosome surface protein lamp2b terminal gene. They then fused CAP-exo with the liposome membrane to encapsulate the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (CRISPR/Cas9) plasmid. The expression of matrix metalloproteinase 13 (MMP-13) in chondrocytes decreased significantly after the intervention of hybrid CAP-exo, which alleviated the damage to cartilage. In addition, Yang et al. [<xref ref-type="bibr" rid="CR187">187</xref>] innovatively introduced a membrane editing technique that uses virus-analogous fusion exosomes to transfer membrane proteins with special functions directly into cell membranes. These studies, based on fusion EV-mediated delivery, broaden the application scope of membrane fusion technology, promote the targeting of EVs to different tissue types, and demonstrate its application potential in promoting tissue repair.</p></sec></sec></sec><sec id="Sec29"><title>Therapeutic potential of unmodified and engineered EVs for wound healing</title><p id="Par59">The skin, as the human body&#8217;s outermost protective barrier, serves a crucial role in defending against external pathogens and contributes to metabolic functions essential for homeostasis [<xref ref-type="bibr" rid="CR25">25</xref>]. The skin is known to be anatomically organized into three primary layers: the epidermis, the dermis, and the subcutaneous layer. Wound healing is a multifaceted process that necessitates the coordinated interaction of a variety of factors, including diverse cells, proteases, growth factors, and extracellular matrix (ECM) [<xref ref-type="bibr" rid="CR188">188</xref>]. In skin defect therapy, EVs hold promise for facilitating wound repair in different phases. This section presents a discussion of the therapeutic potential of unmodified and engineered EVs in the context of skin wound treatment.</p><sec id="Sec30"><title>Biological functions of unmodified EVs in different phases of wound healing</title><p id="Par60">In general, the progression of wound healing is segmented into four phases: hemostasis phase, inflammatory phase, proliferation phase, and remodeling phase [<xref ref-type="bibr" rid="CR189">189</xref>, <xref ref-type="bibr" rid="CR190">190</xref>]. The restoration of skin integrity involves the coordinated action of multiple cell types across a complex and sequentially organized process. The phases of wound healing are closely intertwined and the boundaries between them are not always clear [<xref ref-type="bibr" rid="CR191">191</xref>]. As a result, skin repair is one of the most complex biological processes in the body. Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref> shows the main physiological events in the various stages of wound healing with the cells involved. It is worth noting that the tissue repair process in chronic wounds deviates significantly from the conventional &#8220;linear&#8221; model of sequential and overlapping stages. The different stages of wound repair may alternate and recur, while various sections of the same wound could concurrently be undergoing different stages of the healing process [<xref ref-type="bibr" rid="CR192">192</xref>&#8211;<xref ref-type="bibr" rid="CR194">194</xref>]. Therapeutic applications of exosomes have demonstrated superior efficacy compared to traditional interventions [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR195">195</xref>] and influence all phases of the wound healing process [<xref ref-type="bibr" rid="CR35">35</xref>]. They commonly participate in governing cell viability and differentiation, modulating immunological and inflammatory responses, and facilitating angiogenesis and tissue regeneration [<xref ref-type="bibr" rid="CR196">196</xref>], including wound healing [<xref ref-type="bibr" rid="CR197">197</xref>].<fig id="Fig4" position="float" orientation="portrait"><label>Fig.&#160;4</label><caption><p>The main physiological events and key cellular participants involved in the process of wound healing. The edges of different stages within normal wound healing often lack clarity. In chronic wounds, the healing process&#8217;s stages do not adhere to a defined timeline, which means there may be the possibility of phase recurrence or extension, and some parts of the wound may be in different stages of healing, resulting in a non-linear healing process. The images&#8217; contents are based on currently available knowledge</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO5" position="float" orientation="portrait" xlink:href="12951_2025_3461_Fig4_HTML.jpg"/></fig></p><sec id="Sec31"><title>Hemostasis phase</title><p id="Par61">Upon reaching a certain depth, skin injuries expose intravascular platelets to subendothelial collagen, initiating thrombin formation [<xref ref-type="bibr" rid="CR198">198</xref>]. These resultant blood clots composed of platelets, erythrocytes, and ECM molecules, serve to safeguard the wound site [<xref ref-type="bibr" rid="CR199">199</xref>]. Platelets release growth factors like platelet-derived growth factor (PDGF), epidermal growth factor (EGF), transforming growth factor alpha (TGF-&#945;), and TGF-&#946;, among others [<xref ref-type="bibr" rid="CR191">191</xref>]. These substances spread into the neighboring tissues, attracting monocytes by chemotaxis [<xref ref-type="bibr" rid="CR200">200</xref>], which subsequently differentiate into macrophages. These macrophages then orchestrate a cascade of processes essential for wound healing [<xref ref-type="bibr" rid="CR201">201</xref>].</p><p id="Par62">EVs have been implicated in facilitating hemostasis during this phase. A study conducted by Hu et al. aimed to evaluate the effectiveness of gelatin sponges loaded with exos derived from human umbilical cord mesenchymal stem cells (hUC-MSCs) in promoting wound healing and stopping bleeding. The coagulation index test demonstrated its ability to promote coagulation. Additionally, the outcomes from full-thickness skin wound healing assays in Sprague&#8211;Dawley (SD) rats revealed improved healing in wounds treated with the exosome-infused gelatin sponges compared to controls. Thus, employing gelatin sponges containing exosomes derived from hUC-MSCs proves to be a safe and effective strategy for promoting hemostasis and accelerating wound healing [<xref ref-type="bibr" rid="CR202">202</xref>]. It should be noted that there is currently limited research on EVs during this period, and researchers may need to invest more in the EV therapy of early-stage injuries.</p></sec><sec id="Sec32"><title>Inflammatory phase</title><p id="Par63">A series of myeloid cells, such as neutrophils, monocytes, and macrophages, play a major role in this period. Initially, neutrophils secrete chemokines that not only recruit cytokines from macrophages but also prompt fibroblasts to migrate to the injured site [<xref ref-type="bibr" rid="CR199">199</xref>]. In particular, macrophages are indispensable in the wound healing continuum, and at the end of this stage, they change from M1 to M2, which has anti-inflammatory properties that promote wound repair [<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR134">134</xref>]. Moreover, the duration of this stage has an impact on the wound-healing effect. long-term inflammation is not conducive to effective wound healing, which may lead to scar hyperplasia, mainly in chronic or burn wounds [<xref ref-type="bibr" rid="CR189">189</xref>, <xref ref-type="bibr" rid="CR203">203</xref>]. Therefore, effectively managing the transition of wounds from the inflammatory stage to the proliferative phase through various strategies is crucial for optimal healing [<xref ref-type="bibr" rid="CR204">204</xref>], which is also the focus of many studies.</p><p id="Par64">To date, EVs have been demonstrated to suppress of T-lymphocyte differentiation, activation, and proliferation, while concomitantly diminishing IFN-&#947; production [<xref ref-type="bibr" rid="CR205">205</xref>]. Besides, they have been found to lower the levels of pro-inflammatory cytokines, including TNF-&#945;, inducible nitric oxide synthase (iNOS), IL-1&#946;, and IL-6 [<xref ref-type="bibr" rid="CR206">206</xref>] and concurrently elevate the synthesis of the immunosuppressive cytokine IL-10 [<xref ref-type="bibr" rid="CR207">207</xref>, <xref ref-type="bibr" rid="CR208">208</xref>]. Additionally, exosomes from adipose mesenchymal stem cells (AMSCs) also have been shown to decrease the production of inflammatory markers such as IL-6, TNF-&#945;, CD14, CD19, and CD68, thus promoting the healing of wounds [<xref ref-type="bibr" rid="CR209">209</xref>]. In addition, MSC-exosomes have the capability to adjust pknox1 protein expression through the transport of miR-223 contained within the exosomes, which triggers the polarization of macrophages to the M2-type, thereby aiding in wound recovery [<xref ref-type="bibr" rid="CR52">52</xref>]. The intradermal injection of exos from menstrual blood-derived MSCs (MenSC-Exos) has also been shown to encourage macrophage transition from the M1 to the M2 phenotype [<xref ref-type="bibr" rid="CR210">210</xref>]. Notably, A marked reduction in M1 macrophages and an increase in M2 type macrophages were observed in two different animal models treated with BMSC-Exos. Moreover, BMSC-Exos stimulated with melatonin (MT-Exos) activated the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B (PTEN/PI3K/AKT) signal transduction pathway, leading to M2 polarization of macrophages, angiogenesis, and collagen formation, which in turn improved wound healing, mitigated persistent inflammation, and supported the progression from the inflammatory stage to the proliferative phase of tissue restoration [<xref ref-type="bibr" rid="CR208">208</xref>]. Hao et al. [<xref ref-type="bibr" rid="CR211">211</xref>] developed a gelatin-alginate hydrogel (GelAlg) integrated with reduced graphene oxide (rGO) and platelet-derived extracellular vesicles (pEVs). In a diabetic rat model, the GelAlg@rGO-pEV hydrogel significantly reduced the expression of inflammatory biomarkers and modulated immune responses thereby accelerating wound healing. Their findings suggested that the GelAlg@rGO-pEV hydrogel has the potential to serve as a novel wound dressing that effectively improves the healing process of diabetic wounds.</p></sec><sec id="Sec33"><title>Proliferative phase</title><p id="Par65">Throughout the proliferative stage, fibroblasts transition into myofibroblasts and synthesize a matrix rich in collagen, contributing to the tensile strength of the wound. Meanwhile, these cells release growth factors that not only stimulate the migration and proliferation of keratinocytes but also inhibit cellular migration via contact inhibition, thereby facilitating re-epithelialization. Additionally, the processes of angiogenesis during this phase ensure an adequate oxygen supply, ensuring essential nutritional support for the proliferation of migrating cells [<xref ref-type="bibr" rid="CR199">199</xref>, <xref ref-type="bibr" rid="CR212">212</xref>, <xref ref-type="bibr" rid="CR213">213</xref>].</p><p id="Par66">Exosomes have been demonstrated to facilitate angiogenesis through the positive modulation of vascular endothelial cell (EC) functions. Furthermore, MSC-exos exert a straightforward influence on the proliferative phase of wound healing, enhancing angiogenesis at the injury locus [<xref ref-type="bibr" rid="CR214">214</xref>]. Exos derived from MSCs pretreated with pioglitazone (PGZ-Exos) have been shown to augment the angiogenic capacity of human umbilical vein endothelial cells (HUVECs) by triggering the PI3K/AKT/ endothelial nitric oxide synthase (eNOS) pathway [<xref ref-type="bibr" rid="CR215">215</xref>]. Shabbir et al. also reported a notable increase in cell proliferation following the administration of exos from mesenchymal stem cells [<xref ref-type="bibr" rid="CR216">216</xref>]. In the context of diabetic wounds receiving treatment with exosomes from human MSCs, there was a notable enhancement in angiogenesis, as well as in the proliferation, migration, and differentiation of fibroblasts, coupled with an improved reduction in fibroblast senescence, decreased scar width, and the formation of larger, more structured collagen deposits [<xref ref-type="bibr" rid="CR217">217</xref>].</p><p id="Par67">Adipose mesenchymal stem cell-exos (AMSC-Exos) can improve the migration and proliferation ability of keratinizing cells by activating the AKT/HIF-1&#945; and Wingless/Integrated (Wnt)/&#946;-catenin signal pathways [<xref ref-type="bibr" rid="CR218">218</xref>, <xref ref-type="bibr" rid="CR219">219</xref>]. This action not only promotes angiogenesis but also contributes to the restoration of skin barrier functions and stimulates the production of large, regularly aligned, and densely distributed neo-collagen [<xref ref-type="bibr" rid="CR209">209</xref>]. In addition, MSC-exos derived from the human umbilical cord Wharton&#8217;s jelly have been observed to modulate the function of human immortalized keratinocytes (HaCaT cells) by preventing the nuclear translocation of apoptosis-inducing factor (AIF) and the hyperactivation of poly(ADP-ribose) polymerase-1 (PARP-1), which contributes to the amelioration of full-thickness skin injury through improved re-epithelialization and angiogenesis [<xref ref-type="bibr" rid="CR220">220</xref>]. Fetal dermal-derived MSC-Exos have also been reported to expedite wound closure in an animal model of full-thickness skin wounds, by boosting fibroblast motility and secretory functions via the activation of the Notch signaling pathway [<xref ref-type="bibr" rid="CR221">221</xref>].</p></sec><sec id="Sec34"><title>Remodeling phase</title><p id="Par68">The remodeling phase, marking the conclusive stage of wound healing, extends over a period ranging from several months to years. This phase is distinguished by the programmed cell death of fibroblasts, myofibroblasts, and additional cellular populations, as well as the breakdown of the extracellular matrix [<xref ref-type="bibr" rid="CR199">199</xref>]. The systematic and sufficient accumulation of collagen is crucial for effective wound healing [<xref ref-type="bibr" rid="CR222">222</xref>]. Enzymes such as MMPs play an irreplaceable role throughout all phases of skin wound healing, with particular significance in the remodeling phase [<xref ref-type="bibr" rid="CR223">223</xref>]. Fibroblasts, epidermal cells, endothelial cells, and macrophages degrade most type III collagen fibers by modulating MMP release [<xref ref-type="bibr" rid="CR224">224</xref>]. Similarly, uncontrolled proliferation of myofibroblasts at the wound site during this stage frequently results in scarring. Therefore, managing the appropriate assembly of fibroblasts is also pivotal for achieving optimal wound healing outcomes.</p><p id="Par69">BMSC-Exos have been evidenced to reinstate typical skin architecture in rats afflicted with full-thickness skin tissue injury models. Human umbilical cord MSC (hucMSC-Exos) also promotes phosphorylation of Yes-associated protein (YAP) in the Hippo pathway, thereby negatively regulating the Wnt4/&#946;-catenin pathway and balancing the relationship between tissue regeneration and repair, and curtailing excessive cellular growth and collagen build-up during the remodeling phase [<xref ref-type="bibr" rid="CR225">225</xref>]. Some studies have revealed that intravenous administration of ADSC-Exos can increase the type-III/type-I collagen ratio and TGF-&#946;3/TGF-&#946;1 ratio, inhibit the differentiation of fibroblasts into myofibroblasts, and lessen scarring at the position of incision [<xref ref-type="bibr" rid="CR226">226</xref>]. These insights collectively highlight the indispensable function of MSC-derived exos in the extracellular matrix remodeling stage of wound repair.</p></sec></sec><sec id="Sec35"><title>Therapeutic effects of engineered EVs for skin defects</title><p id="Par70">Unmodified EVs play a pivotal role in all stages of wound healing, demonstrating significant therapeutic potential through diverse mechanisms such as promoting cell proliferation, angiogenesis, and anti-inflammatory effects. However, their therapeutic efficacy is often limited by issues such as lack of target specificity, rapid clearance in vivo, and inconsistent biological activity. In contrast, engineered EVs offer significant advantages in wound treatment. Through modifications, engineered EVs can achieve targeted delivery to wound sites, prolonged circulation time, and optimized therapeutic outcomes. Additionally, engineered EVs can be tailored to address specific pathological mechanisms, such as chronic inflammation or abnormal scar formation, making them a more versatile and effective tool for advanced wound healing applications. Table <xref rid="Tab3" ref-type="table">3</xref> provides examples of research conducted in this field in recent years.<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table&#160;3</label><caption><p>Research examples about tailored exosomes in the management of skin defects recently</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">References</th><th align="left" colspan="1" rowspan="1">Source of exosomes</th><th align="left" colspan="1" rowspan="1">Engineering methods</th><th align="left" colspan="1" rowspan="1">Disease indication</th><th align="left" colspan="1" rowspan="1">Biological functions</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR285">285</xref>]</td><td align="left" colspan="1" rowspan="1">Rat adipose-derived stem cells</td><td align="left" colspan="1" rowspan="1">Genetic engineering</td><td align="left" colspan="1" rowspan="1">Diabetic wound</td><td align="left" colspan="1" rowspan="1">Promoted the proliferation and migration of fibroblasts, and the angiogenesis of endothelial cells</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR229">229</xref>]</td><td align="left" colspan="1" rowspan="1">Human placenta-derived mesenchymal stem cells</td><td align="left" colspan="1" rowspan="1">Genetic engineering</td><td align="left" colspan="1" rowspan="1">Diabetic wound</td><td align="left" colspan="1" rowspan="1">Anti-inflammatory. Promoted collagen deposition and neovascularization</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR248">248</xref>]</td><td align="left" colspan="1" rowspan="1">Adipose stem cells</td><td align="left" colspan="1" rowspan="1">Genetic engineering</td><td align="left" colspan="1" rowspan="1">Diabetic wound</td><td align="left" colspan="1" rowspan="1">Reduced inflammation and promoted angiogenesis</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR232">232</xref>]</td><td align="left" colspan="1" rowspan="1">Adipose-derived stem cells</td><td align="left" colspan="1" rowspan="1">Hypoxia pretreatment</td><td align="left" colspan="1" rowspan="1">Diabetic wound</td><td align="left" colspan="1" rowspan="1">Increased the migratory, proliferative, and blood vessel regeneration potential of vascular endothelial cells</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR286">286</xref>]</td><td align="left" colspan="1" rowspan="1">Umbilical cord mesenchymal stem cells</td><td align="left" colspan="1" rowspan="1">Blue light irradiation</td><td align="left" colspan="1" rowspan="1">Diabetic wound</td><td align="left" colspan="1" rowspan="1">Reduced the expression of inflammatory factors and apoptosis. Enhanced vascular neogenesis and matrix remodeling</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR239">239</xref>]</td><td align="left" colspan="1" rowspan="1">Bone marrow mesenchymal stem cells</td><td align="left" colspan="1" rowspan="1">Electroporation</td><td align="left" colspan="1" rowspan="1">Normal wound</td><td align="left" colspan="1" rowspan="1">Promoted cell proliferation, collagen deposition, and neovascularization</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR247">247</xref>]</td><td align="left" colspan="1" rowspan="1">Adipose mesenchymal stem cells</td><td align="left" colspan="1" rowspan="1">Genetic engineering</td><td align="left" colspan="1" rowspan="1">UV skin injury</td><td align="left" colspan="1" rowspan="1">Induced M2 type macrophage activation and inhibited inflammatory responses</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR287">287</xref>]</td><td align="left" colspan="1" rowspan="1">Adipose-derived stem cells</td><td align="left" colspan="1" rowspan="1">Genetic engineering</td><td align="left" colspan="1" rowspan="1">Normal wound</td><td align="left" colspan="1" rowspan="1">Promoted collagen formation and angiogenesis</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR246">246</xref>]</td><td align="left" colspan="1" rowspan="1">Mesenchymal stem cells</td><td align="left" colspan="1" rowspan="1">TNF-alpha-treated under hypoxia and encapsulated cationic antimicrobial carbon dots</td><td align="left" colspan="1" rowspan="1">Infected diabetic wound</td><td align="left" colspan="1" rowspan="1">Suppressed oxidative injury and tissue inflammation. Promoted angiogenesis. Eradicated bacterial infection</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR237">237</xref>]</td><td align="left" colspan="1" rowspan="1">Milk-derived</td><td align="left" colspan="1" rowspan="1">Electroporation</td><td align="left" colspan="1" rowspan="1">Diabetic wound</td><td align="left" colspan="1" rowspan="1">Promoted angiogenesis</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR288">288</xref>]</td><td align="left" colspan="1" rowspan="1">Mesenchymal stem cells</td><td align="left" colspan="1" rowspan="1">Selenium stimulation</td><td align="left" colspan="1" rowspan="1">Normal wound</td><td align="left" colspan="1" rowspan="1">Inhibited inflammation and pro-angiogenesis</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR289">289</xref>]</td><td align="left" colspan="1" rowspan="1">Human adipose-derived stem cells</td><td align="left" colspan="1" rowspan="1">Genetic engineering</td><td align="left" colspan="1" rowspan="1">Skin explant</td><td align="left" colspan="1" rowspan="1">Promoted skin epidermal stem cell proliferation</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR290">290</xref>]</td><td align="left" colspan="1" rowspan="1">Human embryonic kidney 293 cells</td><td align="left" colspan="1" rowspan="1">Genetic engineering</td><td align="left" colspan="1" rowspan="1">Diabetic wound</td><td align="left" colspan="1" rowspan="1">Promoted angiogenesis, fibrogenesis, and re-epithelization</td></tr><tr><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR291">291</xref>]</td><td align="left" colspan="1" rowspan="1">Umbilical cord-derived mesenchymal stem cells</td><td align="left" colspan="1" rowspan="1">Hypoxia pretreatment</td><td align="left" colspan="1" rowspan="1">Normal wound</td><td align="left" colspan="1" rowspan="1">Reduced hypoxia-induced cell apoptosis</td></tr></tbody></table></table-wrap></p><sec id="Sec36"><title>Promoting tissue regeneration</title><p id="Par71">Angiogenesis is a critical and far-reaching restorative mechanism in the comprehensive tissue regeneration cascade at the wound location. A deficiency in the genes or proteins essential for this process, like vascular endothelial growth factor (VEGF), could hinder neovascularization, leading to delayed healing of wounds [<xref ref-type="bibr" rid="CR227">227</xref>]. Genetic engineering techniques enable the modification of parental source cells to secrete EVs with enhanced pro-angiogenic properties. For example, targeted genetic modifications can amplify the presence of specific miRNAs and proteins within exosomes. A study by Tao et al. [<xref ref-type="bibr" rid="CR228">228</xref>] illustrated that MSC exosomes with overexpressed miR126-3p can stimulate the proliferation, migration, and angiogenesis of human dermal microvascular endothelial cells. In a recent study [<xref ref-type="bibr" rid="CR229">229</xref>], the investigators utilized phage display to screen for a silk fibronectin-binding peptide (SFBP) and subsequently generated SFBP-Gluc-MS2 (SGM) and pac-miR146a-pac fusion proteins. Engineered exos named SGM-Exos, miR146a-Exos, and SGM-miR146a-Exos were then isolated from genetically modified placental mesenchymal stem cells (PMSCs) expressing SGM, pac-miR146a-pac, or both. Subsequent studies revealed that SGM-miR146a-Exo@SFP exhibited the capacity to enhance wound healing, collagen deposition, and neovascularization.</p><p id="Par72">Additionally, modifications to EV compositions through physical or chemical means can enhance their function in angiogenesis. A study found that blue light treatment increased the expression levels of miR-135b-5p and miR-499a-3p in exos derived from hUC-MSCs, thereby promoting the proliferation, migration, and angiogenesis of HUVECs [<xref ref-type="bibr" rid="CR230">230</xref>]. Wu et al. utilized iron oxide nanoparticles and a magnetic field to stimulate exos from BMSCs. Their research revealed that this activation could enhance angiogenesis by increasing the expression of miR-21-5p, targeting SPRY2 gene, and initiating the PI3K/AKT and ERK1/2 pathways in wound repair [<xref ref-type="bibr" rid="CR231">231</xref>]. In a recent study [<xref ref-type="bibr" rid="CR232">232</xref>], a hypoxic environment was utilized to precondition ADSC-derived exosomes for the delivery of circ-Snhg11. The findings suggest that circ-Snhg11-modified ADSC-exosomes enhanced the migration, proliferation, and vascular regeneration of vascular endothelial cells compared to standard exosomes. Subsequent mechanistic investigations revealed that hypoxia-pretreated ADSC-Exo-embedded gelatin methacryloyl hydrogels (GelMA-HExo) facilitated the delivery of circ-Snhg11, potentially improving cell survival and preserving endothelial cell function through the activation of the miR-144-3p/NFE2L2/HIF-1&#945; signal transduction pathway. This engineered stem cell exosome showed promise for therapeutic applications in enhancing wound healing by modulating angiogenic potential.</p><p id="Par73">EVs, with their unique structure, can afford a protective milieu for biomacromolecules against enzymatic or other biological degradation [<xref ref-type="bibr" rid="CR233">233</xref>&#8211;<xref ref-type="bibr" rid="CR235">235</xref>]. This makes them an effective delivery platform for therapeutic substances that can reach the target cells, eliciting desired biological responses [<xref ref-type="bibr" rid="CR155">155</xref>, <xref ref-type="bibr" rid="CR233">233</xref>]. Shi et al. have developed a clinical-grade exosome product, enriched with TGF-&#946;. Such exosomes could promote cell proliferation and migration, skin organogenesis, and exhibit enhanced healing in a full-thickness ischemic wound model [<xref ref-type="bibr" rid="CR236">236</xref>]. Yan et al. utilized milk-derived exos to transport miR-31-5p mimics for diabetic wound therapy. This delivery system stabilized miR-31-5p from degradation and improved angiogenesis at the wound site, thereby promoting wound recovery [<xref ref-type="bibr" rid="CR237">237</xref>]. Electroporation has been used to prepare engineered exos of with miR-21-5p and has been shown to have a role in promoting the healing of diabetic wounds by promoting collagen deposition, angiogenesis, and re-epithelialization, thereby promoting the healing of diabetic wounds. Additionally, the expression level of CD31 and alpha smooth muscle actin (&#945;-SMA) was increased with exosomes containing miR-21 compared to those without miR-21 [<xref ref-type="bibr" rid="CR238">238</xref>]. In a recent study [<xref ref-type="bibr" rid="CR239">239</xref>], electroporation was employed to encapsulate miRNA-542-3p into BMSCs-Exo. The results demonstrate that miRNA-542-3p-Exos can be uptaken by skin fibroblasts (HSFs) and human dermal microvascular endothelial cells (HMECs), stimulating their functionality and enhancing the proliferation, migration, and vasculogenesis of HSFs/HMECs both in vitro and in vivo. These findings suggest that miRNA-542-3p-Exo holds promise as a therapeutic strategy for enhancing cutaneous wound repair.</p><p id="Par74">Low molecular weight pharmaceuticals can also be loaded into EVs presenting pro-angiogenesis capabilities. Pioglitazone (PZG), a drug commonly used to treat type 2 diabetes mellitus [<xref ref-type="bibr" rid="CR240">240</xref>], was employed in a study by Hu et al. Pioglitazone-pretreated bone marrow MSCs were used to obtain PGZ-Exos. Cellular experiments showed that PGZ-Exos enhanced the survival and proliferative capacity of HUVECs under high glucose injury. Furthermore, PGZ-Exos improved in vitro migration, angiogenesis, wound repair, and VEGF expression of HUVECs. Mechanistic studies demonstrated that PGZ-Exos promoted the expression of p-AKT, p-PI3K, and p-eNOS proteins, and inhibited the expression of PTEN proteins. In vivo investigations employing a diabetic rat wound model revealed that pretreatment with pioglitazone enhanced the therapeutic potency of exos derived from MSCs, facilitating accelerated angiogenesis and diabetic wound closure by promoting collagen synthesis, ECM reconstitution, and upregulation of VEGF and CD31 expression. These findings indicate that this approach offers a promising new cell-free strategy for treating diabetic wounds [<xref ref-type="bibr" rid="CR215">215</xref>].</p><p id="Par75">Metallic nanoparticles have garnered significant attention for their application in defective skin regeneration, attributed to their roles in enhancing wound repair and suppressing harmful bacterial growth [<xref ref-type="bibr" rid="CR241">241</xref>&#8211;<xref ref-type="bibr" rid="CR243">243</xref>]. Li and colleagues investigated the effects of exos from MSCs with iron oxide nanoparticles on the wound healing process. They found that exosomes equipped with iron oxide nanoparticles promoted cellular proliferation, migration, and angiogenesis. Additionally, the application of magnetically directed navigation has been shown to improve their accumulation at the injury site, thereby expediting the wound-healing process [<xref ref-type="bibr" rid="CR244">244</xref>]. Qian et al. employed ultrasound techniques to encapsulate silver nanoparticles (AgNPs) within hUCMSC-exos. The dressing based on Ag-Exo has comprehensive antimicrobial activity, moisturizing, and electrolyte-balancing properties, thus facilitating the repair of contaminated injuries [<xref ref-type="bibr" rid="CR245">245</xref>].</p></sec><sec id="Sec37"><title>Anti-inflammation</title><p id="Par76">As described in previous sections, chronic inflammation significantly hinders the wound-healing cascade, and persistent localized inflammatory responses may lead to abnormal wound repair. Scholars have developed many ways to modify EVs aimed at modulating inflammatory responses, either through alterations in the parental cell culture conditions or by modifying the constituent contents of the EVs.</p><p id="Par77">Sun and colleagues created an engineered exosome by pre-treating the parent cells in a hypoxic environment. The researchers used a two-dimensional reduced covalent organic framework coated with an antimicrobial immuno-engineered exosome to stabilize HIF-1&#945;, resulting in anti-inflammatory M2 macrophage polarization, and exhibit bactericidal activity against Gram<sup>&#8722;</sup>, Gram<sup>+</sup>, and antibiotic-resistant bacteria. This approach enables an effective and holistic integrated treatment for diabetic wound management [<xref ref-type="bibr" rid="CR246">246</xref>]. Lu et al. engineered lentivirus vectors carrying siRNA targeting nuclear factor kappa-B (NF-&#954;B), a crucial gene associated with skin damage, to establish stable cell lines capable of producing abundant siRNA exosomes (si-ADMSC-EXOs) through lentiviral transduction of adipose-derived mesenchymal stem cells (ADMSCs). The following findings showed that si-ADMSC-EXOs effectively suppressed the expression of genes linked to skin damage, promoted the healing of injured skin tissue, and attenuated the production of inflammatory cytokines [<xref ref-type="bibr" rid="CR247">247</xref>]. In a recent study, scientists isolated engineered exosomes derived from adipose stem cells with elevated expression of miR-132 (miR-132-exo). The research illustrated that miR-132-exo notably improved flap viability and expedited the recovery of diabetic wounds by mitigating inflammation, fostering angiogenesis, and inducing M2-type macrophage polarization via the NF-&#954;B pathway. These results propose that miR-132-exo holds potential as a promising therapeutic intervention for managing diabetic wounds and disorders associated with inflammation [<xref ref-type="bibr" rid="CR248">248</xref>].</p><p id="Par78">For drug delivery applications, EVs can optimize the delivery of small molecules by elevating drug concentration in targeted cells and augmenting drug stability throughout circulation in the bloodstream and the healing continuum [<xref ref-type="bibr" rid="CR235">235</xref>, <xref ref-type="bibr" rid="CR249">249</xref>]. Fan et al. recently embedded milk-derived extracellular vesicles containing polydopamine (PDA) into Schiff base cross-linked hydrogels through an extrusion process. The resultant hydrogel, imbued with engineered extracellular vesicles containing antioxidants, manifests potential as a prospective therapeutic strategy for wound repair and regeneration, fostering the proliferation, migration, and anti-inflammatory responses of 3T3 cells via the activation of the PI3K-AKT pathway [<xref ref-type="bibr" rid="CR250">250</xref>]. In addition, Gondaliya et al. introduced miR-155 inhibitors into exos derived from MSCs in diabetic wounds. The combined application of the miR-155 inhibitor and MSC-Exos exhibits a synergistic enhancement in the migration of keratinocytes and anti-inflammatory effects [<xref ref-type="bibr" rid="CR251">251</xref>].</p></sec><sec id="Sec38"><title>Decreasing scar formation</title><p id="Par79">Wound healing is an intricately orchestrated process that transcends the mere restoration of skin integrity. With the progression of human evolution into more sophisticated entities, the capacity for healing via regenerative modalities diminished. Instead, humans have adopted strategies aimed at arresting hemorrhage post-trauma and expediting the closure of acute wounds, albeit at the expense of scar formation [<xref ref-type="bibr" rid="CR252">252</xref>]. Scarring ensues as a consequence of the healing of damaged skin, occasionally accompanied by alterations in skin pigmentation [<xref ref-type="bibr" rid="CR253">253</xref>]. Persistent inflammation and the accumulation of myofibroblasts can culminate in the pathological hypertrophy of scars within the wound site. Such an overproduction of scar tissue may precipitate a fibrotic condition, characterized by the development of proliferative scars and keloid genesis. Hypertrophic scarring (HTS), a fibroproliferative disorder, commonly occurs following full-thickness skin defects or severe burns. It is characterized by the transdifferentiating of fibroblasts into myofibroblasts, which then produce an abundance of &#945;-SMA, collagen type-I, and type-III, facilitated by the TGF-&#946;/Smad3 signal transduction pathway [<xref ref-type="bibr" rid="CR254">254</xref>]. Unlike HTS, which remains confined to the boundaries of the original injury, keloids proliferate beyond the initial wound margins. Therefore, the ultimate aim is to diminish scar formation or to achieve healing without scarring, ensuring the wound heals in a manner that is both functionally and aesthetically satisfactory.</p><p id="Par80">Meng et al. designed an engineered exo encapsulating miR-141-3p, which was derived from adipose mesenchymal stem cells transfected with Lv-miR-141-3p. The study showed that this engineered exosome improved the distribution of fibroblasts and the orientation of collagen fibers, thereby diminishing the thickness of hypertrophic scars [<xref ref-type="bibr" rid="CR255">255</xref>]. Similarly, another study by Yuan et al. showed that exosomes derived from human adipose-derived MSCs with overexpressed miR-29a suppress scar hyperplasia following burn injury by targeting the TGF-&#946;2/Smad3 signaling pathway [<xref ref-type="bibr" rid="CR256">256</xref>]. Furthermore, exosomes derived from mesenchymal stem cells that overexpress TNF-stimulated gene-6 (TSG-6) were found to attenuate inflammatory responses, and decrease scar formation [<xref ref-type="bibr" rid="CR257">257</xref>]. All these results collectively suggest that engineered exosomes can effectively enhance their biological activities, improve the reparative outcomes, and mitigate scar formation.</p></sec></sec></sec><sec id="Sec39"><title>Status and perspectives</title><p id="Par81">A wound is delineated as a tissue trauma that disrupts the skin&#8217;s integrity and continuity, potentially leading to severe complications and even mortality [<xref ref-type="bibr" rid="CR258">258</xref>&#8211;<xref ref-type="bibr" rid="CR260">260</xref>]. Chronic wounds, characterized by failing to proceed through the natural healing process and remaining unhealed for an excess of one month [<xref ref-type="bibr" rid="CR261">261</xref>], notably compromise the quality of life to an extent comparable with cardiac and renal diseases. Moreover, it is worth noting that the mortality rates among patients suffering from chronic wounds are akin to those observed in cancer patients. The etiology of chronic wounds includes aging, obesity, diabetes, sensory neuropathy, autoimmune disorders, and cardiovascular system diseases [<xref ref-type="bibr" rid="CR262">262</xref>, <xref ref-type="bibr" rid="CR263">263</xref>]. By the year of 2025, approximately 1% to 2% of individuals in developed countries experience chronic wounds that remain unhealed, notwithstanding advancements in healthcare [<xref ref-type="bibr" rid="CR264">264</xref>]. This issue presents a significant financial burden, with yearly costs in the United States reaching around $25 billion [<xref ref-type="bibr" rid="CR264">264</xref>].</p><p id="Par82">Meanwhile, the global market for wound dressing products is witnessing expansion [<xref ref-type="bibr" rid="CR265">265</xref>]. According to Verified Market Research, the worldwide wound care market is anticipated to experience a compound annual growth rate (CAGR) of 4.61% from 2023 to 2030 [<xref ref-type="bibr" rid="CR266">266</xref>]. This growth trajectory is primarily attributed to the rising incidence of wound healing complications among patients, which are linked to aging and the prevalence of chronic diseases [<xref ref-type="bibr" rid="CR266">266</xref>]. Furthermore, healthcare systems are under strain due to the spread of COVID-19 and other infectious diseases, which has necessitated a re-evaluation of the existing wound care paradigms [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Several studies have highlighted the risks faced by patients with chronic wounds who are infected with COVID-19, particularly those who are older or have pre-existing metabolic and physiological conditions like chronic obstructive pulmonary disease or renal dysfunction [<xref ref-type="bibr" rid="CR267">267</xref>&#8211;<xref ref-type="bibr" rid="CR269">269</xref>].</p><p id="Par83">Therefore, chronic wounds are a global health challenge. Traditionally, primary care was responsible for wound healing [<xref ref-type="bibr" rid="CR270">270</xref>]. Approximately 2500&#160;years ago, Hippocrates introduced seminal concepts such as pus, a binary classification of wound types, and an early form of surgical intervention aimed at facilitating wound healing. These concepts, despite their simplicity, retain a degree of relevance today and underpin the therapeutic strategies currently employed. With the evolution of specialized wound care practices, there has been an emphasis on rigorous clinical training, research, and evidence-based methodologies to enhance the prognosis of wound healing in patients [<xref ref-type="bibr" rid="CR271">271</xref>]. Regional application of diverse modalities is the principal treatment for dermal injuries due to the substantial exposed region of prolonged ulcers and the detrimental impacts of systemic pharmaceuticals. For example, debridement a critical technique in local wound management, entails the removal of necrotic tissue and foreign materials from the wound bed. Additionally, compression therapy, which encompasses the implementation of graded external pressure via customized dressings or pre-manufactured stratified compression bandage apparatuses, stands as the cornerstone treatment modality for venous leg ulcers [<xref ref-type="bibr" rid="CR272">272</xref>&#8211;<xref ref-type="bibr" rid="CR274">274</xref>].</p><p id="Par84">Notwithstanding progressive improvements in the clinical management of chronic wounds, certain challenges remain intractable, including limited therapeutic efficacy and incongruent residence times [<xref ref-type="bibr" rid="CR275">275</xref>&#8211;<xref ref-type="bibr" rid="CR277">277</xref>]. EV interventions have garnered significant research attention as a substitute for cell therapy, which emerged concurrently with the advancement of nanotechnology. At present, the procedure to obtain high-quality EVs relies on assessing their size, density, and immunoaffinity through various methods, including ultracentrifugation, density gradient centrifugation, size-exclusion chromatography, polymer-based precipitation, microfluidic separation, and immunoaffinity capture. Among them, ultracentrifugation is considered the benchmark, widely adopted by researchers for the separation of EVs. However, an optimal method for extracting EVs that combines high yield, rapid production speed, high product purity, and cost-effectiveness has not yet been established. To compensate for the differences between different techniques, researchers need to use a combination of modalities according to their investigational needs.</p><p id="Par85">The route of administration for isolated EVs can vary, encompassing intravenous, intraperitoneal, or subcutaneous injections, with the selected delivery method substantially impacting their in vivo bio-distribution [<xref ref-type="bibr" rid="CR278">278</xref>]. However, upon entry into the bloodstream, EVs are swiftly cleared from the circulatory system, with a subsequent rapid elimination from blood vessels and distribution into parenchymal organs [<xref ref-type="bibr" rid="CR279">279</xref>]. The plasma half-life is notably brief, ranging merely from 2 to 4&#160;min [<xref ref-type="bibr" rid="CR280">280</xref>]. Additionally, EVs are expeditiously cleared from tissue sites. Enhancing the persistence of EVs at the target location is pivotal for attaining the therapeutic dosage required for efficacy. As previously outlined, the intrinsic limitations of unmodified EVs can be reduced by employing an EV engineering strategy that can moderately enhance efficacy, yield and targeting precision. This provides a foundation for the clinical application of EV-based therapies.</p><p id="Par86">Figure&#160;<xref rid="Fig5" ref-type="fig">5</xref>a shows the trend in the number of publications on the topic of exosomes in wound healing, alongside their geographical dissemination (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>b) up to the year 2023, utilizing data sourced from the Web of Science Core Collection database as of March 28th, 2024. Clearly, there has been a marked escalation in scholarly pursuits on this topic, with the leading sources of publication being mainland China and the United States. The propitious applications of exosomes in regenerative medicine [<xref ref-type="bibr" rid="CR17">17</xref>] have also concurrently prompted a progressive rise in clinical trials involving exosome-based therapeutics [<xref ref-type="bibr" rid="CR281">281</xref>]. The International Society for Extracellular Vesicles (ISEV) documented that the expansive intellectual property domain has incited a considerable influx of both interest and financial support for the clinical translation of the research in this area [<xref ref-type="bibr" rid="CR282">282</xref>]. As of the year 2018, research related to exosomes has secured investments amounting to $250 million (USD) [<xref ref-type="bibr" rid="CR283">283</xref>]. Currently, there are 235 clinical trials related to EV treatment registered on <italic toggle="yes">Clinicaltrials.gov</italic>, covering the treatment and diagnosis of a broad spectrum of pathologies. Table <xref rid="Tab4" ref-type="table">4</xref> presents a summary of clinical trials of EV therapies currently available on <italic toggle="yes">Clinicaltrials.gov</italic> for skin injury as of the time of writing. However, the widespread use of EV products in clinical practice remains uncommon [<xref ref-type="bibr" rid="CR284">284</xref>] and there are no exosome-based therapies that have been approved for the treatment of skin defects in the United States or in China. Only Becaplermin gel (biologic) and two generally effective cellular therapies (Dermagraft and Apligraf; Organogenesis, Massachusetts) are approved by the Food and Drug Administration (FDA) of the U.S. for the treatment of refractory wounds. No other therapies have been approved by the FDA for the marketing applications of non-healing chronic wounds yet [<xref ref-type="bibr" rid="CR261">261</xref>].<fig id="Fig5" position="float" orientation="portrait"><label>Fig.&#160;5</label><caption><p>Worldwide publication overview on exosome research in wound healing. <bold>a</bold> The trajectories in the quantity of scholarly works from 2000 to 2023. <bold>b</bold> Geographic distribution of relative publications. The data was extracted from the Web of Science Core Collection Database on March 28th, 2024. The world map with publication data was created using the website <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mapchart.net">www.mapchart.net</ext-link></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO6" position="float" orientation="portrait" xlink:href="12951_2025_3461_Fig5_HTML.jpg"/></fig><table-wrap id="Tab4" position="float" orientation="portrait"><label>Table&#160;4</label><caption><p>Clinical trials of extracellular vesicle therapies for skin injuries</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Study title</th><th align="left" colspan="1" rowspan="1">NCT number</th><th align="left" colspan="1" rowspan="1">Status</th><th align="left" colspan="1" rowspan="1">Conditions</th><th align="left" colspan="1" rowspan="1">Interventions</th><th align="left" colspan="1" rowspan="1">Study type</th><th align="left" colspan="1" rowspan="1">Phase</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06599346">NCT06599346</ext-link></td><td align="left" colspan="1" rowspan="1">Recruiting</td><td align="left" colspan="1" rowspan="1"><p>Mucositis;</p><p>Hematopoietic Stem Cell Transplantation;</p><p>Chemotherapy-Induced Mucositis;</p><p>Radiation-Induced Mucositis</p></td><td align="left" colspan="1" rowspan="1"><p>Other: Standard Care;</p><p>Biological: MSC Supernatant&#8201;+&#8201;Standard Care</p></td><td align="left" colspan="1" rowspan="1">Interventional</td><td align="left" colspan="1" rowspan="1">Not Applicable</td></tr><tr><td align="left" colspan="1" rowspan="1">Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety &amp; Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06319287">NCT06319287</ext-link></td><td align="left" colspan="1" rowspan="1">Recruiting</td><td align="left" colspan="1" rowspan="1">Diabetic Foot Ulcer</td><td align="left" colspan="1" rowspan="1">Biological: PEP (Purified Exosome Product) / TISSEEL</td><td align="left" colspan="1" rowspan="1">Interventional</td><td align="left" colspan="1" rowspan="1">Phase 2</td></tr><tr><td align="left" colspan="1" rowspan="1">Pilot Study of Human Adipose Tissue Derived Exosomes Promoting Wound Healing</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05475418">NCT05475418</ext-link></td><td align="left" colspan="1" rowspan="1">Completed</td><td align="left" colspan="1" rowspan="1">Wounds and Injuries</td><td align="left" colspan="1" rowspan="1">Procedure: Adipose tissue derived exosomes</td><td align="left" colspan="1" rowspan="1">Interventional</td><td align="left" colspan="1" rowspan="1">Not Applicable</td></tr><tr><td align="left" colspan="1" rowspan="1">PEP on a Skin Graft Donor Site Wound</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04664738">NCT04664738</ext-link></td><td align="left" colspan="1" rowspan="1">Active, not recruiting</td><td align="left" colspan="1" rowspan="1">Skin Graft</td><td align="left" colspan="1" rowspan="1"><p>Biological: 10% PEP;</p><p>Drug: TISSEEL;</p><p>Biological: 20% PEP</p></td><td align="left" colspan="1" rowspan="1">Interventional</td><td align="left" colspan="1" rowspan="1">Phase 1</td></tr><tr><td align="left" colspan="1" rowspan="1">Effect of Plasma Derived Exosomes on Cutaneous Wound Healing</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02565264">NCT02565264</ext-link></td><td align="left" colspan="1" rowspan="1">Unknown status</td><td align="left" colspan="1" rowspan="1">Ulcer</td><td align="left" colspan="1" rowspan="1">Other: plasma-derived exosomes</td><td align="left" colspan="1" rowspan="1">Interventional</td><td align="left" colspan="1" rowspan="1">Early Phase 1</td></tr><tr><td align="left" colspan="1" rowspan="1">Clinical Observation of Exosomes in Patients After Q-switched Laser Surgery</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06279039">NCT06279039</ext-link></td><td align="left" colspan="1" rowspan="1">Recruiting</td><td align="left" colspan="1" rowspan="1"><p>Exosome;</p><p>Skin Regeneration;</p><p>Laser</p></td><td align="left" colspan="1" rowspan="1">Drug: Exosome liquid dressing</td><td align="left" colspan="1" rowspan="1">Interventional</td><td align="left" colspan="1" rowspan="1">Not Applicable</td></tr><tr><td align="left" colspan="1" rowspan="1">Randomized, Controlled, Multicenter Study of Extracellular Vesicles from Human Adipose Tissue Promoting Wound Healing</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT06253975">NCT06253975</ext-link></td><td align="left" colspan="1" rowspan="1">Recruiting</td><td align="left" colspan="1" rowspan="1">Wound Heal</td><td align="left" colspan="1" rowspan="1"><p>Biological: adipose tissue derived extracellular vesicles (AT-EVs);</p><p>Drug: Hyaluronic acid</p></td><td align="left" colspan="1" rowspan="1">Interventional</td><td align="left" colspan="1" rowspan="1">Not Applicable</td></tr><tr><td align="left" colspan="1" rowspan="1">Safety of Extracellular Vesicles for Burn Wounds</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05078385">NCT05078385</ext-link></td><td align="left" colspan="1" rowspan="1">Recruiting</td><td align="left" colspan="1" rowspan="1">Burns</td><td align="left" colspan="1" rowspan="1">Drug: AGLE-102</td><td align="left" colspan="1" rowspan="1">Interventional</td><td align="left" colspan="1" rowspan="1">Phase 1</td></tr><tr><td align="left" colspan="1" rowspan="1">Autologous Serum-derived EV for Venous Trophic Lesions Not Responsive to Conventional Treatments</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04652531">NCT04652531</ext-link></td><td align="left" colspan="1" rowspan="1">Recruiting</td><td align="left" colspan="1" rowspan="1">Ulcer Venous</td><td align="left" colspan="1" rowspan="1">Other: Autologous extracellular vesicles from serum</td><td align="left" colspan="1" rowspan="1">Interventional</td><td align="left" colspan="1" rowspan="1">Not Applicable</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec40"><title>Conclusion</title><p id="Par87">Advancements in nanotechnology are driving innovative developments in the future generation of nanotherapies. EV-based investigations in the past decades have enhanced nanomedicine research by leveraging the diverse and versatile properties of EVs. Engineered EVs offer an innovative approach to improve the limitations associated with the low-scale production, reduced purity, and constrained efficacy observed in the application of traditionally sourced EVs. This objective may be realized through the modification of the cells responsible for EV production and their cultivation conditions, or by directly altering the EVs. Translating the most recent advances and technologies into clinical practice necessitates the dissemination of clinical trial findings, optimization of cost-effectiveness for market viability, and strict adherence to regulatory guidelines. In other words, the primary hurdle in advancing EV-based therapies lies in the transition from laboratory practices to clinically approved methodologies that emphasize safety, high fidelity, and operational effectiveness.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Longwei Cui and Yantao Song contributed equally to this article.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>LC and YS organized and wrote the manuscript, designed and prepared illustrations. ZH guided and edited the manuscript. LY, SG, and CW revised the paper and provided financial support. LC and YS contributed equally to this article. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by National Key Research and Development Program of China&#160;(grant No.&#160;2024YFA1107805), and Project of Liaoning Xingliao Talents Plan (grant No.&#160;XLYC2002103),&#160;and&#160;Joint Project of Science and Technology Plan of Liaoning Province (grant No. 2024-MSLH-5512024), and&#160;the Natural Science Foundation of Liaoning Province (grant No.&#160;2024JH2/102600340), and the Support Program for Excellent Young Scholars of China Medical University.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations.</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par88">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par89">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par90">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mondal</surname><given-names>J</given-names></name><name name-style="western"><surname>Pillarisetti</surname><given-names>S</given-names></name><name name-style="western"><surname>Junnuthula</surname><given-names>V</given-names></name><name name-style="western"><surname>Saha</surname><given-names>M</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>SR</given-names></name><name name-style="western"><surname>Park</surname><given-names>IK</given-names></name><etal/></person-group><article-title>Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications</article-title><source>J Controlled Release.</source><year>2023</year><volume>353</volume><fpage>1127</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2022.12.027</pub-id><pub-id pub-id-type="pmid">36528193</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Mondal J, Pillarisetti S, Junnuthula V, Saha M, Hwang SR, Park IK, et al. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J Controlled Release. 2023;353:1127&#8211;49.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jconrel.2022.12.027</pub-id><pub-id pub-id-type="pmid">36528193</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rayamajhi</surname><given-names>S</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>TDT</given-names></name><name name-style="western"><surname>Marasini</surname><given-names>R</given-names></name><name name-style="western"><surname>Aryal</surname><given-names>S</given-names></name></person-group><article-title>Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery</article-title><source>Acta Biomater</source><year>2019</year><volume>94</volume><fpage>482</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2019.05.054</pub-id><pub-id pub-id-type="pmid">31129363</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Rayamajhi S, Nguyen TDT, Marasini R, Aryal S. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery. Acta Biomater. 2019;94:482&#8211;94.<pub-id pub-id-type="pmid">31129363</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2019.05.054</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Min</surname><given-names>Y</given-names></name><name name-style="western"><surname>Caster</surname><given-names>JM</given-names></name><name name-style="western"><surname>Eblan</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>AZ</given-names></name></person-group><article-title>Clinical translation of nanomedicine</article-title><source>Chem Rev</source><year>2015</year><volume>115</volume><issue>19</issue><fpage>11147</fpage><lpage>11190</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.5b00116</pub-id><pub-id pub-id-type="pmid">26088284</pub-id><pub-id pub-id-type="pmcid">PMC4607605</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Min Y, Caster JM, Eblan MJ, Wang AZ. Clinical translation of nanomedicine. Chem Rev. 2015;115(19):11147&#8211;90.<pub-id pub-id-type="pmid">26088284</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.chemrev.5b00116</pub-id><pub-id pub-id-type="pmcid">PMC4607605</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aqil</surname><given-names>F</given-names></name><name name-style="western"><surname>Kausar</surname><given-names>H</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>AK</given-names></name><name name-style="western"><surname>Jeyabalan</surname><given-names>J</given-names></name><name name-style="western"><surname>Kyakulaga</surname><given-names>AH</given-names></name><name name-style="western"><surname>Munagala</surname><given-names>R</given-names></name><etal/></person-group><article-title>Exosomal formulation enhances therapeutic response of celastrol against lung cancer</article-title><source>Exp Mol Pathol</source><year>2016</year><volume>101</volume><issue>1</issue><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.yexmp.2016.05.013</pub-id><pub-id pub-id-type="pmid">27235383</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Aqil F, Kausar H, Agrawal AK, Jeyabalan J, Kyakulaga AH, Munagala R, et al. Exosomal formulation enhances therapeutic response of celastrol against lung cancer. Exp Mol Pathol. 2016;101(1):12&#8211;21.<pub-id pub-id-type="pmid">27235383</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yexmp.2016.05.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Psaraki</surname><given-names>A</given-names></name><name name-style="western"><surname>Ntari</surname><given-names>L</given-names></name><name name-style="western"><surname>Karakostas</surname><given-names>C</given-names></name><name name-style="western"><surname>Korrou-Karava</surname><given-names>D</given-names></name><name name-style="western"><surname>Roubelakis</surname><given-names>MG</given-names></name></person-group><article-title>Extracellular vesicles derived from mesenchymal stem/stromal cells: The regenerative impact in liver diseases</article-title><source>Hepatol Baltim Md</source><year>2022</year><volume>75</volume><issue>6</issue><fpage>1590</fpage><lpage>1603</lpage><pub-id pub-id-type="doi">10.1002/hep.32129</pub-id><pub-id pub-id-type="pmid">34449901</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Psaraki A, Ntari L, Karakostas C, Korrou-Karava D, Roubelakis MG. Extracellular vesicles derived from mesenchymal stem/stromal cells: The regenerative impact in liver diseases. Hepatol Baltim Md. 2022;75(6):1590&#8211;603.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep.32129</pub-id><pub-id pub-id-type="pmid">34449901</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thakur</surname><given-names>A</given-names></name><name name-style="western"><surname>Parra</surname><given-names>DC</given-names></name><name name-style="western"><surname>Motallebnejad</surname><given-names>P</given-names></name><name name-style="western"><surname>Brocchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HJ</given-names></name></person-group><article-title>Exosomes: small vesicles with big roles in cancer, vaccine development, and therapeutics</article-title><source>Bioact Mater</source><year>2022</year><volume>10</volume><fpage>281</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">34901546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioactmat.2021.08.029</pub-id><pub-id pub-id-type="pmcid">PMC8636666</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Thakur A, Parra DC, Motallebnejad P, Brocchi M, Chen HJ. Exosomes: small vesicles with big roles in cancer, vaccine development, and therapeutics. Bioact Mater. 2022;10:281&#8211;94.<pub-id pub-id-type="pmid">34901546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioactmat.2021.08.029</pub-id><pub-id pub-id-type="pmcid">PMC8636666</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Niel</surname><given-names>G</given-names></name><name name-style="western"><surname>D&#8217;Angelo</surname><given-names>G</given-names></name><name name-style="western"><surname>Raposo</surname><given-names>G</given-names></name></person-group><article-title>Shedding light on the cell biology of extracellular vesicles</article-title><source>Nat Rev Mol Cell Biol</source><year>2018</year><volume>19</volume><issue>4</issue><fpage>213</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.125</pub-id><pub-id pub-id-type="pmid">29339798</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">van Niel G, D&#8217;Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213&#8211;28.<pub-id pub-id-type="pmid">29339798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm.2017.125</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnstone</surname><given-names>RM</given-names></name><name name-style="western"><surname>Adam</surname><given-names>M</given-names></name><name name-style="western"><surname>Hammond</surname><given-names>JR</given-names></name><name name-style="western"><surname>Orr</surname><given-names>L</given-names></name><name name-style="western"><surname>Turbide</surname><given-names>C</given-names></name></person-group><article-title>Vesicle formation during reticulocyte maturation Association of plasma membrane activities with released vesicles (exosomes)</article-title><source>J Biol Chem.</source><year>1987</year><volume>262</volume><issue>19</issue><fpage>9412</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)48095-7</pub-id><pub-id pub-id-type="pmid">3597417</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412&#8211;20.<pub-id pub-id-type="pmid">3597417</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yi</surname><given-names>YW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SY</given-names></name><name name-style="western"><surname>Pack</surname><given-names>CG</given-names></name><name name-style="western"><surname>Ha</surname><given-names>DH</given-names></name><name name-style="western"><surname>Park</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Advances in analysis of biodistribution of exosomes by molecular imaging</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>2</issue><fpage>665</fpage><pub-id pub-id-type="doi">10.3390/ijms21020665</pub-id><pub-id pub-id-type="pmid">31963931</pub-id><pub-id pub-id-type="pmcid">PMC7014306</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Yi YW, Lee JH, Kim SY, Pack CG, Ha DH, Park SR, et al. Advances in analysis of biodistribution of exosomes by molecular imaging. Int J Mol Sci. 2020;21(2):665.<pub-id pub-id-type="pmid">31963931</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21020665</pub-id><pub-id pub-id-type="pmcid">PMC7014306</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X</given-names></name><name name-style="western"><surname>Shao</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Global scientific trends on exosome research during 2007&#8211;2016: a bibliometric analysis</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><issue>29</issue><fpage>48460</fpage><lpage>48470</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.17223</pub-id><pub-id pub-id-type="pmid">28477015</pub-id><pub-id pub-id-type="pmcid">PMC5564662</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Wang Y, Wang Q, Wei X, Shao J, Zhao J, Zhang Z, et al. Global scientific trends on exosome research during 2007&#8211;2016: a bibliometric analysis. Oncotarget. 2017;8(29):48460&#8211;70.<pub-id pub-id-type="pmid">28477015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.17223</pub-id><pub-id pub-id-type="pmcid">PMC5564662</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valadi</surname><given-names>H</given-names></name><name name-style="western"><surname>Ekstr&#246;m</surname><given-names>K</given-names></name><name name-style="western"><surname>Bossios</surname><given-names>A</given-names></name><name name-style="western"><surname>Sj&#246;strand</surname><given-names>M</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JJ</given-names></name><name name-style="western"><surname>L&#246;tvall</surname><given-names>JO</given-names></name></person-group><article-title>Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells</article-title><source>Nat Cell Biol</source><year>2007</year><volume>9</volume><issue>6</issue><fpage>654</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1038/ncb1596</pub-id><pub-id pub-id-type="pmid">17486113</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Valadi H, Ekstr&#246;m K, Bossios A, Sj&#246;strand M, Lee JJ, L&#246;tvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654&#8211;9.<pub-id pub-id-type="pmid">17486113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncb1596</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Timmers</surname><given-names>L</given-names></name><name name-style="western"><surname>Lim</surname><given-names>SK</given-names></name><name name-style="western"><surname>Arslan</surname><given-names>F</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>JS</given-names></name><name name-style="western"><surname>Hoefer</surname><given-names>IE</given-names></name><name name-style="western"><surname>Doevendans</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium</article-title><source>Stem Cell Res</source><year>2007</year><volume>1</volume><issue>2</issue><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.scr.2008.02.002</pub-id><pub-id pub-id-type="pmid">19383393</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 2007;1(2):129&#8211;37.<pub-id pub-id-type="pmid">19383393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scr.2008.02.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chargaff</surname><given-names>E</given-names></name><name name-style="western"><surname>West</surname><given-names>R</given-names></name></person-group><article-title>The biological significance of the thromboplastic protein of blood</article-title><source>J Biol Chem</source><year>1946</year><volume>166</volume><issue>1</issue><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(17)34997-9</pub-id><pub-id pub-id-type="pmid">20273687</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Chargaff E, West R. The biological significance of the thromboplastic protein of blood. J Biol Chem. 1946;166(1):189&#8211;97.<pub-id pub-id-type="pmid">20273687</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>C</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Exosomes and their therapeutic potentials of stem cells</article-title><source>Stem Cells Int</source><year>2016</year><volume>2016</volume><fpage>7653489</fpage><pub-id pub-id-type="doi">10.1155/2016/7653489</pub-id><pub-id pub-id-type="pmid">26770213</pub-id><pub-id pub-id-type="pmcid">PMC4684885</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Han C, Sun X, Liu L, Jiang H, Shen Y, Xu X, et al. Exosomes and their therapeutic potentials of stem cells. Stem Cells Int. 2016;2016:7653489.<pub-id pub-id-type="pmid">26770213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2016/7653489</pub-id><pub-id pub-id-type="pmcid">PMC4684885</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lou</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases</article-title><source>Exp Mol Med</source><year>2017</year><volume>49</volume><issue>6</issue><fpage>e346</fpage><pub-id pub-id-type="doi">10.1038/emm.2017.63</pub-id><pub-id pub-id-type="pmid">28620221</pub-id><pub-id pub-id-type="pmcid">PMC5519012</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49(6):e346.<pub-id pub-id-type="pmid">28620221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/emm.2017.63</pub-id><pub-id pub-id-type="pmcid">PMC5519012</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>BS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JO</given-names></name><name name-style="western"><surname>Ha</surname><given-names>DH</given-names></name><name name-style="western"><surname>Yi</surname><given-names>YW</given-names></name></person-group><article-title>Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis</article-title><source>Stem Cell Res Ther</source><year>2018</year><volume>9</volume><issue>1</issue><fpage>187</fpage><pub-id pub-id-type="doi">10.1186/s13287-018-0939-5</pub-id><pub-id pub-id-type="pmid">29996938</pub-id><pub-id pub-id-type="pmcid">PMC6042362</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Cho BS, Kim JO, Ha DH, Yi YW. Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis. Stem Cell Res Ther. 2018;9(1):187.<pub-id pub-id-type="pmid">29996938</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-018-0939-5</pub-id><pub-id pub-id-type="pmcid">PMC6042362</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phinney</surname><given-names>DG</given-names></name><name name-style="western"><surname>Pittenger</surname><given-names>MF</given-names></name></person-group><article-title>Concise review: MSC-derived exosomes for cell-free therapy</article-title><source>Stem Cells Dayt Ohio</source><year>2017</year><volume>35</volume><issue>4</issue><fpage>851</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1002/stem.2575</pub-id><pub-id pub-id-type="pmid">28294454</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells Dayt Ohio. 2017;35(4):851&#8211;8.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/stem.2575</pub-id><pub-id pub-id-type="pmid">28294454</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name></person-group><article-title>Harnessing exosomes for the development of brain drug delivery systems</article-title><source>Bioconjug Chem</source><year>2019</year><volume>30</volume><issue>4</issue><fpage>994</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1021/acs.bioconjchem.9b00085</pub-id><pub-id pub-id-type="pmid">30855944</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Zheng M, Huang M, Ma X, Chen H, Gao X. Harnessing exosomes for the development of brain drug delivery systems. Bioconjug Chem. 2019;30(4):994&#8211;1005.<pub-id pub-id-type="pmid">30855944</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.bioconjchem.9b00085</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>YL</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>YY</given-names></name><name name-style="western"><surname>Liang</surname><given-names>GF</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YY</given-names></name><name name-style="western"><surname>Hu</surname><given-names>FH</given-names></name><etal/></person-group><article-title>Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery</article-title><source>J Biol Chem</source><year>2014</year><volume>289</volume><issue>32</issue><fpage>22258</fpage><lpage>22267</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.588046</pub-id><pub-id pub-id-type="pmid">24951588</pub-id><pub-id pub-id-type="pmcid">PMC4139237</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH, et al. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. 2014;289(32):22258&#8211;67.<pub-id pub-id-type="pmid">24951588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M114.588046</pub-id><pub-id pub-id-type="pmcid">PMC4139237</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>HC</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H</given-names></name></person-group><article-title>Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway</article-title><source>Biosci Rep.</source><year>2017</year><volume>37</volume><issue>6</issue><fpage>BSR201756</fpage><pub-id pub-id-type="doi">10.1042/BSR20171056</pub-id><pub-id pub-id-type="pmcid">PMC5691142</pub-id><pub-id pub-id-type="pmid">29046370</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Wang XJ, Xiao JJ, Liu L, Jiao HC, Lin H. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway. Biosci Rep. 2017;37(6):BSR201756.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BSR20171056</pub-id><pub-id pub-id-type="pmcid">PMC5691142</pub-id><pub-id pub-id-type="pmid">29046370</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amariglio</surname><given-names>N</given-names></name><name name-style="western"><surname>Hirshberg</surname><given-names>A</given-names></name><name name-style="western"><surname>Scheithauer</surname><given-names>BW</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Loewenthal</surname><given-names>R</given-names></name><name name-style="western"><surname>Trakhtenbrot</surname><given-names>L</given-names></name><etal/></person-group><article-title>Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient</article-title><source>PLoS Med</source><year>2009</year><volume>6</volume><issue>2</issue><fpage>e1000029</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1000029</pub-id><pub-id pub-id-type="pmid">19226183</pub-id><pub-id pub-id-type="pmcid">PMC2642879</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009;6(2):e1000029.<pub-id pub-id-type="pmid">19226183</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pmed.1000029</pub-id><pub-id pub-id-type="pmcid">PMC2642879</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><name name-style="western"><surname>Shi</surname><given-names>H</given-names></name><name name-style="western"><surname>Qian</surname><given-names>H</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name></person-group><article-title>MSC-exosome: A novel cell-free therapy for cutaneous regeneration</article-title><source>Cytotherapy</source><year>2018</year><volume>20</volume><issue>3</issue><fpage>291</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2017.11.002</pub-id><pub-id pub-id-type="pmid">29434006</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Wu P, Zhang B, Shi H, Qian H, Xu W. MSC-exosome: A novel cell-free therapy for cutaneous regeneration. Cytotherapy. 2018;20(3):291&#8211;301.<pub-id pub-id-type="pmid">29434006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcyt.2017.11.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vig</surname><given-names>K</given-names></name><name name-style="western"><surname>Chaudhari</surname><given-names>A</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>S</given-names></name><name name-style="western"><surname>Dixit</surname><given-names>S</given-names></name><name name-style="western"><surname>Sahu</surname><given-names>R</given-names></name><name name-style="western"><surname>Pillai</surname><given-names>S</given-names></name><etal/></person-group><article-title>Advances in skin regeneration using tissue engineering</article-title><source>Int J Mol Sci</source><year>2017</year><volume>18</volume><issue>4</issue><fpage>E789</fpage><pub-id pub-id-type="doi">10.3390/ijms18040789</pub-id><pub-id pub-id-type="pmcid">PMC5412373</pub-id><pub-id pub-id-type="pmid">28387714</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Vig K, Chaudhari A, Tripathi S, Dixit S, Sahu R, Pillai S, et al. Advances in skin regeneration using tissue engineering. Int J Mol Sci. 2017;18(4):E789.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms18040789</pub-id><pub-id pub-id-type="pmcid">PMC5412373</pub-id><pub-id pub-id-type="pmid">28387714</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ooi</surname><given-names>K</given-names></name></person-group><article-title>Protection of the skin barrier function in inflammatory disease</article-title><source>Yakugaku Zasshi</source><year>2019</year><volume>139</volume><issue>12</issue><fpage>1553</fpage><lpage>1556</lpage><pub-id pub-id-type="doi">10.1248/yakushi.19-00181-2</pub-id><pub-id pub-id-type="pmid">31787644</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Ooi K. Protection of the skin barrier function in inflammatory disease. Yakugaku Zasshi. 2019;139(12):1553&#8211;6.<pub-id pub-id-type="pmid">31787644</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1248/yakushi.19-00181-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chambers</surname><given-names>ES</given-names></name><name name-style="western"><surname>Vukmanovic-Stejic</surname><given-names>M</given-names></name></person-group><article-title>Skin barrier immunity and ageing</article-title><source>Immunology</source><year>2020</year><volume>160</volume><issue>2</issue><fpage>116</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1111/imm.13152</pub-id><pub-id pub-id-type="pmid">31709535</pub-id><pub-id pub-id-type="pmcid">PMC7218662</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Chambers ES, Vukmanovic-Stejic M. Skin barrier immunity and ageing. Immunology. 2020;160(2):116&#8211;25.<pub-id pub-id-type="pmid">31709535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/imm.13152</pub-id><pub-id pub-id-type="pmcid">PMC7218662</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tavakoli</surname><given-names>S</given-names></name><name name-style="western"><surname>Klar</surname><given-names>AS</given-names></name></person-group><article-title>Advanced hydrogels as wound dressings</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><issue>8</issue><fpage>E1169</fpage><pub-id pub-id-type="doi">10.3390/biom10081169</pub-id><pub-id pub-id-type="pmcid">PMC7464761</pub-id><pub-id pub-id-type="pmid">32796593</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Tavakoli S, Klar AS. Advanced hydrogels as wound dressings. Biomolecules. 2020;10(8):E1169.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biom10081169</pub-id><pub-id pub-id-type="pmcid">PMC7464761</pub-id><pub-id pub-id-type="pmid">32796593</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>da Silva</surname><given-names>LP</given-names></name><name name-style="western"><surname>Reis</surname><given-names>RL</given-names></name><name name-style="western"><surname>Correlo</surname><given-names>VM</given-names></name><name name-style="western"><surname>Marques</surname><given-names>AP</given-names></name></person-group><article-title>Hydrogel-based strategies to advance therapies for chronic skin wounds</article-title><source>Annu Rev Biomed Eng</source><year>2019</year><volume>4</volume><issue>21</issue><fpage>145</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1146/annurev-bioeng-060418-052422</pub-id><pub-id pub-id-type="pmid">30822099</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">da Silva LP, Reis RL, Correlo VM, Marques AP. Hydrogel-based strategies to advance therapies for chronic skin wounds. Annu Rev Biomed Eng. 2019;4(21):145&#8211;69.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-bioeng-060418-052422</pub-id><pub-id pub-id-type="pmid">30822099</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prachand</surname><given-names>VN</given-names></name><name name-style="western"><surname>Milner</surname><given-names>R</given-names></name><name name-style="western"><surname>Angelos</surname><given-names>P</given-names></name><name name-style="western"><surname>Posner</surname><given-names>MC</given-names></name><name name-style="western"><surname>Fung</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>N</given-names></name><etal/></person-group><article-title>Medically necessary, time-sensitive procedures: scoring system to ethically and efficiently manage resource scarcity and provider risk during the COVID-19 pandemic</article-title><source>J Am Coll Surg</source><year>2020</year><volume>231</volume><issue>2</issue><fpage>281</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2020.04.011</pub-id><pub-id pub-id-type="pmid">32278725</pub-id><pub-id pub-id-type="pmcid">PMC7195575</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Prachand VN, Milner R, Angelos P, Posner MC, Fung JJ, Agrawal N, et al. Medically necessary, time-sensitive procedures: scoring system to ethically and efficiently manage resource scarcity and provider risk during the COVID-19 pandemic. J Am Coll Surg. 2020;231(2):281&#8211;8.<pub-id pub-id-type="pmid">32278725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jamcollsurg.2020.04.011</pub-id><pub-id pub-id-type="pmcid">PMC7195575</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>LC</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>DG</given-names></name><name name-style="western"><surname>Capotorto</surname><given-names>J</given-names></name><name name-style="western"><surname>Fife</surname><given-names>CE</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>JR</given-names></name><name name-style="western"><surname>Gelly</surname><given-names>H</given-names></name><etal/></person-group><article-title>Wound center without walls: the new model of providing care during the COVID-19 pandemic</article-title><source>Wounds Compend Clin Res Pract</source><year>2020</year><volume>32</volume><issue>7</issue><fpage>178</fpage><lpage>185</lpage><pub-id pub-id-type="pmcid">PMC8356413</pub-id><pub-id pub-id-type="pmid">32335520</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Rogers LC, Armstrong DG, Capotorto J, Fife CE, Garcia JR, Gelly H, et al. Wound center without walls: the new model of providing care during the COVID-19 pandemic. Wounds Compend Clin Res Pract. 2020;32(7):178&#8211;85.<pub-id pub-id-type="pmcid">PMC8356413</pub-id><pub-id pub-id-type="pmid">32335520</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>P</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name></person-group><article-title>Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats</article-title><source>Biochem Biophys Res Commun</source><year>2013</year><volume>438</volume><issue>2</issue><fpage>410</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2013.07.088</pub-id><pub-id pub-id-type="pmid">23899518</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Kong P, Xie X, Li F, Liu Y, Lu Y. Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats. Biochem Biophys Res Commun. 2013;438(2):410&#8211;9.<pub-id pub-id-type="pmid">23899518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2013.07.088</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>SC</given-names></name><name name-style="western"><surname>Tao</surname><given-names>SC</given-names></name><name name-style="western"><surname>Yin</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Qi</surname><given-names>X</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>CQ</given-names></name></person-group><article-title>Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model</article-title><source>Theranostics</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>81</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.7150/thno.16803</pub-id><pub-id pub-id-type="pmid">28042318</pub-id><pub-id pub-id-type="pmcid">PMC5196887</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Guo SC, Tao SC, Yin WJ, Qi X, Yuan T, Zhang CQ. Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics. 2017;7(1):81&#8211;96.<pub-id pub-id-type="pmid">28042318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.16803</pub-id><pub-id pub-id-type="pmcid">PMC5196887</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>D</given-names></name><name name-style="western"><surname>Zickler</surname><given-names>AM</given-names></name><name name-style="western"><surname>El Andaloussi</surname><given-names>S</given-names></name></person-group><article-title>Dosing extracellular vesicles</article-title><source>Adv Drug Deliv Rev</source><year>2021</year><volume>178</volume><fpage>113961</fpage><pub-id pub-id-type="doi">10.1016/j.addr.2021.113961</pub-id><pub-id pub-id-type="pmid">34481030</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev. 2021;178:113961.<pub-id pub-id-type="pmid">34481030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addr.2021.113961</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reynolds</surname><given-names>JL</given-names></name><name name-style="western"><surname>Mahajan</surname><given-names>SD</given-names></name></person-group><article-title>Transmigration of tetraspanin 2 (Tspan2) siRNA via microglia derived exosomes across the blood brain barrier modifies the production of immune mediators by microglia cells</article-title><source>J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol</source><year>2020</year><volume>15</volume><issue>3</issue><fpage>554</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1007/s11481-019-09895-6</pub-id><pub-id pub-id-type="pmcid">PMC7282939</pub-id><pub-id pub-id-type="pmid">31823250</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Reynolds JL, Mahajan SD. Transmigration of tetraspanin 2 (Tspan2) siRNA via microglia derived exosomes across the blood brain barrier modifies the production of immune mediators by microglia cells. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol. 2020;15(3):554&#8211;63.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11481-019-09895-6</pub-id><pub-id pub-id-type="pmcid">PMC7282939</pub-id><pub-id pub-id-type="pmid">31823250</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farooqi</surname><given-names>AA</given-names></name><name name-style="western"><surname>Desai</surname><given-names>NN</given-names></name><name name-style="western"><surname>Qureshi</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Librelotto</surname><given-names>DRN</given-names></name><name name-style="western"><surname>Gasparri</surname><given-names>ML</given-names></name><name name-style="western"><surname>Bishayee</surname><given-names>A</given-names></name><etal/></person-group><article-title>Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds</article-title><source>Biotechnol Adv</source><year>2018</year><volume>36</volume><issue>1</issue><fpage>328</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2017.12.010</pub-id><pub-id pub-id-type="pmid">29248680</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Farooqi AA, Desai NN, Qureshi MZ, Librelotto DRN, Gasparri ML, Bishayee A, et al. Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds. Biotechnol Adv. 2018;36(1):328&#8211;34.<pub-id pub-id-type="pmid">29248680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biotechadv.2017.12.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vu</surname><given-names>NB</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>HT</given-names></name><name name-style="western"><surname>Palumbo</surname><given-names>R</given-names></name><name name-style="western"><surname>Pellicano</surname><given-names>R</given-names></name><name name-style="western"><surname>Fagoonee</surname><given-names>S</given-names></name><name name-style="western"><surname>Pham</surname><given-names>PV</given-names></name></person-group><article-title>Stem cell-derived exosomes for wound healing: current status and promising directions</article-title><source>Minerva Med</source><year>2021</year><volume>112</volume><issue>3</issue><fpage>384</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.23736/S0026-4806.20.07205-5</pub-id><pub-id pub-id-type="pmid">33263376</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Vu NB, Nguyen HT, Palumbo R, Pellicano R, Fagoonee S, Pham PV. Stem cell-derived exosomes for wound healing: current status and promising directions. Minerva Med. 2021;112(3):384&#8211;400.<pub-id pub-id-type="pmid">33263376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.23736/S0026-4806.20.07205-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jella</surname><given-names>K</given-names></name><name name-style="western"><surname>Nasti</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Malla</surname><given-names>S</given-names></name><name name-style="western"><surname>Buchwald</surname><given-names>Z</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M</given-names></name></person-group><article-title>Exosomes, their biogenesis and role in inter-cellular communication, tumor microenvironment and cancer immunotherapy</article-title><source>Vaccines</source><year>2018</year><volume>6</volume><issue>4</issue><fpage>69</fpage><pub-id pub-id-type="doi">10.3390/vaccines6040069</pub-id><pub-id pub-id-type="pmid">30261592</pub-id><pub-id pub-id-type="pmcid">PMC6313856</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Jella K, Nasti T, Li Z, Malla S, Buchwald Z, Khan M. Exosomes, their biogenesis and role in inter-cellular communication, tumor microenvironment and cancer immunotherapy. Vaccines. 2018;6(4):69.<pub-id pub-id-type="pmid">30261592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/vaccines6040069</pub-id><pub-id pub-id-type="pmcid">PMC6313856</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalluri</surname><given-names>R</given-names></name><name name-style="western"><surname>LeBleu</surname><given-names>VS</given-names></name></person-group><article-title>The biology, function, and biomedical applications of exosomes</article-title><source>Science.</source><year>2020</year><volume>367</volume><issue>6478</issue><fpage>eaau6977</fpage><pub-id pub-id-type="doi">10.1126/science.aau6977</pub-id><pub-id pub-id-type="pmid">32029601</pub-id><pub-id pub-id-type="pmcid">PMC7717626</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.<pub-id pub-id-type="pmid">32029601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aau6977</pub-id><pub-id pub-id-type="pmcid">PMC7717626</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name><name name-style="western"><surname>Hao</surname><given-names>L</given-names></name><name name-style="western"><surname>Diao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>J</given-names></name></person-group><article-title>Exosomes and autophagy in ocular surface and retinal diseases: new insights into pathophysiology and treatment</article-title><source>Stem Cell Res Ther</source><year>2022</year><volume>13</volume><issue>1</issue><fpage>174</fpage><pub-id pub-id-type="doi">10.1186/s13287-022-02854-8</pub-id><pub-id pub-id-type="pmid">35505403</pub-id><pub-id pub-id-type="pmcid">PMC9066793</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Ma S, Liu X, Yin J, Hao L, Diao Y, Zhong J. Exosomes and autophagy in ocular surface and retinal diseases: new insights into pathophysiology and treatment. Stem Cell Res Ther. 2022;13(1):174.<pub-id pub-id-type="pmid">35505403</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-022-02854-8</pub-id><pub-id pub-id-type="pmcid">PMC9066793</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Tang</surname><given-names>WH</given-names></name></person-group><article-title>Exosomes: biogenesis, biologic function and clinical potential</article-title><source>Cell Biosci</source><year>2019</year><volume>9</volume><issue>1</issue><fpage>19</fpage><pub-id pub-id-type="doi">10.1186/s13578-019-0282-2</pub-id><pub-id pub-id-type="pmid">30815248</pub-id><pub-id pub-id-type="pmcid">PMC6377728</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9(1):19.<pub-id pub-id-type="pmid">30815248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13578-019-0282-2</pub-id><pub-id pub-id-type="pmcid">PMC6377728</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rai</surname><given-names>AK</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>PJ</given-names></name></person-group><article-title>Trichomonas vaginalis extracellular vesicles are internalized by host cells using proteoglycans and caveolin-dependent endocytosis</article-title><source>Proc Natl Acad Sci</source><year>2019</year><volume>116</volume><issue>43</issue><fpage>21354</fpage><lpage>21360</lpage><pub-id pub-id-type="doi">10.1073/pnas.1912356116</pub-id><pub-id pub-id-type="pmid">31601738</pub-id><pub-id pub-id-type="pmcid">PMC6815132</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Rai AK, Johnson PJ. Trichomonas vaginalis extracellular vesicles are internalized by host cells using proteoglycans and caveolin-dependent endocytosis. Proc Natl Acad Sci. 2019;116(43):21354&#8211;60.<pub-id pub-id-type="pmid">31601738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1912356116</pub-id><pub-id pub-id-type="pmcid">PMC6815132</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costa Verdera</surname><given-names>H</given-names></name><name name-style="western"><surname>Gitz-Francois</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Schiffelers</surname><given-names>RM</given-names></name><name name-style="western"><surname>Vader</surname><given-names>P</given-names></name></person-group><article-title>Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis</article-title><source>J Controll Release</source><year>2017</year><volume>266</volume><fpage>100</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2017.09.019</pub-id><pub-id pub-id-type="pmid">28919558</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Costa Verdera H, Gitz-Francois JJ, Schiffelers RM, Vader P. Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis. J Controll Release. 2017;266:100&#8211;8.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jconrel.2017.09.019</pub-id><pub-id pub-id-type="pmid">28919558</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isaac</surname><given-names>R</given-names></name><name name-style="western"><surname>Reis</surname><given-names>FCG</given-names></name><name name-style="western"><surname>Ying</surname><given-names>W</given-names></name><name name-style="western"><surname>Olefsky</surname><given-names>JM</given-names></name></person-group><article-title>Exosomes as mediators of intercellular crosstalk in metabolism</article-title><source>Cell Metab</source><year>2021</year><volume>33</volume><issue>9</issue><fpage>1744</fpage><lpage>1762</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2021.08.006</pub-id><pub-id pub-id-type="pmid">34496230</pub-id><pub-id pub-id-type="pmcid">PMC8428804</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Isaac R, Reis FCG, Ying W, Olefsky JM. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 2021;33(9):1744&#8211;62.<pub-id pub-id-type="pmid">34496230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2021.08.006</pub-id><pub-id pub-id-type="pmcid">PMC8428804</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katzmann</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Babst</surname><given-names>M</given-names></name><name name-style="western"><surname>Emr</surname><given-names>SD</given-names></name></person-group><article-title>Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex</article-title><source>ESCRT-I Cell</source><year>2001</year><volume>106</volume><issue>2</issue><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00434-2</pub-id><pub-id pub-id-type="pmid">11511343</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Katzmann DJ, Babst M, Emr SD. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex. ESCRT-I Cell. 2001;106(2):145&#8211;55.<pub-id pub-id-type="pmid">11511343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0092-8674(01)00434-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hurley</surname><given-names>JH</given-names></name></person-group><article-title>ESCRTs are everywhere</article-title><source>EMBO J</source><year>2015</year><volume>34</volume><issue>19</issue><fpage>2398</fpage><lpage>2407</lpage><pub-id pub-id-type="doi">10.15252/embj.201592484</pub-id><pub-id pub-id-type="pmid">26311197</pub-id><pub-id pub-id-type="pmcid">PMC4601661</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Hurley JH. ESCRTs are everywhere. EMBO J. 2015;34(19):2398&#8211;407.<pub-id pub-id-type="pmid">26311197</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.201592484</pub-id><pub-id pub-id-type="pmcid">PMC4601661</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henne</surname><given-names>WM</given-names></name><name name-style="western"><surname>Buchkovich</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Emr</surname><given-names>SD</given-names></name></person-group><article-title>The ESCRT pathway</article-title><source>Dev Cell</source><year>2011</year><volume>21</volume><issue>1</issue><fpage>77</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.05.015</pub-id><pub-id pub-id-type="pmid">21763610</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Henne WM, Buchkovich NJ, Emr SD. The ESCRT pathway. Dev Cell. 2011;21(1):77&#8211;91.<pub-id pub-id-type="pmid">21763610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.devcel.2011.05.015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>W</given-names></name><name name-style="western"><surname>Lai</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><etal/></person-group><article-title>Exosome release is regulated by mTORC1</article-title><source>Adv Sci</source><year>2019</year><volume>6</volume><issue>3</issue><fpage>1801313</fpage><pub-id pub-id-type="doi">10.1002/advs.201801313</pub-id><pub-id pub-id-type="pmcid">PMC6364500</pub-id><pub-id pub-id-type="pmid">30775228</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Zou W, Lai M, Zhang Y, Zheng L, Xing Z, Li T, et al. Exosome release is regulated by mTORC1. Adv Sci. 2019;6(3):1801313.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.201801313</pub-id><pub-id pub-id-type="pmcid">PMC6364500</pub-id><pub-id pub-id-type="pmid">30775228</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauwers</surname><given-names>E</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Gallardo</surname><given-names>R</given-names></name><name name-style="western"><surname>Van Der Kant</surname><given-names>R</given-names></name><name name-style="western"><surname>Michiels</surname><given-names>E</given-names></name><name name-style="western"><surname>Swerts</surname><given-names>J</given-names></name><etal/></person-group><article-title>Hsp90 mediates membrane deformation and exosome release</article-title><source>Mol Cell</source><year>2018</year><volume>71</volume><issue>5</issue><fpage>689</fpage><lpage>702.e9</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.07.016</pub-id><pub-id pub-id-type="pmid">30193096</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Lauwers E, Wang YC, Gallardo R, Van Der Kant R, Michiels E, Swerts J, et al. Hsp90 mediates membrane deformation and exosome release. Mol Cell. 2018;71(5):689-702.e9.<pub-id pub-id-type="pmid">30193096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2018.07.016</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babst</surname><given-names>M</given-names></name></person-group><article-title>MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between</article-title><source>Curr Opin Cell Biol</source><year>2011</year><volume>23</volume><issue>4</issue><fpage>452</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2011.04.008</pub-id><pub-id pub-id-type="pmid">21570275</pub-id><pub-id pub-id-type="pmcid">PMC3148405</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Babst M. MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between. Curr Opin Cell Biol. 2011;23(4):452&#8211;7.<pub-id pub-id-type="pmid">21570275</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ceb.2011.04.008</pub-id><pub-id pub-id-type="pmcid">PMC3148405</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Jin</surname><given-names>K</given-names></name><name name-style="western"><surname>Gao</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>F</given-names></name><etal/></person-group><article-title>Methods and technologies for exosome isolation and characterization</article-title><source>Small Methods</source><year>2018</year><volume>2</volume><issue>9</issue><fpage>1800021</fpage><pub-id pub-id-type="doi">10.1002/smtd.201800021</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Zhang M, Jin K, Gao L, Zhang Z, Li F, Zhou F, et al. Methods and technologies for exosome isolation and characterization. Small Methods. 2018;2(9):1800021.</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunggulawa</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Yin</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N</given-names></name><name name-style="western"><surname>Durkan</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Recent advancements in the use of exosomes as drug delivery systems</article-title><source>J Nanobiotechnology</source><year>2018</year><volume>16</volume><issue>1</issue><fpage>81</fpage><pub-id pub-id-type="doi">10.1186/s12951-018-0403-9</pub-id><pub-id pub-id-type="pmid">30326899</pub-id><pub-id pub-id-type="pmcid">PMC6190562</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Bunggulawa EJ, Wang W, Yin T, Wang N, Durkan C, Wang Y, et al. Recent advancements in the use of exosomes as drug delivery systems. J Nanobiotechnology. 2018;16(1):81.<pub-id pub-id-type="pmid">30326899</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-018-0403-9</pub-id><pub-id pub-id-type="pmcid">PMC6190562</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Konoshenko</surname><given-names>MYu</given-names></name><name name-style="western"><surname>Lekchnov</surname><given-names>EA</given-names></name><name name-style="western"><surname>Vlassov</surname><given-names>AV</given-names></name><name name-style="western"><surname>Laktionov</surname><given-names>PP</given-names></name></person-group><article-title>Isolation of extracellular vesicles: general methodologies and latest trends</article-title><source>Biomed Res Int</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1155/2018/8545347</pub-id><pub-id pub-id-type="pmcid">PMC5831698</pub-id><pub-id pub-id-type="pmid">29662902</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Konoshenko MYu, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018:1&#8211;27.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2018/8545347</pub-id><pub-id pub-id-type="pmcid">PMC5831698</pub-id><pub-id pub-id-type="pmid">29662902</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Liao</surname><given-names>L</given-names></name><etal/></person-group><article-title>MSC-derived exosome promotes M2 polarization and enhances cutaneous wound healing</article-title><source>Stem Cells Int</source><year>2019</year><volume>9</volume><issue>2019</issue><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/7132708</pub-id><pub-id pub-id-type="pmcid">PMC6754952</pub-id><pub-id pub-id-type="pmid">31582986</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">He X, Dong Z, Cao Y, Wang H, Liu S, Liao L, et al. MSC-derived exosome promotes M2 polarization and enhances cutaneous wound healing. Stem Cells Int. 2019;9(2019):1&#8211;16.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/7132708</pub-id><pub-id pub-id-type="pmcid">PMC6754952</pub-id><pub-id pub-id-type="pmid">31582986</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnstone</surname><given-names>RM</given-names></name><name name-style="western"><surname>Bianchini</surname><given-names>A</given-names></name><name name-style="western"><surname>Teng</surname><given-names>K</given-names></name></person-group><article-title>Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions</article-title><source>Blood</source><year>1989</year><volume>74</volume><issue>5</issue><fpage>1844</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1182/blood.V74.5.1844.1844</pub-id><pub-id pub-id-type="pmid">2790208</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Johnstone RM, Bianchini A, Teng K. Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood. 1989;74(5):1844&#8211;51.<pub-id pub-id-type="pmid">2790208</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Th&#233;ry</surname><given-names>C</given-names></name><name name-style="western"><surname>Amigorena</surname><given-names>S</given-names></name><name name-style="western"><surname>Raposo</surname><given-names>G</given-names></name><name name-style="western"><surname>Clayton</surname><given-names>A</given-names></name></person-group><article-title>Isolation and characterization of exosomes from cell culture supernatants and biological fluids</article-title><source>Curr Protoc Cell Biol.</source><year>2006</year><volume>30</volume><issue>1</issue><fpage>3.22.1</fpage><lpage>3.22.29</lpage><pub-id pub-id-type="doi">10.1002/0471143030.cb0322s30</pub-id><pub-id pub-id-type="pmid">18228490</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Th&#233;ry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;30(1):3.22.1-3.22.29.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/0471143030.cb0322s30</pub-id><pub-id pub-id-type="pmid">18228490</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muller</surname><given-names>L</given-names></name><name name-style="western"><surname>Hong</surname><given-names>CS</given-names></name><name name-style="western"><surname>Stolz</surname><given-names>DB</given-names></name><name name-style="western"><surname>Watkins</surname><given-names>SC</given-names></name><name name-style="western"><surname>Whiteside</surname><given-names>TL</given-names></name></person-group><article-title>Isolation of biologically-active exosomes from human plasma</article-title><source>J Immunol Methods</source><year>2014</year><volume>411</volume><fpage>55</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.jim.2014.06.007</pub-id><pub-id pub-id-type="pmid">24952243</pub-id><pub-id pub-id-type="pmcid">PMC4260336</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL. Isolation of biologically-active exosomes from human plasma. J Immunol Methods. 2014;411:55&#8211;65.<pub-id pub-id-type="pmid">24952243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jim.2014.06.007</pub-id><pub-id pub-id-type="pmcid">PMC4260336</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hiemstra</surname><given-names>TF</given-names></name><name name-style="western"><surname>Charles</surname><given-names>PD</given-names></name><name name-style="western"><surname>Gracia</surname><given-names>T</given-names></name><name name-style="western"><surname>Hester</surname><given-names>SS</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>L</given-names></name><name name-style="western"><surname>Al-Lamki</surname><given-names>R</given-names></name><etal/></person-group><article-title>Human urinary exosomes as innate immune effectors</article-title><source>J Am Soc Nephrol</source><year>2014</year><volume>25</volume><issue>9</issue><fpage>2017</fpage><lpage>2027</lpage><pub-id pub-id-type="doi">10.1681/ASN.2013101066</pub-id><pub-id pub-id-type="pmid">24700864</pub-id><pub-id pub-id-type="pmcid">PMC4147985</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Hiemstra TF, Charles PD, Gracia T, Hester SS, Gatto L, Al-Lamki R, et al. Human urinary exosomes as innate immune effectors. J Am Soc Nephrol. 2014;25(9):2017&#8211;27.<pub-id pub-id-type="pmid">24700864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1681/ASN.2013101066</pub-id><pub-id pub-id-type="pmcid">PMC4147985</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Livshits</surname><given-names>MA</given-names></name><name name-style="western"><surname>Khomyakova</surname><given-names>E</given-names></name><name name-style="western"><surname>Evtushenko</surname><given-names>EG</given-names></name><name name-style="western"><surname>Lazarev</surname><given-names>VN</given-names></name><name name-style="western"><surname>Kulemin</surname><given-names>NA</given-names></name><name name-style="western"><surname>Semina</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Isolation of exosomes by differential centrifugation: theoretical analysis of a commonly used protocol</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><issue>1</issue><fpage>17319</fpage><pub-id pub-id-type="doi">10.1038/srep17319</pub-id><pub-id pub-id-type="pmid">26616523</pub-id><pub-id pub-id-type="pmcid">PMC4663484</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Livshits MA, Khomyakova E, Evtushenko EG, Lazarev VN, Kulemin NA, Semina SE, et al. Isolation of exosomes by differential centrifugation: theoretical analysis of a commonly used protocol. Sci Rep. 2015;5(1):17319.<pub-id pub-id-type="pmid">26616523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep17319</pub-id><pub-id pub-id-type="pmcid">PMC4663484</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langevin</surname><given-names>SM</given-names></name><name name-style="western"><surname>Kuhnell</surname><given-names>D</given-names></name><name name-style="western"><surname>Orr-Asman</surname><given-names>MA</given-names></name><name name-style="western"><surname>Biesiada</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Medvedovic</surname><given-names>M</given-names></name><etal/></person-group><article-title>Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serum</article-title><source>RNA Biol</source><year>2019</year><volume>16</volume><issue>1</issue><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1080/15476286.2018.1564465</pub-id><pub-id pub-id-type="pmid">30604646</pub-id><pub-id pub-id-type="pmcid">PMC6380284</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Langevin SM, Kuhnell D, Orr-Asman MA, Biesiada J, Zhang X, Medvedovic M, et al. Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serum. RNA Biol. 2019;16(1):5&#8211;12.<pub-id pub-id-type="pmid">30604646</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15476286.2018.1564465</pub-id><pub-id pub-id-type="pmcid">PMC6380284</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chia</surname><given-names>BS</given-names></name><name name-style="western"><surname>Low</surname><given-names>YP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Z</given-names></name></person-group><article-title>Advances in exosome quantification techniques</article-title><source>TRAC Trends Anal Chem</source><year>2017</year><volume>86</volume><fpage>93</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.trac.2016.10.012</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Chia BS, Low YP, Wang Q, Li P, Gao Z. Advances in exosome quantification techniques. TRAC Trends Anal Chem. 2017;86:93&#8211;106.</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Kaslan</surname><given-names>M</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Yao</surname><given-names>J</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Z</given-names></name></person-group><article-title>Progress in exosome isolation techniques</article-title><source>Theranostics</source><year>2017</year><volume>7</volume><issue>3</issue><fpage>789</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.7150/thno.18133</pub-id><pub-id pub-id-type="pmid">28255367</pub-id><pub-id pub-id-type="pmcid">PMC5327650</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789&#8211;804.<pub-id pub-id-type="pmid">28255367</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.18133</pub-id><pub-id pub-id-type="pmcid">PMC5327650</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name><name name-style="western"><surname>Ni</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation</article-title><source>Theranostics</source><year>2019</year><volume>9</volume><issue>23</issue><fpage>6901</fpage><lpage>6919</lpage><pub-id pub-id-type="doi">10.7150/thno.37357</pub-id><pub-id pub-id-type="pmid">31660076</pub-id><pub-id pub-id-type="pmcid">PMC6815950</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Zhu J, Liu B, Wang Z, Wang D, Ni H, Zhang L, et al. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. Theranostics. 2019;9(23):6901&#8211;19.<pub-id pub-id-type="pmid">31660076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.37357</pub-id><pub-id pub-id-type="pmcid">PMC6815950</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuldner</surname><given-names>M</given-names></name><name name-style="western"><surname>D&#246;rsam</surname><given-names>B</given-names></name><name name-style="western"><surname>Shatnyeva</surname><given-names>O</given-names></name><name name-style="western"><surname>Reiners</surname><given-names>KS</given-names></name><name name-style="western"><surname>Kubarenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>HP</given-names></name><etal/></person-group><article-title>Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53</article-title><source>Theranostics</source><year>2019</year><volume>9</volume><issue>21</issue><fpage>6047</fpage><lpage>6062</lpage><pub-id pub-id-type="doi">10.7150/thno.36378</pub-id><pub-id pub-id-type="pmid">31534536</pub-id><pub-id pub-id-type="pmcid">PMC6735508</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Schuldner M, D&#246;rsam B, Shatnyeva O, Reiners KS, Kubarenko A, Hansen HP, et al. Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53. Theranostics. 2019;9(21):6047&#8211;62.<pub-id pub-id-type="pmid">31534536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.36378</pub-id><pub-id pub-id-type="pmcid">PMC6735508</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;rez-Gonz&#225;lez</surname><given-names>R</given-names></name><name name-style="western"><surname>Gauthier</surname><given-names>SA</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Saito</surname><given-names>M</given-names></name><name name-style="western"><surname>Saito</surname><given-names>M</given-names></name><name name-style="western"><surname>Levy</surname><given-names>E</given-names></name></person-group><article-title>A method for isolation of extracellular vesicles and characterization of exosomes from brain extracellular space</article-title><source>Methods Mol Biol.</source><year>2017</year><volume>1545</volume><fpage>139</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6728-5_10</pub-id><pub-id pub-id-type="pmid">27943212</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">P&#233;rez-Gonz&#225;lez R, Gauthier SA, Kumar A, Saito M, Saito M, Levy E. A method for isolation of extracellular vesicles and characterization of exosomes from brain extracellular space. Methods Mol Biol. 2017;1545:139&#8211;51.<pub-id pub-id-type="pmid">27943212</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4939-6728-5_10</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Street</surname><given-names>JM</given-names></name><name name-style="western"><surname>Koritzinsky</surname><given-names>EH</given-names></name><name name-style="western"><surname>Glispie</surname><given-names>DM</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>PST</given-names></name></person-group><article-title>Urine exosome isolation and characterization</article-title><source>Methods Mol Biol.</source><year>2017</year><volume>1641</volume><fpage>413</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-7172-5_23</pub-id><pub-id pub-id-type="pmid">28748478</pub-id><pub-id pub-id-type="pmcid">PMC9374111</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Street JM, Koritzinsky EH, Glispie DM, Yuen PST. Urine exosome isolation and characterization. Methods Mol Biol. 2017;1641:413&#8211;23.<pub-id pub-id-type="pmid">28748478</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4939-7172-5_23</pub-id><pub-id pub-id-type="pmcid">PMC9374111</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>BY</given-names></name><name name-style="western"><surname>Sung</surname><given-names>CWH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>CM</given-names></name><name name-style="western"><surname>Lin</surname><given-names>DPC</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Advances in exosomes technology</article-title><source>Clin Chim Acta</source><year>2019</year><volume>493</volume><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2019.02.021</pub-id><pub-id pub-id-type="pmid">30797770</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Chen BY, Sung CWH, Chen C, Cheng CM, Lin DPC, Huang CT, et al. Advances in exosomes technology. Clin Chim Acta. 2019;493:14&#8211;9.<pub-id pub-id-type="pmid">30797770</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cca.2019.02.021</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name></person-group><article-title>A highly efficient method for isolating urinary exosomes</article-title><source>Int J Mol Med</source><year>2018</year><volume>43</volume><issue>1</issue><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">30365060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/ijmm.2018.3944</pub-id><pub-id pub-id-type="pmcid">PMC6257847</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">He L, Zhu D, Wang J, Wu X. A highly efficient method for isolating urinary exosomes. Int J Mol Med. 2018;43(1):83&#8211;90.<pub-id pub-id-type="pmid">30365060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/ijmm.2018.3944</pub-id><pub-id pub-id-type="pmcid">PMC6257847</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>LL</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JX</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>F</given-names></name><name name-style="western"><surname>Ni</surname><given-names>WK</given-names></name><name name-style="western"><surname>Qu</surname><given-names>LS</given-names></name><etal/></person-group><article-title>A comparison of traditional and novel methods for the separation of exosomes from human samples</article-title><source>Biomed Res Int</source><year>2018</year><volume>26</volume><issue>2018</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2018/3634563</pub-id><pub-id pub-id-type="pmcid">PMC6083592</pub-id><pub-id pub-id-type="pmid">30148165</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Yu LL, Zhu J, Liu JX, Jiang F, Ni WK, Qu LS, et al. A comparison of traditional and novel methods for the separation of exosomes from human samples. Biomed Res Int. 2018;26(2018):1&#8211;9.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2018/3634563</pub-id><pub-id pub-id-type="pmcid">PMC6083592</pub-id><pub-id pub-id-type="pmid">30148165</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heinemann</surname><given-names>ML</given-names></name><name name-style="western"><surname>Vykoukal</surname><given-names>J</given-names></name></person-group><article-title>Sequential filtration: a gentle method for the isolation of functional extracellular vesicles</article-title><source>Methods Mol Biol.</source><year>2017</year><volume>1660</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-7253-1_4</pub-id><pub-id pub-id-type="pmid">28828646</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Heinemann ML, Vykoukal J. Sequential filtration: a gentle method for the isolation of functional extracellular vesicles. Methods Mol Biol. 2017;1660:33&#8211;41.<pub-id pub-id-type="pmid">28828646</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4939-7253-1_4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sidhom</surname><given-names>K</given-names></name><name name-style="western"><surname>Obi</surname><given-names>PO</given-names></name><name name-style="western"><surname>Saleem</surname><given-names>A</given-names></name></person-group><article-title>A review of exosomal isolation methods: is size exclusion chromatography the best option?</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>18</issue><fpage>6466</fpage><pub-id pub-id-type="doi">10.3390/ijms21186466</pub-id><pub-id pub-id-type="pmid">32899828</pub-id><pub-id pub-id-type="pmcid">PMC7556044</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Sidhom K, Obi PO, Saleem A. A review of exosomal isolation methods: is size exclusion chromatography the best option? Int J Mol Sci. 2020;21(18):6466.<pub-id pub-id-type="pmid">32899828</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21186466</pub-id><pub-id pub-id-type="pmcid">PMC7556044</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lathe</surname><given-names>GH</given-names></name><name name-style="western"><surname>Ruthven</surname><given-names>CR</given-names></name></person-group><article-title>The separation of substances on the basis of their molecular weights, using columns of starch and water</article-title><source>Biochem J.</source><year>1955</year><volume>60</volume><issue>4</issue><fpage>xxxiv</fpage><pub-id pub-id-type="pmid">13249976</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Lathe GH, Ruthven CR. The separation of substances on the basis of their molecular weights, using columns of starch and water. Biochem J. 1955;60(4):xxxiv.<pub-id pub-id-type="pmid">13249976</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruysschaert</surname><given-names>T</given-names></name><name name-style="western"><surname>Marque</surname><given-names>A</given-names></name><name name-style="western"><surname>Duteyrat</surname><given-names>JL</given-names></name><name name-style="western"><surname>Lesieur</surname><given-names>S</given-names></name><name name-style="western"><surname>Winterhalter</surname><given-names>M</given-names></name><name name-style="western"><surname>Fournier</surname><given-names>D</given-names></name></person-group><article-title>Liposome retention in size exclusion chromatography</article-title><source>BMC Biotechnol</source><year>2005</year><volume>5</volume><issue>1</issue><fpage>11</fpage><pub-id pub-id-type="doi">10.1186/1472-6750-5-11</pub-id><pub-id pub-id-type="pmid">15885140</pub-id><pub-id pub-id-type="pmcid">PMC1142305</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Ruysschaert T, Marque A, Duteyrat JL, Lesieur S, Winterhalter M, Fournier D. Liposome retention in size exclusion chromatography. BMC Biotechnol. 2005;5(1):11.<pub-id pub-id-type="pmid">15885140</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1472-6750-5-11</pub-id><pub-id pub-id-type="pmcid">PMC1142305</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#225;mez-Valero</surname><given-names>A</given-names></name><name name-style="western"><surname>Mongui&#243;-Tortajada</surname><given-names>M</given-names></name><name name-style="western"><surname>Carreras-Planella</surname><given-names>L</given-names></name><name name-style="western"><surname>Franquesa</surname><given-names>M</given-names></name><name name-style="western"><surname>Beyer</surname><given-names>K</given-names></name><name name-style="western"><surname>Borr&#224;s</surname><given-names>FE</given-names></name></person-group><article-title>Size-exclusion chromatography-based isolation minimally alters extracellular vesicles&#8217; characteristics compared to precipitating agents</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><issue>1</issue><fpage>33641</fpage><pub-id pub-id-type="doi">10.1038/srep33641</pub-id><pub-id pub-id-type="pmid">27640641</pub-id><pub-id pub-id-type="pmcid">PMC5027519</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">G&#225;mez-Valero A, Mongui&#243;-Tortajada M, Carreras-Planella L, Franquesa M, Beyer K, Borr&#224;s FE. Size-exclusion chromatography-based isolation minimally alters extracellular vesicles&#8217; characteristics compared to precipitating agents. Sci Rep. 2016;6(1):33641.<pub-id pub-id-type="pmid">27640641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep33641</pub-id><pub-id pub-id-type="pmcid">PMC5027519</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>DD</given-names></name><name name-style="western"><surname>Shah</surname><given-names>S</given-names></name></person-group><article-title>Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes</article-title><source>Methods</source><year>2015</year><volume>87</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2015.02.019</pub-id><pub-id pub-id-type="pmid">25766927</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Taylor DD, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 2015;87:3&#8211;10.<pub-id pub-id-type="pmid">25766927</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymeth.2015.02.019</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><etal/></person-group><article-title>Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics</article-title><source>Theranostics</source><year>2020</year><volume>10</volume><issue>8</issue><fpage>3684</fpage><lpage>3707</lpage><pub-id pub-id-type="doi">10.7150/thno.41580</pub-id><pub-id pub-id-type="pmid">32206116</pub-id><pub-id pub-id-type="pmcid">PMC7069071</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, et al. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684&#8211;707.<pub-id pub-id-type="pmid">32206116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.41580</pub-id><pub-id pub-id-type="pmcid">PMC7069071</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andreu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Y&#225;&#241;ez-M&#243;</surname><given-names>M</given-names></name></person-group><article-title>Tetraspanins in extracellular vesicle formation and function</article-title><source>Front Immunol</source><year>2014</year><volume>16</volume><issue>5</issue><fpage>442</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2014.00442</pub-id><pub-id pub-id-type="pmcid">PMC4165315</pub-id><pub-id pub-id-type="pmid">25278937</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">Andreu Z, Y&#225;&#241;ez-M&#243; M. Tetraspanins in extracellular vesicle formation and function. Front Immunol. 2014;16(5):442.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2014.00442</pub-id><pub-id pub-id-type="pmcid">PMC4165315</pub-id><pub-id pub-id-type="pmid">25278937</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Su</surname><given-names>C</given-names></name></person-group><article-title>Design strategies and application progress of therapeutic exosomes</article-title><source>Theranostics</source><year>2019</year><volume>9</volume><issue>4</issue><fpage>1015</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.7150/thno.30853</pub-id><pub-id pub-id-type="pmid">30867813</pub-id><pub-id pub-id-type="pmcid">PMC6401399</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Liu C, Su C. Design strategies and application progress of therapeutic exosomes. Theranostics. 2019;9(4):1015&#8211;28.<pub-id pub-id-type="pmid">30867813</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.30853</pub-id><pub-id pub-id-type="pmcid">PMC6401399</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sim</surname><given-names>SL</given-names></name><name name-style="western"><surname>He</surname><given-names>T</given-names></name><name name-style="western"><surname>Tscheliessnig</surname><given-names>A</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>M</given-names></name><name name-style="western"><surname>Tan</surname><given-names>RBH</given-names></name><name name-style="western"><surname>Jungbauer</surname><given-names>A</given-names></name></person-group><article-title>Protein precipitation by polyethylene glycol: a generalized model based on hydrodynamic radius</article-title><source>J Biotechnol</source><year>2012</year><volume>157</volume><issue>2</issue><fpage>315</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2011.09.028</pub-id><pub-id pub-id-type="pmid">22001847</pub-id></element-citation><mixed-citation id="mc-CR77" publication-type="journal">Sim SL, He T, Tscheliessnig A, Mueller M, Tan RBH, Jungbauer A. Protein precipitation by polyethylene glycol: a generalized model based on hydrodynamic radius. J Biotechnol. 2012;157(2):315&#8211;9.<pub-id pub-id-type="pmid">22001847</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbiotec.2011.09.028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>T</given-names></name><name name-style="western"><surname>Ferran</surname><given-names>B</given-names></name><name name-style="western"><surname>Tsukahara</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Desai</surname><given-names>S</given-names></name><name name-style="western"><surname>Fedoce</surname><given-names>A</given-names></name><etal/></person-group><article-title>Production of adeno-associated virus vectors for in vitro and in vivo applications</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><issue>1</issue><fpage>13601</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-49624-w</pub-id><pub-id pub-id-type="pmid">31537820</pub-id><pub-id pub-id-type="pmcid">PMC6753157</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Kimura T, Ferran B, Tsukahara Y, Shang Q, Desai S, Fedoce A, et al. Production of adeno-associated virus vectors for in vitro and in vivo applications. Sci Rep. 2019;9(1):13601.<pub-id pub-id-type="pmid">31537820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-49624-w</pub-id><pub-id pub-id-type="pmcid">PMC6753157</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Skog</surname><given-names>J</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>CH</given-names></name><name name-style="western"><surname>Lessard</surname><given-names>RT</given-names></name><name name-style="western"><surname>Balaj</surname><given-names>L</given-names></name><name name-style="western"><surname>Wurdinger</surname><given-names>T</given-names></name><etal/></person-group><article-title>Microfluidic isolation and transcriptome analysis of serum microvesicles</article-title><source>Lab Chip</source><year>2010</year><volume>10</volume><issue>4</issue><fpage>505</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1039/B916199F</pub-id><pub-id pub-id-type="pmid">20126692</pub-id><pub-id pub-id-type="pmcid">PMC3136803</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">Chen C, Skog J, Hsu CH, Lessard RT, Balaj L, Wurdinger T, et al. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip. 2010;10(4):505&#8211;11.<pub-id pub-id-type="pmid">20126692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/b916199f</pub-id><pub-id pub-id-type="pmcid">PMC3136803</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gholizadeh</surname><given-names>S</given-names></name><name name-style="western"><surname>Shehata Draz</surname><given-names>M</given-names></name><name name-style="western"><surname>Zarghooni</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanati-Nezhad</surname><given-names>A</given-names></name><name name-style="western"><surname>Ghavami</surname><given-names>S</given-names></name><name name-style="western"><surname>Shafiee</surname><given-names>H</given-names></name><etal/></person-group><article-title>Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: current status and future directions</article-title><source>Biosens Bioelectron</source><year>2017</year><volume>91</volume><fpage>588</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1016/j.bios.2016.12.062</pub-id><pub-id pub-id-type="pmid">28088752</pub-id><pub-id pub-id-type="pmcid">PMC5323331</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Gholizadeh S, Shehata Draz M, Zarghooni M, Sanati-Nezhad A, Ghavami S, Shafiee H, et al. Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: current status and future directions. Biosens Bioelectron. 2017;91:588&#8211;605.<pub-id pub-id-type="pmid">28088752</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2016.12.062</pub-id><pub-id pub-id-type="pmcid">PMC5323331</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jackson</surname><given-names>EL</given-names></name><name name-style="western"><surname>Lu</surname><given-names>H</given-names></name></person-group><article-title>Advances in microfluidic cell separation and manipulation</article-title><source>Curr Opin Chem Eng</source><year>2013</year><volume>2</volume><issue>4</issue><fpage>398</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/j.coche.2013.10.001</pub-id><pub-id pub-id-type="pmid">24701393</pub-id><pub-id pub-id-type="pmcid">PMC3970816</pub-id></element-citation><mixed-citation id="mc-CR81" publication-type="journal">Jackson EL, Lu H. Advances in microfluidic cell separation and manipulation. Curr Opin Chem Eng. 2013;2(4):398&#8211;404.<pub-id pub-id-type="pmid">24701393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.coche.2013.10.001</pub-id><pub-id pub-id-type="pmcid">PMC3970816</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joo</surname><given-names>HS</given-names></name><name name-style="western"><surname>Suh</surname><given-names>JH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Bang</surname><given-names>ES</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JM</given-names></name></person-group><article-title>current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>3</issue><fpage>727</fpage><pub-id pub-id-type="doi">10.3390/ijms21030727</pub-id><pub-id pub-id-type="pmid">31979113</pub-id><pub-id pub-id-type="pmcid">PMC7036914</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Joo HS, Suh JH, Lee HJ, Bang ES, Lee JM. current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent. Int J Mol Sci. 2020;21(3):727.<pub-id pub-id-type="pmid">31979113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21030727</pub-id><pub-id pub-id-type="pmcid">PMC7036914</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gan</surname><given-names>L</given-names></name><etal/></person-group><article-title>Exosomes as drug carriers for clinical application</article-title><source>Artif Cells Nanomed Biotechnol</source><year>2018</year><volume>46</volume><issue>sup3</issue><fpage>564</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1080/21691401.2018.1501381</pub-id><pub-id pub-id-type="pmid">30431368</pub-id></element-citation><mixed-citation id="mc-CR83" publication-type="journal">Di C, Zhang Q, Wang Y, Wang F, Chen Y, Gan L, et al. Exosomes as drug carriers for clinical application. Artif Cells Nanomed Biotechnol. 2018;46(sup3):564&#8211;70.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21691401.2018.1501381</pub-id><pub-id pub-id-type="pmid">30431368</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ha</surname><given-names>D</given-names></name><name name-style="western"><surname>Yang</surname><given-names>N</given-names></name><name name-style="western"><surname>Nadithe</surname><given-names>V</given-names></name></person-group><article-title>Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges</article-title><source>Acta Pharm Sin B</source><year>2016</year><volume>6</volume><issue>4</issue><fpage>287</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2016.02.001</pub-id><pub-id pub-id-type="pmid">27471669</pub-id><pub-id pub-id-type="pmcid">PMC4951582</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016;6(4):287&#8211;96.<pub-id pub-id-type="pmid">27471669</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.apsb.2016.02.001</pub-id><pub-id pub-id-type="pmcid">PMC4951582</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>JR</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>GQ</given-names></name><name name-style="western"><surname>Santos</surname><given-names>SG</given-names></name><name name-style="western"><surname>Barbosa</surname><given-names>MA</given-names></name><name name-style="western"><surname>Almeida-Porada</surname><given-names>G</given-names></name><name name-style="western"><surname>Gon&#231;alves</surname><given-names>RM</given-names></name></person-group><article-title>Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning</article-title><source>Front Immunol</source><year>2018</year><volume>9</volume><fpage>2837</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.02837</pub-id><pub-id pub-id-type="pmid">30564236</pub-id><pub-id pub-id-type="pmcid">PMC6288292</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Ferreira JR, Teixeira GQ, Santos SG, Barbosa MA, Almeida-Porada G, Gon&#231;alves RM. Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Front Immunol. 2018;9:2837.<pub-id pub-id-type="pmid">30564236</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2018.02837</pub-id><pub-id pub-id-type="pmcid">PMC6288292</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>PD</given-names></name><name name-style="western"><surname>Burt</surname><given-names>AM</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>JN</given-names></name></person-group><article-title>Critical effect of oxygen tension on rate of growth of animal cells in continuous suspended culture</article-title><source>Nature</source><year>1958</year><volume>182</volume><issue>4648</issue><fpage>1508</fpage><lpage>1509</lpage><pub-id pub-id-type="doi">10.1038/1821508b0</pub-id><pub-id pub-id-type="pmid">13613312</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Cooper PD, Burt AM, Wilson JN. Critical effect of oxygen tension on rate of growth of animal cells in continuous suspended culture. Nature. 1958;182(4648):1508&#8211;9.<pub-id pub-id-type="pmid">13613312</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/1821508b0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorgun</surname><given-names>C</given-names></name><name name-style="western"><surname>Ceresa</surname><given-names>D</given-names></name><name name-style="western"><surname>Lesage</surname><given-names>R</given-names></name><name name-style="western"><surname>Villa</surname><given-names>F</given-names></name><name name-style="western"><surname>Reverberi</surname><given-names>D</given-names></name><name name-style="western"><surname>Balbi</surname><given-names>C</given-names></name><etal/></person-group><article-title>Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs)</article-title><source>Biomaterials</source><year>2021</year><volume>269</volume><fpage>120633</fpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.120633</pub-id><pub-id pub-id-type="pmid">33453634</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Gorgun C, Ceresa D, Lesage R, Villa F, Reverberi D, Balbi C, et al. Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs). Biomaterials. 2021;269:120633.<pub-id pub-id-type="pmid">33453634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2020.120633</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Estrada</surname><given-names>JC</given-names></name><name name-style="western"><surname>Albo</surname><given-names>C</given-names></name><name name-style="western"><surname>Bengur&#237;a</surname><given-names>A</given-names></name><name name-style="western"><surname>Dopazo</surname><given-names>A</given-names></name><name name-style="western"><surname>L&#243;pez-Romero</surname><given-names>P</given-names></name><name name-style="western"><surname>Carrera-Quintanar</surname><given-names>L</given-names></name><etal/></person-group><article-title>Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis</article-title><source>Cell Death Differ</source><year>2012</year><volume>19</volume><issue>5</issue><fpage>743</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.172</pub-id><pub-id pub-id-type="pmid">22139129</pub-id><pub-id pub-id-type="pmcid">PMC3321628</pub-id></element-citation><mixed-citation id="mc-CR88" publication-type="journal">Estrada JC, Albo C, Bengur&#237;a A, Dopazo A, L&#243;pez-Romero P, Carrera-Quintanar L, et al. Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ. 2012;19(5):743&#8211;55.<pub-id pub-id-type="pmid">22139129</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cdd.2011.172</pub-id><pub-id pub-id-type="pmcid">PMC3321628</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andalib</surname><given-names>E</given-names></name><name name-style="western"><surname>Kashfi</surname><given-names>M</given-names></name><name name-style="western"><surname>Mahmoudvand</surname><given-names>G</given-names></name><name name-style="western"><surname>Rezaei</surname><given-names>E</given-names></name><name name-style="western"><surname>Mahjoor</surname><given-names>M</given-names></name><name name-style="western"><surname>Torki</surname><given-names>A</given-names></name><etal/></person-group><article-title>Application of hypoxia-mesenchymal stem cells in treatment of anaerobic bacterial wound infection: wound healing and infection recovery</article-title><source>Front Microbiol</source><year>2023</year><volume>5</volume><fpage>14</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2023.1251956</pub-id><pub-id pub-id-type="pmcid">PMC10586055</pub-id><pub-id pub-id-type="pmid">37869672</pub-id></element-citation><mixed-citation id="mc-CR89" publication-type="journal">Andalib E, Kashfi M, Mahmoudvand G, Rezaei E, Mahjoor M, Torki A, et al. Application of hypoxia-mesenchymal stem cells in treatment of anaerobic bacterial wound infection: wound healing and infection recovery. Front Microbiol. 2023;5:14.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2023.1251956</pub-id><pub-id pub-id-type="pmcid">PMC10586055</pub-id><pub-id pub-id-type="pmid">37869672</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tian</surname><given-names>M</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><etal/></person-group><article-title>Hypoxia signaling in human health and diseases: implications and prospects for therapeutics</article-title><source>Signal Transduct Target Ther</source><year>2022</year><volume>7</volume><issue>1</issue><fpage>218</fpage><pub-id pub-id-type="doi">10.1038/s41392-022-01080-1</pub-id><pub-id pub-id-type="pmid">35798726</pub-id><pub-id pub-id-type="pmcid">PMC9261907</pub-id></element-citation><mixed-citation id="mc-CR90" publication-type="journal">Luo Z, Tian M, Yang G, Tan Q, Chen Y, Li G, et al. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduct Target Ther. 2022;7(1):218.<pub-id pub-id-type="pmid">35798726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-022-01080-1</pub-id><pub-id pub-id-type="pmcid">PMC9261907</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palom&#228;ki</surname><given-names>S</given-names></name><name name-style="western"><surname>Pietil&#228;</surname><given-names>M</given-names></name><name name-style="western"><surname>Laitinen</surname><given-names>S</given-names></name><name name-style="western"><surname>Pes&#228;l&#228;</surname><given-names>J</given-names></name><name name-style="western"><surname>Sormunen</surname><given-names>R</given-names></name><name name-style="western"><surname>Lehenkari</surname><given-names>P</given-names></name><etal/></person-group><article-title>HIF-1&#945; is upregulated in human mesenchymal stem cells</article-title><source>Stem Cells Dayt Ohio</source><year>2013</year><volume>31</volume><issue>9</issue><fpage>1902</fpage><lpage>1909</lpage><pub-id pub-id-type="doi">10.1002/stem.1435</pub-id><pub-id pub-id-type="pmid">23744828</pub-id></element-citation><mixed-citation id="mc-CR91" publication-type="journal">Palom&#228;ki S, Pietil&#228; M, Laitinen S, Pes&#228;l&#228; J, Sormunen R, Lehenkari P, et al. HIF-1&#945; is upregulated in human mesenchymal stem cells. Stem Cells Dayt Ohio. 2013;31(9):1902&#8211;9.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/stem.1435</pub-id><pub-id pub-id-type="pmid">23744828</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cao</surname><given-names>J</given-names></name><etal/></person-group><article-title>Hypoxia-stimulated mesenchymal stem cell-derived exosomes loaded by adhesive hydrogel for effective angiogenic treatment of spinal cord injury</article-title><source>Biomater Sci</source><year>2022</year><volume>10</volume><issue>7</issue><fpage>1803</fpage><lpage>1811</lpage><pub-id pub-id-type="doi">10.1039/D1BM01722E</pub-id><pub-id pub-id-type="pmid">35234220</pub-id></element-citation><mixed-citation id="mc-CR92" publication-type="journal">Mu J, Li L, Wu J, Huang T, Zhang Y, Cao J, et al. Hypoxia-stimulated mesenchymal stem cell-derived exosomes loaded by adhesive hydrogel for effective angiogenic treatment of spinal cord injury. Biomater Sci. 2022;10(7):1803&#8211;11.<pub-id pub-id-type="pmid">35234220</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d1bm01722e</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Gao</surname><given-names>C</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><name name-style="western"><surname>Ren</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Conductive hydrogels as an &#8216;innovative healer&#8217; for the treatment of diabetic wounds</article-title><source>Mater Chem Front</source><year>2024</year><volume>8</volume><issue>18</issue><fpage>2944</fpage><lpage>2977</lpage><pub-id pub-id-type="doi">10.1039/D4QM00405A</pub-id></element-citation><mixed-citation id="mc-CR93" publication-type="journal">Zhao J, Gao C, Guo W, Zhang B, Ren S, Wu S, et al. Conductive hydrogels as an &#8216;innovative healer&#8217; for the treatment of diabetic wounds. Mater Chem Front. 2024;8(18):2944&#8211;77.</mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peltzer</surname><given-names>J</given-names></name><name name-style="western"><surname>Lund</surname><given-names>K</given-names></name><name name-style="western"><surname>Goriot</surname><given-names>ME</given-names></name><name name-style="western"><surname>Grosbot</surname><given-names>M</given-names></name><name name-style="western"><surname>Lataillade</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Mauduit</surname><given-names>P</given-names></name><etal/></person-group><article-title>Interferon-&#947; and hypoxia priming have limited effect on the miRNA landscape of human mesenchymal stromal cells-derived extracellular vesicles</article-title><source>Front Cell Dev Biol</source><year>2020</year><volume>8</volume><fpage>581436</fpage><pub-id pub-id-type="doi">10.3389/fcell.2020.581436</pub-id><pub-id pub-id-type="pmid">33384991</pub-id><pub-id pub-id-type="pmcid">PMC7769832</pub-id></element-citation><mixed-citation id="mc-CR94" publication-type="journal">Peltzer J, Lund K, Goriot ME, Grosbot M, Lataillade JJ, Mauduit P, et al. Interferon-&#947; and hypoxia priming have limited effect on the miRNA landscape of human mesenchymal stromal cells-derived extracellular vesicles. Front Cell Dev Biol. 2020;8:581436.<pub-id pub-id-type="pmid">33384991</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcell.2020.581436</pub-id><pub-id pub-id-type="pmcid">PMC7769832</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>BM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CS</given-names></name></person-group><article-title>Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues</article-title><source>J Cell Sci.</source><year>2012</year><volume>125</volume><issue>Pt 13</issue><fpage>jcs.79509</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/jcs.079509</pub-id><pub-id pub-id-type="pmcid">PMC3434846</pub-id><pub-id pub-id-type="pmid">22797912</pub-id></element-citation><mixed-citation id="mc-CR95" publication-type="journal">Baker BM, Chen CS. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012;125(Pt 13):jcs.79509.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/jcs.079509</pub-id><pub-id pub-id-type="pmcid">PMC3434846</pub-id><pub-id pub-id-type="pmid">22797912</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lechanteur</surname><given-names>C</given-names></name><name name-style="western"><surname>Briquet</surname><given-names>A</given-names></name><name name-style="western"><surname>Giet</surname><given-names>O</given-names></name><name name-style="western"><surname>Delloye</surname><given-names>O</given-names></name><name name-style="western"><surname>Baudoux</surname><given-names>E</given-names></name><name name-style="western"><surname>Beguin</surname><given-names>Y</given-names></name></person-group><article-title>Clinical-scale expansion of mesenchymal stromal cells: a large banking experience</article-title><source>J Transl Med</source><year>2016</year><volume>14</volume><issue>1</issue><fpage>145</fpage><pub-id pub-id-type="doi">10.1186/s12967-016-0892-y</pub-id><pub-id pub-id-type="pmid">27207011</pub-id><pub-id pub-id-type="pmcid">PMC4875672</pub-id></element-citation><mixed-citation id="mc-CR96" publication-type="journal">Lechanteur C, Briquet A, Giet O, Delloye O, Baudoux E, Beguin Y. Clinical-scale expansion of mesenchymal stromal cells: a large banking experience. J Transl Med. 2016;14(1):145.<pub-id pub-id-type="pmid">27207011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-016-0892-y</pub-id><pub-id pub-id-type="pmcid">PMC4875672</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rafiq</surname><given-names>QA</given-names></name><name name-style="western"><surname>Coopman</surname><given-names>K</given-names></name><name name-style="western"><surname>Nienow</surname><given-names>AW</given-names></name><name name-style="western"><surname>Hewitt</surname><given-names>CJ</given-names></name></person-group><article-title>Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors</article-title><source>Biotechnol J</source><year>2016</year><volume>11</volume><issue>4</issue><fpage>473</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1002/biot.201400862</pub-id><pub-id pub-id-type="pmid">26632496</pub-id><pub-id pub-id-type="pmcid">PMC4991290</pub-id></element-citation><mixed-citation id="mc-CR97" publication-type="journal">Rafiq QA, Coopman K, Nienow AW, Hewitt CJ. Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors. Biotechnol J. 2016;11(4):473&#8211;86.<pub-id pub-id-type="pmid">26632496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/biot.201400862</pub-id><pub-id pub-id-type="pmcid">PMC4991290</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baraniak</surname><given-names>PR</given-names></name><name name-style="western"><surname>McDevitt</surname><given-names>TC</given-names></name></person-group><article-title>Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential</article-title><source>Cell Tissue Res</source><year>2012</year><volume>347</volume><issue>3</issue><fpage>701</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1007/s00441-011-1215-5</pub-id><pub-id pub-id-type="pmid">21833761</pub-id><pub-id pub-id-type="pmcid">PMC4149251</pub-id></element-citation><mixed-citation id="mc-CR98" publication-type="journal">Baraniak PR, McDevitt TC. Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential. Cell Tissue Res. 2012;347(3):701&#8211;11.<pub-id pub-id-type="pmid">21833761</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00441-011-1215-5</pub-id><pub-id pub-id-type="pmcid">PMC4149251</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>N</given-names></name><name name-style="western"><surname>Gao</surname><given-names>PL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name></person-group><article-title>Fibrous scaffolds potentiate the paracrine function of mesenchymal stem cells: a new dimension in cell-material interaction</article-title><source>Biomaterials</source><year>2017</year><volume>141</volume><fpage>74</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.06.028</pub-id><pub-id pub-id-type="pmid">28667901</pub-id></element-citation><mixed-citation id="mc-CR99" publication-type="journal">Su N, Gao PL, Wang K, Wang JY, Zhong Y, Luo Y. Fibrous scaffolds potentiate the paracrine function of mesenchymal stem cells: a new dimension in cell-material interaction. Biomaterials. 2017;141:74&#8211;85.<pub-id pub-id-type="pmid">28667901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2017.06.028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>IK</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>N</given-names></name><name name-style="western"><surname>Borrelli</surname><given-names>DA</given-names></name><name name-style="western"><surname>Patel</surname><given-names>T</given-names></name></person-group><article-title>Use of a&#160;hollow fiber bioreactor to collect extracellular vesicles from cells in culture</article-title><source>Methods Mol Biol.</source><year>2018</year><volume>1740</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-7652-2_4</pub-id><pub-id pub-id-type="pmid">29388134</pub-id></element-citation><mixed-citation id="mc-CR100" publication-type="journal">Yan IK, Shukla N, Borrelli DA, Patel T. Use of a&#160;hollow fiber bioreactor to collect extracellular vesicles from cells in culture. Methods Mol Biol. 2018;1740:35&#8211;41.<pub-id pub-id-type="pmid">29388134</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4939-7652-2_4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanley</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Mei</surname><given-names>Z</given-names></name><name name-style="western"><surname>Durett</surname><given-names>AG</given-names></name><name name-style="western"><surname>Da Graca</surname><given-names>C-H</given-names></name><name name-style="western"><surname>Klis</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><etal/></person-group><article-title>Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the quantum cell expansion system</article-title><source>Cytotherapy</source><year>2014</year><volume>16</volume><issue>8</issue><fpage>1048</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2014.01.417</pub-id><pub-id pub-id-type="pmid">24726657</pub-id><pub-id pub-id-type="pmcid">PMC4087082</pub-id></element-citation><mixed-citation id="mc-CR101" publication-type="journal">Hanley PJ, Mei Z, Durett AG, Da Graca C-H, Klis M, Li W, et al. Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the quantum cell expansion system. Cytotherapy. 2014;16(8):1048&#8211;58.<pub-id pub-id-type="pmid">24726657</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcyt.2014.01.417</pub-id><pub-id pub-id-type="pmcid">PMC4087082</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Mori</surname><given-names>T</given-names></name><name name-style="western"><surname>Mahnen</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Everson</surname><given-names>HR</given-names></name><name name-style="western"><surname>Leslie</surname><given-names>MT</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Effects of structural variations on the cellular response and mechanical properties of biocompatible, biodegradable, and porous smectic liquid crystal elastomers</article-title><source>Macromol Biosci.</source><year>2017</year><pub-id pub-id-type="doi">10.1002/mabi.201600278</pub-id><pub-id pub-id-type="pmid">27805765</pub-id></element-citation><mixed-citation id="mc-CR102" publication-type="journal">Sharma A, Mori T, Mahnen CJ, Everson HR, Leslie MT, Nielsen AD, et al. Effects of structural variations on the cellular response and mechanical properties of biocompatible, biodegradable, and porous smectic liquid crystal elastomers. Macromol Biosci. 2017. 10.1002/mabi.201600278.<pub-id pub-id-type="pmid">27805765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mabi.201600278</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo</surname><given-names>YP</given-names></name><name name-style="western"><surname>Liu</surname><given-names>YS</given-names></name><name name-style="western"><surname>Rimando</surname><given-names>MG</given-names></name><name name-style="western"><surname>Ho</surname><given-names>JHC</given-names></name><name name-style="western"><surname>Lin</surname><given-names>KH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>OK</given-names></name></person-group><article-title>Three-dimensional spherical spatial boundary conditions differentially regulate osteogenic differentiation of mesenchymal stromal cells</article-title><source>Sci Rep.</source><year>2016</year><volume>6</volume><issue>1</issue><fpage>21253</fpage><pub-id pub-id-type="doi">10.1038/srep21253</pub-id><pub-id pub-id-type="pmid">26884253</pub-id><pub-id pub-id-type="pmcid">PMC4756701</pub-id></element-citation><mixed-citation id="mc-CR103" publication-type="journal">Lo YP, Liu YS, Rimando MG, Ho JHC, Lin KH, Lee OK. Three-dimensional spherical spatial boundary conditions differentially regulate osteogenic differentiation of mesenchymal stromal cells. Sci Rep. 2016;6(1):21253.<pub-id pub-id-type="pmid">26884253</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep21253</pub-id><pub-id pub-id-type="pmcid">PMC4756701</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Tang</surname><given-names>T</given-names></name><name name-style="western"><surname>Lv</surname><given-names>L</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury</article-title><source>Stem Cell Res Ther</source><year>2020</year><volume>11</volume><issue>1</issue><fpage>206</fpage><pub-id pub-id-type="doi">10.1186/s13287-020-01719-2</pub-id><pub-id pub-id-type="pmid">32460853</pub-id><pub-id pub-id-type="pmcid">PMC7251891</pub-id></element-citation><mixed-citation id="mc-CR104" publication-type="journal">Cao J, Wang B, Tang T, Lv L, Ding Z, Li Z, et al. Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury. Stem Cell Res Ther. 2020;11(1):206.<pub-id pub-id-type="pmid">32460853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-020-01719-2</pub-id><pub-id pub-id-type="pmcid">PMC7251891</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>W</given-names></name><name name-style="western"><surname>Liang</surname><given-names>T</given-names></name><name name-style="western"><surname>He</surname><given-names>R</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J</given-names></name><name name-style="western"><surname>Yao</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><etal/></person-group><article-title>Exosomes from 3D culture of marrow stem cells enhances endothelial cell proliferation, migration, and angiogenesis via activation of the HMGB1/AKT pathway</article-title><source>Stem Cell Res</source><year>2021</year><volume>50</volume><fpage>102122</fpage><pub-id pub-id-type="doi">10.1016/j.scr.2020.102122</pub-id><pub-id pub-id-type="pmid">33316600</pub-id></element-citation><mixed-citation id="mc-CR105" publication-type="journal">Gao W, Liang T, He R, Ren J, Yao H, Wang K, et al. Exosomes from 3D culture of marrow stem cells enhances endothelial cell proliferation, migration, and angiogenesis via activation of the HMGB1/AKT pathway. Stem Cell Res. 2021;50:102122.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scr.2020.102122</pub-id><pub-id pub-id-type="pmid">33316600</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Sun</surname><given-names>F</given-names></name><name name-style="western"><surname>Qian</surname><given-names>H</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name></person-group><article-title>Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy</article-title><source>Stem Cells Int</source><year>2022</year><volume>14</volume><issue>2022</issue><fpage>1779346</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/1779346</pub-id><pub-id pub-id-type="pmcid">PMC9124131</pub-id><pub-id pub-id-type="pmid">35607400</pub-id></element-citation><mixed-citation id="mc-CR106" publication-type="journal">Chen S, Sun F, Qian H, Xu W, Jiang J. Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy. Stem Cells Int. 2022;14(2022):1779346.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/1779346</pub-id><pub-id pub-id-type="pmcid">PMC9124131</pub-id><pub-id pub-id-type="pmid">35607400</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kusuyama</surname><given-names>J</given-names></name><name name-style="western"><surname>Bandow</surname><given-names>K</given-names></name><name name-style="western"><surname>Shamoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Kakimoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Ohnishi</surname><given-names>T</given-names></name><name name-style="western"><surname>Matsuguchi</surname><given-names>T</given-names></name></person-group><article-title>Low intensity pulsed ultrasound (LIPUS) influences the multilineage differentiation of mesenchymal stem and progenitor cell lines through ROCK-Cot/Tpl2-MEK-ERK signaling pathway</article-title><source>J Biol Chem</source><year>2014</year><volume>289</volume><issue>15</issue><fpage>10330</fpage><lpage>10344</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.546382</pub-id><pub-id pub-id-type="pmid">24550383</pub-id><pub-id pub-id-type="pmcid">PMC4036157</pub-id></element-citation><mixed-citation id="mc-CR107" publication-type="journal">Kusuyama J, Bandow K, Shamoto M, Kakimoto K, Ohnishi T, Matsuguchi T. Low intensity pulsed ultrasound (LIPUS) influences the multilineage differentiation of mesenchymal stem and progenitor cell lines through ROCK-Cot/Tpl2-MEK-ERK signaling pathway. J Biol Chem. 2014;289(15):10330&#8211;44.<pub-id pub-id-type="pmid">24550383</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M113.546382</pub-id><pub-id pub-id-type="pmcid">PMC4036157</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>P</given-names></name><name name-style="western"><surname>Gul-Uludag</surname><given-names>H</given-names></name><name name-style="western"><surname>Ang</surname><given-names>WT</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M</given-names></name><name name-style="western"><surname>Marquez-Curtis</surname><given-names>L</given-names></name><etal/></person-group><article-title>Low-intensity pulsed ultrasound-mediated stimulation of hematopoietic stem/progenitor cell viability, proliferation and differentiation in vitro</article-title><source>Biotechnol Lett</source><year>2012</year><volume>34</volume><issue>10</issue><fpage>1965</fpage><lpage>1973</lpage><pub-id pub-id-type="doi">10.1007/s10529-012-0984-6</pub-id><pub-id pub-id-type="pmid">22763849</pub-id></element-citation><mixed-citation id="mc-CR108" publication-type="journal">Xu P, Gul-Uludag H, Ang WT, Yang X, Huang M, Marquez-Curtis L, et al. Low-intensity pulsed ultrasound-mediated stimulation of hematopoietic stem/progenitor cell viability, proliferation and differentiation in vitro. Biotechnol Lett. 2012;34(10):1965&#8211;73.<pub-id pub-id-type="pmid">22763849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10529-012-0984-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>P</given-names></name><name name-style="western"><surname>Pan</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Production and biological effects of extracellular vesicles from adipose-derived stem cells were markedly increased by low-intensity ultrasound stimulation for promoting diabetic wound healing</article-title><source>STEM CELL Rev Rep</source><year>2023</year><volume>19</volume><issue>3</issue><fpage>784</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1007/s12015-022-10487-w</pub-id><pub-id pub-id-type="pmid">36562958</pub-id></element-citation><mixed-citation id="mc-CR109" publication-type="journal">Zheng Y, Xu P, Pan C, Wang Y, Liu Z, Chen Y, et al. Production and biological effects of extracellular vesicles from adipose-derived stem cells were markedly increased by low-intensity ultrasound stimulation for promoting diabetic wound healing. STEM CELL Rev Rep. 2023;19(3):784&#8211;806.<pub-id pub-id-type="pmid">36562958</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12015-022-10487-w</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foretz</surname><given-names>M</given-names></name><name name-style="western"><surname>Guigas</surname><given-names>B</given-names></name><name name-style="western"><surname>Bertrand</surname><given-names>L</given-names></name><name name-style="western"><surname>Pollak</surname><given-names>M</given-names></name><name name-style="western"><surname>Viollet</surname><given-names>B</given-names></name></person-group><article-title>Metformin: from mechanisms of action to therapies</article-title><source>Cell Metab</source><year>2014</year><volume>20</volume><issue>6</issue><fpage>953</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.09.018</pub-id><pub-id pub-id-type="pmid">25456737</pub-id></element-citation><mixed-citation id="mc-CR110" publication-type="journal">Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20(6):953&#8211;66.<pub-id pub-id-type="pmid">25456737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2014.09.018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><citation-alternatives><element-citation id="ec-CR111" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name><name name-style="western"><surname>Mi</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways</article-title><source>J Exp Clin Cancer Res</source><year>2018</year><volume>37</volume><issue>1</issue><fpage>63</fpage><pub-id pub-id-type="doi">10.1186/s13046-018-0731-5</pub-id><pub-id pub-id-type="pmid">29554968</pub-id><pub-id pub-id-type="pmcid">PMC5859411</pub-id></element-citation><mixed-citation id="mc-CR111" publication-type="journal">Wang Y, Xu W, Yan Z, Zhao W, Mi J, Li J, et al. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways. J Exp Clin Cancer Res. 2018;37(1):63.<pub-id pub-id-type="pmid">29554968</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13046-018-0731-5</pub-id><pub-id pub-id-type="pmcid">PMC5859411</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><etal/></person-group><article-title>Metformin facilitates mesenchymal stem cell-derived extracellular nanovesicles release and optimizes therapeutic efficacy in intervertebral disc degeneration</article-title><source>Biomaterials</source><year>2021</year><volume>274</volume><fpage>120850</fpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.120850</pub-id><pub-id pub-id-type="pmid">33984637</pub-id></element-citation><mixed-citation id="mc-CR112" publication-type="journal">Liao Z, Li S, Lu S, Liu H, Li G, Ma L, et al. Metformin facilitates mesenchymal stem cell-derived extracellular nanovesicles release and optimizes therapeutic efficacy in intervertebral disc degeneration. Biomaterials. 2021;274:120850.<pub-id pub-id-type="pmid">33984637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2021.120850</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foretz</surname><given-names>M</given-names></name><name name-style="western"><surname>Guigas</surname><given-names>B</given-names></name><name name-style="western"><surname>Viollet</surname><given-names>B</given-names></name></person-group><article-title>Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus</article-title><source>Nat Rev Endocrinol</source><year>2019</year><volume>15</volume><issue>10</issue><fpage>569</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41574-019-0242-2</pub-id><pub-id pub-id-type="pmid">31439934</pub-id></element-citation><mixed-citation id="mc-CR113" publication-type="journal">Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol. 2019;15(10):569&#8211;89.<pub-id pub-id-type="pmid">31439934</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41574-019-0242-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cui</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Melatonin attenuates choroidal neovascularization by regulating macrophage/microglia polarization via inhibition of RhoA/ROCK signaling pathway</article-title><source>J Pineal Res</source><year>2020</year><volume>69</volume><issue>1</issue><fpage>e12660</fpage><pub-id pub-id-type="doi">10.1111/jpi.12660</pub-id><pub-id pub-id-type="pmid">32323368</pub-id></element-citation><mixed-citation id="mc-CR114" publication-type="journal">Xu Y, Cui K, Li J, Tang X, Lin J, Lu X, et al. Melatonin attenuates choroidal neovascularization by regulating macrophage/microglia polarization via inhibition of RhoA/ROCK signaling pathway. J Pineal Res. 2020;69(1):e12660.<pub-id pub-id-type="pmid">32323368</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jpi.12660</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><citation-alternatives><element-citation id="ec-CR115" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luengo</surname><given-names>E</given-names></name><name name-style="western"><surname>Buendia</surname><given-names>I</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Mend&#237;vil</surname><given-names>C</given-names></name><name name-style="western"><surname>Trigo-Alonso</surname><given-names>P</given-names></name><name name-style="western"><surname>Negredo</surname><given-names>P</given-names></name><name name-style="western"><surname>Michalska</surname><given-names>P</given-names></name><etal/></person-group><article-title>Pharmacological doses of melatonin impede cognitive decline in tau-related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux</article-title><source>J Pineal Res</source><year>2019</year><volume>67</volume><issue>1</issue><fpage>e12578</fpage><pub-id pub-id-type="doi">10.1111/jpi.12578</pub-id><pub-id pub-id-type="pmid">30943316</pub-id></element-citation><mixed-citation id="mc-CR115" publication-type="journal">Luengo E, Buendia I, Fern&#225;ndez-Mend&#237;vil C, Trigo-Alonso P, Negredo P, Michalska P, et al. Pharmacological doses of melatonin impede cognitive decline in tau-related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux. J Pineal Res. 2019;67(1):e12578.<pub-id pub-id-type="pmid">30943316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jpi.12578</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Di</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non-small cell lung cancer after melatonin treatment</article-title><source>J Pineal Res</source><year>2019</year><volume>67</volume><issue>2</issue><fpage>e12587</fpage><pub-id pub-id-type="doi">10.1111/jpi.12587</pub-id><pub-id pub-id-type="pmid">31090223</pub-id></element-citation><mixed-citation id="mc-CR116" publication-type="journal">Ma Z, Liu D, Di S, Zhang Z, Li W, Zhang J, et al. Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non-small cell lung cancer after melatonin treatment. J Pineal Res. 2019;67(2):e12587.<pub-id pub-id-type="pmid">31090223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jpi.12587</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mortezaee</surname><given-names>K</given-names></name><name name-style="western"><surname>Khanlarkhani</surname><given-names>N</given-names></name></person-group><article-title>Melatonin application in targeting oxidative-induced liver injuries: a review</article-title><source>J Cell Physiol</source><year>2018</year><volume>233</volume><issue>5</issue><fpage>4015</fpage><lpage>4032</lpage><pub-id pub-id-type="doi">10.1002/jcp.26209</pub-id><pub-id pub-id-type="pmid">29023783</pub-id></element-citation><mixed-citation id="mc-CR117" publication-type="journal">Mortezaee K, Khanlarkhani N. Melatonin application in targeting oxidative-induced liver injuries: a review. J Cell Physiol. 2018;233(5):4015&#8211;32.<pub-id pub-id-type="pmid">29023783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcp.26209</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><citation-alternatives><element-citation id="ec-CR118" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Go</surname><given-names>G</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>YM</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G</given-names></name><name name-style="western"><surname>Lim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Han</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Melatonin protects chronic kidney disease mesenchymal stem/stromal cells against accumulation of methylglyoxal via modulation of hexokinase-2 expression</article-title><source>Biomol Ther</source><year>2022</year><volume>30</volume><issue>1</issue><fpage>28</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.4062/biomolther.2021.058</pub-id><pub-id pub-id-type="pmcid">PMC8724841</pub-id><pub-id pub-id-type="pmid">34261819</pub-id></element-citation><mixed-citation id="mc-CR118" publication-type="journal">Go G, Yoon YM, Yoon S, Lee G, Lim JH, Han SY, et al. Melatonin protects chronic kidney disease mesenchymal stem/stromal cells against accumulation of methylglyoxal via modulation of hexokinase-2 expression. Biomol Ther. 2022;30(1):28&#8211;37.<pub-id pub-id-type="doi" assigning-authority="pmc">10.4062/biomolther.2021.058</pub-id><pub-id pub-id-type="pmcid">PMC8724841</pub-id><pub-id pub-id-type="pmid">34261819</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR119"><label>119.</label><citation-alternatives><element-citation id="ec-CR119" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Tang</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Ye</surname><given-names>W</given-names></name><name name-style="western"><surname>Ge</surname><given-names>X</given-names></name><name name-style="western"><surname>Rong</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Extracellular vesicles derived from melatonin-preconditioned mesenchymal stem cells containing USP29 repair traumatic spinal cord injury by stabilizing NRF2</article-title><source>J Pineal Res</source><year>2021</year><volume>71</volume><issue>4</issue><fpage>e12769</fpage><pub-id pub-id-type="doi">10.1111/jpi.12769</pub-id><pub-id pub-id-type="pmid">34562326</pub-id></element-citation><mixed-citation id="mc-CR119" publication-type="journal">Liu W, Tang P, Wang J, Ye W, Ge X, Rong Y, et al. Extracellular vesicles derived from melatonin-preconditioned mesenchymal stem cells containing USP29 repair traumatic spinal cord injury by stabilizing NRF2. J Pineal Res. 2021;71(4):e12769.<pub-id pub-id-type="pmid">34562326</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jpi.12769</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR120"><label>120.</label><citation-alternatives><element-citation id="ec-CR120" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alzahrani</surname><given-names>FA</given-names></name></person-group><article-title>Melatonin improves therapeutic potential of mesenchymal stem cells-derived exosomes against renal ischemia-reperfusion injury in rats</article-title><source>Am J Transl Res</source><year>2019</year><volume>11</volume><issue>5</issue><fpage>2887</fpage><lpage>2907</lpage><pub-id pub-id-type="pmid">31217862</pub-id><pub-id pub-id-type="pmcid">PMC6556638</pub-id></element-citation><mixed-citation id="mc-CR120" publication-type="journal">Alzahrani FA. Melatonin improves therapeutic potential of mesenchymal stem cells-derived exosomes against renal ischemia-reperfusion injury in rats. Am J Transl Res. 2019;11(5):2887&#8211;907.<pub-id pub-id-type="pmid">31217862</pub-id><pub-id pub-id-type="pmcid">PMC6556638</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR121"><label>121.</label><citation-alternatives><element-citation id="ec-CR121" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>YM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Song</surname><given-names>KH</given-names></name><name name-style="western"><surname>Noh</surname><given-names>H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name></person-group><article-title>Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins</article-title><source>J Pineal Res</source><year>2020</year><volume>68</volume><issue>3</issue><fpage>e12632</fpage><pub-id pub-id-type="doi">10.1111/jpi.12632</pub-id><pub-id pub-id-type="pmid">31989677</pub-id></element-citation><mixed-citation id="mc-CR121" publication-type="journal">Yoon YM, Lee JH, Song KH, Noh H, Lee SH. Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins. J Pineal Res. 2020;68(3):e12632.<pub-id pub-id-type="pmid">31989677</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jpi.12632</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR122"><label>122.</label><citation-alternatives><element-citation id="ec-CR122" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Ru</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Melatonin enhances the therapeutic effect of plasma exosomes against cerebral ischemia-induced pyroptosis through the TLR4/NF-&#954;B pathway</article-title><source>Front Neurosci</source><year>2020</year><volume>14</volume><fpage>848</fpage><pub-id pub-id-type="doi">10.3389/fnins.2020.00848</pub-id><pub-id pub-id-type="pmid">33013286</pub-id><pub-id pub-id-type="pmcid">PMC7461850</pub-id></element-citation><mixed-citation id="mc-CR122" publication-type="journal">Wang K, Ru J, Zhang H, Chen J, Lin X, Lin Z, et al. Melatonin enhances the therapeutic effect of plasma exosomes against cerebral ischemia-induced pyroptosis through the TLR4/NF-&#954;B pathway. Front Neurosci. 2020;14:848.<pub-id pub-id-type="pmid">33013286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnins.2020.00848</pub-id><pub-id pub-id-type="pmcid">PMC7461850</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR123"><label>123.</label><citation-alternatives><element-citation id="ec-CR123" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>X</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name><name name-style="western"><surname>Tian</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Peng</surname><given-names>M</given-names></name><etal/></person-group><article-title>Administration of glycyrrhetinic acid reinforces therapeutic effects of mesenchymal stem cell-derived exosome against acute liver ischemia-reperfusion injury</article-title><source>J Cell Mol Med</source><year>2020</year><volume>24</volume><issue>19</issue><fpage>11211</fpage><lpage>11220</lpage><pub-id pub-id-type="doi">10.1111/jcmm.15675</pub-id><pub-id pub-id-type="pmid">32902129</pub-id><pub-id pub-id-type="pmcid">PMC7576231</pub-id></element-citation><mixed-citation id="mc-CR123" publication-type="journal">Wei X, Zheng W, Tian P, Liu H, He Y, Peng M, et al. Administration of glycyrrhetinic acid reinforces therapeutic effects of mesenchymal stem cell-derived exosome against acute liver ischemia-reperfusion injury. J Cell Mol Med. 2020;24(19):11211&#8211;20.<pub-id pub-id-type="pmid">32902129</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jcmm.15675</pub-id><pub-id pub-id-type="pmcid">PMC7576231</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR124"><label>124.</label><citation-alternatives><element-citation id="ec-CR124" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name></person-group><article-title>Kartogenin enhances the therapeutic effect of bone marrow mesenchymal stem cells derived exosomes in cartilage repair</article-title><source>Nanomed</source><year>2020</year><volume>15</volume><issue>3</issue><fpage>273</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.2217/nnm-2019-0208</pub-id><pub-id pub-id-type="pmid">31789105</pub-id></element-citation><mixed-citation id="mc-CR124" publication-type="journal">Liu C, Li Y, Yang Z, Zhou Z, Lou Z, Zhang Q. Kartogenin enhances the therapeutic effect of bone marrow mesenchymal stem cells derived exosomes in cartilage repair. Nanomed. 2020;15(3):273&#8211;88.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2217/nnm-2019-0208</pub-id><pub-id pub-id-type="pmid">31789105</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR125"><label>125.</label><citation-alternatives><element-citation id="ec-CR125" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>DK</given-names></name><name name-style="western"><surname>Sung</surname><given-names>SI</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>SY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>YS</given-names></name><name name-style="western"><surname>Park</surname><given-names>WS</given-names></name></person-group><article-title>Thrombin preconditioning boosts biogenesis of extracellular vesicles from mesenchymal stem cells and enriches their cargo contents via protease-activated receptor-mediated signaling pathways</article-title><source>Int J Mol Sci</source><year>2019</year><volume>20</volume><issue>12</issue><fpage>2899</fpage><pub-id pub-id-type="doi">10.3390/ijms20122899</pub-id><pub-id pub-id-type="pmid">31197089</pub-id><pub-id pub-id-type="pmcid">PMC6627943</pub-id></element-citation><mixed-citation id="mc-CR125" publication-type="journal">Sung DK, Sung SI, Ahn SY, Chang YS, Park WS. Thrombin preconditioning boosts biogenesis of extracellular vesicles from mesenchymal stem cells and enriches their cargo contents via protease-activated receptor-mediated signaling pathways. Int J Mol Sci. 2019;20(12):2899.<pub-id pub-id-type="pmid">31197089</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms20122899</pub-id><pub-id pub-id-type="pmcid">PMC6627943</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR126"><label>126.</label><citation-alternatives><element-citation id="ec-CR126" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>M</given-names></name><name name-style="western"><surname>Xie</surname><given-names>D</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><etal/></person-group><article-title>Exosomes derived from MSC pre-treated with oridonin alleviates myocardial IR injury by suppressing apoptosis via regulating autophagy activation</article-title><source>J Cell Mol Med</source><year>2021</year><volume>25</volume><issue>12</issue><fpage>5486</fpage><lpage>5496</lpage><pub-id pub-id-type="doi">10.1111/jcmm.16558</pub-id><pub-id pub-id-type="pmid">33955654</pub-id><pub-id pub-id-type="pmcid">PMC8184716</pub-id></element-citation><mixed-citation id="mc-CR126" publication-type="journal">Fu M, Xie D, Sun Y, Pan Y, Zhang Y, Chen X, et al. Exosomes derived from MSC pre-treated with oridonin alleviates myocardial IR injury by suppressing apoptosis via regulating autophagy activation. J Cell Mol Med. 2021;25(12):5486&#8211;96.<pub-id pub-id-type="pmid">33955654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jcmm.16558</pub-id><pub-id pub-id-type="pmcid">PMC8184716</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR127"><label>127.</label><citation-alternatives><element-citation id="ec-CR127" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tian</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19</article-title><source>Cardiovasc Res</source><year>2020</year><volume>116</volume><issue>2</issue><fpage>353</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvz139</pub-id><pub-id pub-id-type="pmid">31119268</pub-id><pub-id pub-id-type="pmcid">PMC8204482</pub-id></element-citation><mixed-citation id="mc-CR127" publication-type="journal">Huang P, Wang L, Li Q, Tian X, Xu J, Xu J, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116(2):353&#8211;67.<pub-id pub-id-type="pmid">31119268</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cvr/cvz139</pub-id><pub-id pub-id-type="pmcid">PMC8204482</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR128"><label>128.</label><citation-alternatives><element-citation id="ec-CR128" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ti</surname><given-names>D</given-names></name><name name-style="western"><surname>Hao</surname><given-names>H</given-names></name><name name-style="western"><surname>Tong</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Dong</surname><given-names>L</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><etal/></person-group><article-title>LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b</article-title><source>J Transl Med</source><year>2015</year><volume>19</volume><issue>13</issue><fpage>308</fpage><pub-id pub-id-type="doi">10.1186/s12967-015-0642-6</pub-id><pub-id pub-id-type="pmcid">PMC4575470</pub-id><pub-id pub-id-type="pmid">26386558</pub-id></element-citation><mixed-citation id="mc-CR128" publication-type="journal">Ti D, Hao H, Tong C, Liu J, Dong L, Zheng J, et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 2015;19(13):308.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-015-0642-6</pub-id><pub-id pub-id-type="pmcid">PMC4575470</pub-id><pub-id pub-id-type="pmid">26386558</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR129"><label>129.</label><citation-alternatives><element-citation id="ec-CR129" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Wu</surname><given-names>YP</given-names></name><name name-style="western"><surname>Li</surname><given-names>XD</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SH</given-names></name><name name-style="western"><surname>Ye</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Xue</surname><given-names>XY</given-names></name><etal/></person-group><article-title>TNF-&#945;-induced exosomal miR-146a mediates mesenchymal stem cell-dependent suppression of urethral stricture</article-title><source>J Cell Physiol</source><year>2019</year><volume>234</volume><issue>12</issue><fpage>23243</fpage><lpage>23255</lpage><pub-id pub-id-type="doi">10.1002/jcp.28891</pub-id><pub-id pub-id-type="pmid">31144307</pub-id></element-citation><mixed-citation id="mc-CR129" publication-type="journal">Liang YC, Wu YP, Li XD, Chen SH, Ye XJ, Xue XY, et al. TNF-&#945;-induced exosomal miR-146a mediates mesenchymal stem cell-dependent suppression of urethral stricture. J Cell Physiol. 2019;234(12):23243&#8211;55.<pub-id pub-id-type="pmid">31144307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcp.28891</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR130"><label>130.</label><citation-alternatives><element-citation id="ec-CR130" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fukuda</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Sanui</surname><given-names>T</given-names></name><name name-style="western"><surname>Shinjo</surname><given-names>T</given-names></name><name name-style="western"><surname>Kou</surname><given-names>X</given-names></name><etal/></person-group><article-title>Exosomes from TNF-&#945;-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss</article-title><source>Acta Biomater</source><year>2021</year><volume>1</volume><issue>122</issue><fpage>306</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2020.12.046</pub-id><pub-id pub-id-type="pmcid">PMC7897289</pub-id><pub-id pub-id-type="pmid">33359765</pub-id></element-citation><mixed-citation id="mc-CR130" publication-type="journal">Nakao Y, Fukuda T, Zhang Q, Sanui T, Shinjo T, Kou X, et al. Exosomes from TNF-&#945;-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss. Acta Biomater. 2021;1(122):306&#8211;24.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2020.12.046</pub-id><pub-id pub-id-type="pmcid">PMC7897289</pub-id><pub-id pub-id-type="pmid">33359765</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR131"><label>131.</label><citation-alternatives><element-citation id="ec-CR131" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Pretreatment of exosomes derived from hUCMSCs with TNF-&#945; ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage</article-title><source>Life Sci</source><year>2020</year><volume>1</volume><issue>246</issue><fpage>117401</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2020.117401</pub-id><pub-id pub-id-type="pmid">32035931</pub-id></element-citation><mixed-citation id="mc-CR131" publication-type="journal">Zhang S, Jiang L, Hu H, Wang H, Wang X, Jiang J, et al. Pretreatment of exosomes derived from hUCMSCs with TNF-&#945; ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage. Life Sci. 2020;1(246):117401.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2020.117401</pub-id><pub-id pub-id-type="pmid">32035931</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR132"><label>132.</label><citation-alternatives><element-citation id="ec-CR132" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name></person-group><article-title>TGF-&#946;1-modified MSC-derived exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarization by targeting MAPK6</article-title><source>Cell Tissue Res</source><year>2021</year><volume>384</volume><issue>1</issue><fpage>113</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1007/s00441-020-03319-1</pub-id><pub-id pub-id-type="pmid">33404840</pub-id></element-citation><mixed-citation id="mc-CR132" publication-type="journal">Wang R, Xu B. TGF-&#946;1-modified MSC-derived exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarization by targeting MAPK6. Cell Tissue Res. 2021;384(1):113&#8211;27.<pub-id pub-id-type="pmid">33404840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00441-020-03319-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR133"><label>133.</label><citation-alternatives><element-citation id="ec-CR133" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krzyszczyk</surname><given-names>P</given-names></name><name name-style="western"><surname>Schloss</surname><given-names>R</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>A</given-names></name><name name-style="western"><surname>Berthiaume</surname><given-names>F</given-names></name></person-group><article-title>The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes</article-title><source>Front Physiol</source><year>2018</year><volume>9</volume><fpage>419</fpage><pub-id pub-id-type="doi">10.3389/fphys.2018.00419</pub-id><pub-id pub-id-type="pmid">29765329</pub-id><pub-id pub-id-type="pmcid">PMC5938667</pub-id></element-citation><mixed-citation id="mc-CR133" publication-type="journal">Krzyszczyk P, Schloss R, Palmer A, Berthiaume F. The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes. Front Physiol. 2018;9:419.<pub-id pub-id-type="pmid">29765329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphys.2018.00419</pub-id><pub-id pub-id-type="pmcid">PMC5938667</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR134"><label>134.</label><citation-alternatives><element-citation id="ec-CR134" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hesketh</surname><given-names>M</given-names></name><name name-style="western"><surname>Sahin</surname><given-names>KB</given-names></name><name name-style="western"><surname>West</surname><given-names>ZE</given-names></name><name name-style="western"><surname>Murray</surname><given-names>RZ</given-names></name></person-group><article-title>Macrophage phenotypes regulate scar formation and chronic wound healing</article-title><source>Int J Mol Sci</source><year>2017</year><volume>18</volume><issue>7</issue><fpage>E1545</fpage><pub-id pub-id-type="doi">10.3390/ijms18071545</pub-id><pub-id pub-id-type="pmcid">PMC5536033</pub-id><pub-id pub-id-type="pmid">28714933</pub-id></element-citation><mixed-citation id="mc-CR134" publication-type="journal">Hesketh M, Sahin KB, West ZE, Murray RZ. Macrophage phenotypes regulate scar formation and chronic wound healing. Int J Mol Sci. 2017;18(7):E1545.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms18071545</pub-id><pub-id pub-id-type="pmcid">PMC5536033</pub-id><pub-id pub-id-type="pmid">28714933</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR135"><label>135.</label><citation-alternatives><element-citation id="ec-CR135" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>M</given-names></name><name name-style="western"><surname>Shin</surname><given-names>DI</given-names></name><name name-style="western"><surname>Choi</surname><given-names>BH</given-names></name><name name-style="western"><surname>Min</surname><given-names>BH</given-names></name></person-group><article-title>Exosomes from IL-1&#946;-primed mesenchymal stem cells inhibited IL-1&#946;- and TNF-&#945;-mediated inflammatory responses in osteoarthritic SW982 cells</article-title><source>Tissue Eng Regen Med</source><year>2021</year><volume>18</volume><issue>4</issue><fpage>525</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1007/s13770-020-00324-x</pub-id><pub-id pub-id-type="pmid">33495946</pub-id><pub-id pub-id-type="pmcid">PMC8325746</pub-id></element-citation><mixed-citation id="mc-CR135" publication-type="journal">Kim M, Shin DI, Choi BH, Min BH. Exosomes from IL-1&#946;-primed mesenchymal stem cells inhibited IL-1&#946;- and TNF-&#945;-mediated inflammatory responses in osteoarthritic SW982 cells. Tissue Eng Regen Med. 2021;18(4):525&#8211;36.<pub-id pub-id-type="pmid">33495946</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13770-020-00324-x</pub-id><pub-id pub-id-type="pmcid">PMC8325746</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR136"><label>136.</label><citation-alternatives><element-citation id="ec-CR136" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>R</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Cui</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name></person-group><article-title>IFN-&#947; promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b</article-title><source>Cell Death Dis</source><year>2020</year><volume>11</volume><issue>7</issue><fpage>603</fpage><pub-id pub-id-type="doi">10.1038/s41419-020-02788-0</pub-id><pub-id pub-id-type="pmid">32733020</pub-id><pub-id pub-id-type="pmcid">PMC7393506</pub-id></element-citation><mixed-citation id="mc-CR136" publication-type="journal">Yang R, Huang H, Cui S, Zhou Y, Zhang T, Zhou Y. IFN-&#947; promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b. Cell Death Dis. 2020;11(7):603.<pub-id pub-id-type="pmid">32733020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-020-02788-0</pub-id><pub-id pub-id-type="pmcid">PMC7393506</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR137"><label>137.</label><citation-alternatives><element-citation id="ec-CR137" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Fu</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Paintable bioactive extracellular vesicle ink for wound healing</article-title><source>ACS Appl Mater Interfaces</source><year>2023</year><volume>15</volume><issue>21</issue><fpage>25427</fpage><lpage>25436</lpage><pub-id pub-id-type="doi">10.1021/acsami.3c03630</pub-id><pub-id pub-id-type="pmid">37204052</pub-id></element-citation><mixed-citation id="mc-CR137" publication-type="journal">Li L, Wang Z, Wang K, Fu S, Li D, Wang M, et al. Paintable bioactive extracellular vesicle ink for wound healing. ACS Appl Mater Interfaces. 2023;15(21):25427&#8211;36.<pub-id pub-id-type="pmid">37204052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsami.3c03630</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR138"><label>138.</label><citation-alternatives><element-citation id="ec-CR138" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hu</surname><given-names>X</given-names></name><name name-style="western"><surname>Meng</surname><given-names>Q</given-names></name></person-group><article-title>Engineering of MSC-derived exosomes: a promising cell-free therapy for osteoarthritis</article-title><source>Membranes</source><year>2022</year><volume>12</volume><issue>8</issue><fpage>739</fpage><pub-id pub-id-type="doi">10.3390/membranes12080739</pub-id><pub-id pub-id-type="pmid">36005656</pub-id><pub-id pub-id-type="pmcid">PMC9413347</pub-id></element-citation><mixed-citation id="mc-CR138" publication-type="journal">Cheng J, Sun Y, Ma Y, Ao Y, Hu X, Meng Q. Engineering of MSC-derived exosomes: a promising cell-free therapy for osteoarthritis. Membranes. 2022;12(8):739.<pub-id pub-id-type="pmid">36005656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/membranes12080739</pub-id><pub-id pub-id-type="pmcid">PMC9413347</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR139"><label>139.</label><citation-alternatives><element-citation id="ec-CR139" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanchanapally</surname><given-names>R</given-names></name><name name-style="western"><surname>Khan</surname><given-names>MA</given-names></name><name name-style="western"><surname>Deshmukh</surname><given-names>SK</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>SK</given-names></name><name name-style="western"><surname>Khushman</surname><given-names>M</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name><etal/></person-group><article-title>Exosomal formulation escalates cellular uptake of honokiol leading to the enhancement of its antitumor efficacy</article-title><source>ACS Omega</source><year>2020</year><volume>5</volume><issue>36</issue><fpage>23299</fpage><lpage>23307</lpage><pub-id pub-id-type="doi">10.1021/acsomega.0c03136</pub-id><pub-id pub-id-type="pmid">32954181</pub-id><pub-id pub-id-type="pmcid">PMC7495913</pub-id></element-citation><mixed-citation id="mc-CR139" publication-type="journal">Kanchanapally R, Khan MA, Deshmukh SK, Srivastava SK, Khushman M, Singh S, et al. Exosomal formulation escalates cellular uptake of honokiol leading to the enhancement of its antitumor efficacy. ACS Omega. 2020;5(36):23299&#8211;307.<pub-id pub-id-type="pmid">32954181</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsomega.0c03136</pub-id><pub-id pub-id-type="pmcid">PMC7495913</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR140"><label>140.</label><citation-alternatives><element-citation id="ec-CR140" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name></person-group><article-title>Dapagliflozin-loaded exosome mimetics facilitate diabetic wound healing by HIF-1&#945;-mediated enhancement of angiogenesis</article-title><source>Adv Healthc Mater</source><year>2023</year><volume>12</volume><issue>7</issue><fpage>2202751</fpage><pub-id pub-id-type="doi">10.1002/adhm.202202751</pub-id><pub-id pub-id-type="pmid">36442997</pub-id><pub-id pub-id-type="pmcid">PMC11469070</pub-id></element-citation><mixed-citation id="mc-CR140" publication-type="journal">Zhang W, Wang L, Guo H, Chen L, Huang X. Dapagliflozin-loaded exosome mimetics facilitate diabetic wound healing by HIF-1&#945;-mediated enhancement of angiogenesis. Adv Healthc Mater. 2023;12(7):2202751.<pub-id pub-id-type="pmid">36442997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adhm.202202751</pub-id><pub-id pub-id-type="pmcid">PMC11469070</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR141"><label>141.</label><citation-alternatives><element-citation id="ec-CR141" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Hao</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yi</surname><given-names>D</given-names></name><etal/></person-group><article-title>Engineering stem cells to produce exosomes with enhanced bone regeneration effects: an alternative strategy for gene therapy</article-title><source>J Nanobiotechnology</source><year>2022</year><volume>20</volume><issue>1</issue><fpage>135</fpage><pub-id pub-id-type="doi">10.1186/s12951-022-01347-3</pub-id><pub-id pub-id-type="pmid">35292020</pub-id><pub-id pub-id-type="pmcid">PMC8922796</pub-id></element-citation><mixed-citation id="mc-CR141" publication-type="journal">Li F, Wu J, Li D, Hao L, Li Y, Yi D, et al. Engineering stem cells to produce exosomes with enhanced bone regeneration effects: an alternative strategy for gene therapy. J Nanobiotechnology. 2022;20(1):135.<pub-id pub-id-type="pmid">35292020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-022-01347-3</pub-id><pub-id pub-id-type="pmcid">PMC8922796</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR142"><label>142.</label><citation-alternatives><element-citation id="ec-CR142" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Ye</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name><etal/></person-group><article-title>A novel delivery nanobiotechnology: engineered miR-181b exosomes improved osteointegration by regulating macrophage polarization</article-title><source>J Nanobiotechnology</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>269</fpage><pub-id pub-id-type="doi">10.1186/s12951-021-01015-y</pub-id><pub-id pub-id-type="pmid">34493305</pub-id><pub-id pub-id-type="pmcid">PMC8424816</pub-id></element-citation><mixed-citation id="mc-CR142" publication-type="journal">Liu W, Yu M, Chen F, Wang L, Ye C, Chen Q, et al. A novel delivery nanobiotechnology: engineered miR-181b exosomes improved osteointegration by regulating macrophage polarization. J Nanobiotechnology. 2021;19(1):269.<pub-id pub-id-type="pmid">34493305</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-021-01015-y</pub-id><pub-id pub-id-type="pmcid">PMC8424816</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR143"><label>143.</label><citation-alternatives><element-citation id="ec-CR143" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Kang</surname><given-names>M</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shirazi</surname><given-names>S</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>JI</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>LF</given-names></name><etal/></person-group><article-title>Functionally engineered extracellular vesicles improve bone regeneration</article-title><source>Acta Biomater</source><year>2020</year><volume>109</volume><fpage>182</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2020.04.017</pub-id><pub-id pub-id-type="pmid">32305445</pub-id><pub-id pub-id-type="pmcid">PMC8040700</pub-id></element-citation><mixed-citation id="mc-CR143" publication-type="journal">Huang CC, Kang M, Lu Y, Shirazi S, Diaz JI, Cooper LF, et al. Functionally engineered extracellular vesicles improve bone regeneration. Acta Biomater. 2020;109:182&#8211;94.<pub-id pub-id-type="pmid">32305445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2020.04.017</pub-id><pub-id pub-id-type="pmcid">PMC8040700</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR144"><label>144.</label><citation-alternatives><element-citation id="ec-CR144" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Lv</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Exosomes derived from miR-375-overexpressing human adipose mesenchymal stem cells promote bone regeneration</article-title><source>Cell Prolif</source><year>2019</year><volume>52</volume><issue>5</issue><fpage>e12669</fpage><pub-id pub-id-type="doi">10.1111/cpr.12669</pub-id><pub-id pub-id-type="pmid">31380594</pub-id><pub-id pub-id-type="pmcid">PMC6797519</pub-id></element-citation><mixed-citation id="mc-CR144" publication-type="journal">Chen S, Tang Y, Liu Y, Zhang P, Lv L, Zhang X, et al. Exosomes derived from miR-375-overexpressing human adipose mesenchymal stem cells promote bone regeneration. Cell Prolif. 2019;52(5):e12669.<pub-id pub-id-type="pmid">31380594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cpr.12669</pub-id><pub-id pub-id-type="pmcid">PMC6797519</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR145"><label>145.</label><citation-alternatives><element-citation id="ec-CR145" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>SC</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YL</given-names></name><name name-style="western"><surname>Yin</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Guo</surname><given-names>SC</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>CQ</given-names></name></person-group><article-title>Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model</article-title><source>Theranostics</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>180</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.7150/thno.17133</pub-id><pub-id pub-id-type="pmid">28042326</pub-id><pub-id pub-id-type="pmcid">PMC5196895</pub-id></element-citation><mixed-citation id="mc-CR145" publication-type="journal">Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 2017;7(1):180&#8211;95.<pub-id pub-id-type="pmid">28042326</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.17133</pub-id><pub-id pub-id-type="pmcid">PMC5196895</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR146"><label>146.</label><citation-alternatives><element-citation id="ec-CR146" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><etal/></person-group><article-title>Exosomes derived from Akt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D</article-title><source>Stem Cells Transl Med</source><year>2017</year><volume>6</volume><issue>1</issue><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.5966/sctm.2016-0038</pub-id><pub-id pub-id-type="pmid">28170176</pub-id><pub-id pub-id-type="pmcid">PMC5442756</pub-id></element-citation><mixed-citation id="mc-CR146" publication-type="journal">Ma J, Zhao Y, Sun L, Sun X, Zhao X, Sun X, et al. Exosomes derived from Akt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D. Stem Cells Transl Med. 2017;6(1):51&#8211;9.<pub-id pub-id-type="pmid">28170176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5966/sctm.2016-0038</pub-id><pub-id pub-id-type="pmcid">PMC5442756</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR147"><label>147.</label><citation-alternatives><element-citation id="ec-CR147" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>H</given-names></name><name name-style="western"><surname>Green</surname><given-names>E</given-names></name><name name-style="western"><surname>Ball</surname><given-names>L</given-names></name><name name-style="western"><surname>Fan</surname><given-names>H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Strange</surname><given-names>C</given-names></name><etal/></person-group><article-title>Proteomic analysis of exosomes secreted from human alpha-1 antitrypsin overexpressing mesenchymal stromal cells</article-title><source>Biology</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>9</fpage><pub-id pub-id-type="doi">10.3390/biology11010009</pub-id><pub-id pub-id-type="pmid">35053007</pub-id><pub-id pub-id-type="pmcid">PMC8773149</pub-id></element-citation><mixed-citation id="mc-CR147" publication-type="journal">Wei H, Green E, Ball L, Fan H, Lee J, Strange C, et al. Proteomic analysis of exosomes secreted from human alpha-1 antitrypsin overexpressing mesenchymal stromal cells. Biology. 2021;11(1):9.<pub-id pub-id-type="pmid">35053007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biology11010009</pub-id><pub-id pub-id-type="pmcid">PMC8773149</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR148"><label>148.</label><citation-alternatives><element-citation id="ec-CR148" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>N</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><name name-style="western"><surname>Lin</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells</article-title><source>Aging</source><year>2020</year><volume>12</volume><issue>19</issue><fpage>19660</fpage><lpage>19676</lpage><pub-id pub-id-type="doi">10.18632/aging.103997</pub-id><pub-id pub-id-type="pmid">33040049</pub-id><pub-id pub-id-type="pmcid">PMC7732307</pub-id></element-citation><mixed-citation id="mc-CR148" publication-type="journal">Xu Y, Liu N, Wei Y, Zhou D, Lin R, Wang X, et al. Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells. Aging. 2020;12(19):19660&#8211;76.<pub-id pub-id-type="pmid">33040049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/aging.103997</pub-id><pub-id pub-id-type="pmcid">PMC7732307</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR149"><label>149.</label><citation-alternatives><element-citation id="ec-CR149" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>You</surname><given-names>B</given-names></name><name name-style="western"><surname>Jin</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Z</given-names></name><etal/></person-group><article-title>MSC-derived extracellular vesicle-delivered L-PGDS inhibit gastric cancer progression by suppressing cancer cell stemness and STAT3 phosphorylation</article-title><source>Stem Cells Int</source><year>2022</year><volume>2022</volume><fpage>9668239</fpage><pub-id pub-id-type="doi">10.1155/2022/9668239</pub-id><pub-id pub-id-type="pmid">35087591</pub-id><pub-id pub-id-type="pmcid">PMC8789473</pub-id></element-citation><mixed-citation id="mc-CR149" publication-type="journal">You B, Jin C, Zhang J, Xu M, Xu W, Sun Z, et al. MSC-derived extracellular vesicle-delivered L-PGDS inhibit gastric cancer progression by suppressing cancer cell stemness and STAT3 phosphorylation. Stem Cells Int. 2022;2022:9668239.<pub-id pub-id-type="pmid">35087591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/9668239</pub-id><pub-id pub-id-type="pmcid">PMC8789473</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR150"><label>150.</label><citation-alternatives><element-citation id="ec-CR150" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Meng</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>circCDK13-loaded small extracellular vesicles accelerate healing in preclinical diabetic wound models</article-title><source>Nat Commun</source><year>2024</year><volume>15</volume><issue>1</issue><fpage>3904</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-48284-3</pub-id><pub-id pub-id-type="pmid">38724502</pub-id><pub-id pub-id-type="pmcid">PMC11082226</pub-id></element-citation><mixed-citation id="mc-CR150" publication-type="journal">Huang Q, Chu Z, Wang Z, Li Q, Meng S, Lu Y, et al. circCDK13-loaded small extracellular vesicles accelerate healing in preclinical diabetic wound models. Nat Commun. 2024;15(1):3904.<pub-id pub-id-type="pmid">38724502</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-48284-3</pub-id><pub-id pub-id-type="pmcid">PMC11082226</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR151"><label>151.</label><citation-alternatives><element-citation id="ec-CR151" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raghav</surname><given-names>A</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>P</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>BK</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>GB</given-names></name><name name-style="western"><surname>Banday</surname><given-names>S</given-names></name><name name-style="western"><surname>Gautam</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Mesenchymal stromal cell-derived tailored exosomes treat bacteria-associated diabetes foot ulcers: a customized approach from bench to bed</article-title><source>Front Microbiol</source><year>2021</year><volume>27</volume><issue>12</issue><fpage>712588</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.712588</pub-id><pub-id pub-id-type="pmcid">PMC8354005</pub-id><pub-id pub-id-type="pmid">34385994</pub-id></element-citation><mixed-citation id="mc-CR151" publication-type="journal">Raghav A, Tripathi P, Mishra BK, Jeong GB, Banday S, Gautam KA, et al. Mesenchymal stromal cell-derived tailored exosomes treat bacteria-associated diabetes foot ulcers: a customized approach from bench to bed. Front Microbiol. 2021;27(12):712588.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2021.712588</pub-id><pub-id pub-id-type="pmcid">PMC8354005</pub-id><pub-id pub-id-type="pmid">34385994</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR152"><label>152.</label><citation-alternatives><element-citation id="ec-CR152" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Cui</surname><given-names>J</given-names></name><name name-style="western"><surname>Du</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Bioengineering extracellular vesicles as novel nanocarriers towards brain disorders</article-title><source>Nano Res</source><year>2023</year><volume>16</volume><issue>2</issue><fpage>2635</fpage><lpage>2659</lpage><pub-id pub-id-type="doi">10.1007/s12274-022-4913-2</pub-id></element-citation><mixed-citation id="mc-CR152" publication-type="journal">Wu J, Ma L, Sun D, Zhang X, Cui J, Du Y, et al. Bioengineering extracellular vesicles as novel nanocarriers towards brain disorders. Nano Res. 2023;16(2):2635&#8211;59.</mixed-citation></citation-alternatives></ref><ref id="CR153"><label>153.</label><citation-alternatives><element-citation id="ec-CR153" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xia</surname><given-names>X</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>JC</given-names></name></person-group><article-title>Exosome engineering: current progress in cargo loading and targeted delivery</article-title><source>NanoImpact</source><year>2020</year><volume>20</volume><fpage>100261</fpage><pub-id pub-id-type="doi">10.1016/j.impact.2020.100261</pub-id></element-citation><mixed-citation id="mc-CR153" publication-type="journal">Fu S, Wang Y, Xia X, Zheng JC. Exosome engineering: current progress in cargo loading and targeted delivery. NanoImpact. 2020;20:100261.</mixed-citation></citation-alternatives></ref><ref id="CR154"><label>154.</label><citation-alternatives><element-citation id="ec-CR154" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salarpour</surname><given-names>S</given-names></name><name name-style="western"><surname>Forootanfar</surname><given-names>H</given-names></name><name name-style="western"><surname>Pournamdari</surname><given-names>M</given-names></name><name name-style="western"><surname>Ahmadi-Zeidabadi</surname><given-names>M</given-names></name><name name-style="western"><surname>Esmaeeli</surname><given-names>M</given-names></name><name name-style="western"><surname>Pardakhty</surname><given-names>A</given-names></name></person-group><article-title>Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques</article-title><source>DARU J Pharm Sci</source><year>2019</year><volume>27</volume><issue>2</issue><fpage>533</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1007/s40199-019-00280-5</pub-id><pub-id pub-id-type="pmcid">PMC6895332</pub-id><pub-id pub-id-type="pmid">31317441</pub-id></element-citation><mixed-citation id="mc-CR154" publication-type="journal">Salarpour S, Forootanfar H, Pournamdari M, Ahmadi-Zeidabadi M, Esmaeeli M, Pardakhty A. Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. DARU J Pharm Sci. 2019;27(2):533&#8211;9.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40199-019-00280-5</pub-id><pub-id pub-id-type="pmcid">PMC6895332</pub-id><pub-id pub-id-type="pmid">31317441</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR155"><label>155.</label><citation-alternatives><element-citation id="ec-CR155" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luan</surname><given-names>X</given-names></name><name name-style="western"><surname>Sansanaphongpricha</surname><given-names>K</given-names></name><name name-style="western"><surname>Myers</surname><given-names>I</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>H</given-names></name><name name-style="western"><surname>Sun</surname><given-names>D</given-names></name></person-group><article-title>Engineering exosomes as refined biological nanoplatforms for drug delivery</article-title><source>Acta Pharmacol Sin</source><year>2017</year><volume>38</volume><issue>6</issue><fpage>754</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1038/aps.2017.12</pub-id><pub-id pub-id-type="pmid">28392567</pub-id><pub-id pub-id-type="pmcid">PMC5520184</pub-id></element-citation><mixed-citation id="mc-CR155" publication-type="journal">Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38(6):754&#8211;63.<pub-id pub-id-type="pmid">28392567</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/aps.2017.12</pub-id><pub-id pub-id-type="pmcid">PMC5520184</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR156"><label>156.</label><citation-alternatives><element-citation id="ec-CR156" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ku&#269;uk</surname><given-names>N</given-names></name><name name-style="western"><surname>Primo&#382;i&#269;</surname><given-names>M</given-names></name><name name-style="western"><surname>Knez</surname><given-names>&#381;</given-names></name><name name-style="western"><surname>Leitgeb</surname><given-names>M</given-names></name></person-group><article-title>Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers</article-title><source>Int J Mol Sci</source><year>2021</year><volume>22</volume><issue>17</issue><fpage>9543</fpage><pub-id pub-id-type="doi">10.3390/ijms22179543</pub-id><pub-id pub-id-type="pmid">34502452</pub-id><pub-id pub-id-type="pmcid">PMC8431173</pub-id></element-citation><mixed-citation id="mc-CR156" publication-type="journal">Ku&#269;uk N, Primo&#382;i&#269; M, Knez &#381;, Leitgeb M. Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers. Int J Mol Sci. 2021;22(17):9543.<pub-id pub-id-type="pmid">34502452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22179543</pub-id><pub-id pub-id-type="pmcid">PMC8431173</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR157"><label>157.</label><citation-alternatives><element-citation id="ec-CR157" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ning</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Suo</surname><given-names>M</given-names></name><name name-style="western"><surname>Lyu</surname><given-names>M</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Platelet-derived exosomes hybrid liposomes facilitate uninterrupted singlet oxygen generation to enhance breast cancer immunotherapy</article-title><source>Cell Rep Phys Sci</source><year>2023</year><volume>4</volume><issue>7</issue><fpage>101505</fpage><pub-id pub-id-type="doi">10.1016/j.xcrp.2023.101505</pub-id></element-citation><mixed-citation id="mc-CR157" publication-type="journal">Ning S, Zhang X, Suo M, Lyu M, Pan Y, Jiang Y, et al. Platelet-derived exosomes hybrid liposomes facilitate uninterrupted singlet oxygen generation to enhance breast cancer immunotherapy. Cell Rep Phys Sci. 2023;4(7):101505.</mixed-citation></citation-alternatives></ref><ref id="CR158"><label>158.</label><citation-alternatives><element-citation id="ec-CR158" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>D</given-names></name><name name-style="western"><surname>Cores</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Platelet membrane and stem cell exosome hybrids enhance cellular uptake and targeting to heart injury</article-title><source>Nano Today</source><year>2021</year><volume>1</volume><issue>39</issue><fpage>101210</fpage><pub-id pub-id-type="doi">10.1016/j.nantod.2021.101210</pub-id><pub-id pub-id-type="pmcid">PMC8294084</pub-id><pub-id pub-id-type="pmid">34306170</pub-id></element-citation><mixed-citation id="mc-CR158" publication-type="journal">Hu S, Wang X, Li Z, Zhu D, Cores J, Wang Z, et al. Platelet membrane and stem cell exosome hybrids enhance cellular uptake and targeting to heart injury. Nano Today. 2021;1(39):101210.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nantod.2021.101210</pub-id><pub-id pub-id-type="pmcid">PMC8294084</pub-id><pub-id pub-id-type="pmid">34306170</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR159"><label>159.</label><citation-alternatives><element-citation id="ec-CR159" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evers</surname><given-names>MJW</given-names></name><name name-style="western"><surname>van de Wakker</surname><given-names>SI</given-names></name><name name-style="western"><surname>de Groot</surname><given-names>EM</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>OG</given-names></name><name name-style="western"><surname>Gitz-Fran&#231;ois</surname><given-names>JJJ</given-names></name><name name-style="western"><surname>Seinen</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles</article-title><source>Adv Healthc Mater</source><year>2022</year><volume>11</volume><issue>5</issue><fpage>2101202</fpage><pub-id pub-id-type="doi">10.1002/adhm.202101202</pub-id><pub-id pub-id-type="pmid">34382360</pub-id><pub-id pub-id-type="pmcid">PMC11468224</pub-id></element-citation><mixed-citation id="mc-CR159" publication-type="journal">Evers MJW, van de Wakker SI, de Groot EM, de Jong OG, Gitz-Fran&#231;ois JJJ, Seinen CS, et al. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles. Adv Healthc Mater. 2022;11(5):2101202.<pub-id pub-id-type="pmid">34382360</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adhm.202101202</pub-id><pub-id pub-id-type="pmcid">PMC11468224</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR160"><label>160.</label><citation-alternatives><element-citation id="ec-CR160" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Aghaloo</surname><given-names>T</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M</given-names></name></person-group><article-title>Generation of small RNA-modulated exosome mimetics for bone regeneration</article-title><source>ACS Nano</source><year>2020</year><volume>14</volume><issue>9</issue><fpage>11973</fpage><lpage>11984</lpage><pub-id pub-id-type="doi">10.1021/acsnano.0c05122</pub-id><pub-id pub-id-type="pmid">32897692</pub-id><pub-id pub-id-type="pmcid">PMC7530137</pub-id></element-citation><mixed-citation id="mc-CR160" publication-type="journal">Fan J, Lee CS, Kim S, Chen C, Aghaloo T, Lee M. Generation of small RNA-modulated exosome mimetics for bone regeneration. ACS Nano. 2020;14(9):11973&#8211;84.<pub-id pub-id-type="pmid">32897692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.0c05122</pub-id><pub-id pub-id-type="pmcid">PMC7530137</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR161"><label>161.</label><citation-alternatives><element-citation id="ec-CR161" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuhrmann</surname><given-names>G</given-names></name><name name-style="western"><surname>Serio</surname><given-names>A</given-names></name><name name-style="western"><surname>Mazo</surname><given-names>M</given-names></name><name name-style="western"><surname>Nair</surname><given-names>R</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>MM</given-names></name></person-group><article-title>Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins</article-title><source>J Controll Release</source><year>2015</year><volume>205</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2014.11.029</pub-id><pub-id pub-id-type="pmid">25483424</pub-id></element-citation><mixed-citation id="mc-CR161" publication-type="journal">Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Controll Release. 2015;205:35&#8211;44.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jconrel.2014.11.029</pub-id><pub-id pub-id-type="pmid">25483424</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR162"><label>162.</label><citation-alternatives><element-citation id="ec-CR162" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>C</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><etal/></person-group><article-title>An injectable, activated neutrophil-derived exosome mimetics/extracellular matrix hybrid hydrogel with antibacterial activity and wound healing promotion effect for diabetic wound therapy</article-title><source>J Nanobiotechnol</source><year>2023</year><volume>21</volume><issue>1</issue><fpage>308</fpage><pub-id pub-id-type="doi">10.1186/s12951-023-02073-0</pub-id><pub-id pub-id-type="pmcid">PMC10466714</pub-id><pub-id pub-id-type="pmid">37649022</pub-id></element-citation><mixed-citation id="mc-CR162" publication-type="journal">Yu Y, Jin H, Li L, Zhang X, Zheng C, Gao X, et al. An injectable, activated neutrophil-derived exosome mimetics/extracellular matrix hybrid hydrogel with antibacterial activity and wound healing promotion effect for diabetic wound therapy. J Nanobiotechnol. 2023;21(1):308.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-023-02073-0</pub-id><pub-id pub-id-type="pmcid">PMC10466714</pub-id><pub-id pub-id-type="pmid">37649022</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR163"><label>163.</label><citation-alternatives><element-citation id="ec-CR163" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wan</surname><given-names>G</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>T</given-names></name><name name-style="western"><surname>Yan</surname><given-names>C</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Engineered biomimetic nanovesicles-laden multifunctional hydrogel enhances targeted therapy of diabetic wound</article-title><source>Mater Today Bio</source><year>2024</year><volume>1</volume><issue>29</issue><fpage>101330</fpage><pub-id pub-id-type="doi">10.1016/j.mtbio.2024.101330</pub-id><pub-id pub-id-type="pmcid">PMC11609681</pub-id><pub-id pub-id-type="pmid">39624053</pub-id></element-citation><mixed-citation id="mc-CR163" publication-type="journal">Liu S, Wan G, Jiang T, Yan C, Jiang G, Zhang M, et al. Engineered biomimetic nanovesicles-laden multifunctional hydrogel enhances targeted therapy of diabetic wound. Mater Today Bio. 2024;1(29):101330.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mtbio.2024.101330</pub-id><pub-id pub-id-type="pmcid">PMC11609681</pub-id><pub-id pub-id-type="pmid">39624053</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR164"><label>164.</label><citation-alternatives><element-citation id="ec-CR164" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woo</surname><given-names>CH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name><name name-style="western"><surname>Jung</surname><given-names>GY</given-names></name><name name-style="western"><surname>Jung</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KS</given-names></name><name name-style="western"><surname>Yun</surname><given-names>YE</given-names></name><etal/></person-group><article-title>Small extracellular vesicles from human adipose-derived stem cells attenuate cartilage degeneration</article-title><source>J Extracell Vesicles</source><year>2020</year><volume>9</volume><issue>1</issue><fpage>1735249</fpage><pub-id pub-id-type="doi">10.1080/20013078.2020.1735249</pub-id><pub-id pub-id-type="pmid">32284824</pub-id><pub-id pub-id-type="pmcid">PMC7144299</pub-id></element-citation><mixed-citation id="mc-CR164" publication-type="journal">Woo CH, Kim HK, Jung GY, Jung YJ, Lee KS, Yun YE, et al. Small extracellular vesicles from human adipose-derived stem cells attenuate cartilage degeneration. J Extracell Vesicles. 2020;9(1):1735249.<pub-id pub-id-type="pmid">32284824</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/20013078.2020.1735249</pub-id><pub-id pub-id-type="pmcid">PMC7144299</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR165"><label>165.</label><citation-alternatives><element-citation id="ec-CR165" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vakilian</surname><given-names>S</given-names></name><name name-style="western"><surname>Jamshidi-adegani</surname><given-names>F</given-names></name><name name-style="western"><surname>Al-Fahdi</surname><given-names>F</given-names></name><name name-style="western"><surname>Mirsanei</surname><given-names>Z</given-names></name><name name-style="western"><surname>Al-kindi</surname><given-names>J</given-names></name><name name-style="western"><surname>Al-Riyami</surname><given-names>K</given-names></name><etal/></person-group><article-title>Engineered local delivery of extracellular vesicles loaded with si-TNF-&#945;, via a core-sheath 3D-bio-printed scaffold as an effective wound dressing</article-title><source>J Drug Deliv Sci Technol</source><year>2024</year><volume>1</volume><issue>101</issue><fpage>106189</fpage><pub-id pub-id-type="doi">10.1016/j.jddst.2024.106189</pub-id></element-citation><mixed-citation id="mc-CR165" publication-type="journal">Vakilian S, Jamshidi-adegani F, Al-Fahdi F, Mirsanei Z, Al-kindi J, Al-Riyami K, et al. Engineered local delivery of extracellular vesicles loaded with si-TNF-&#945;, via a core-sheath 3D-bio-printed scaffold as an effective wound dressing. J Drug Deliv Sci Technol. 2024;1(101):106189.</mixed-citation></citation-alternatives></ref><ref id="CR166"><label>166.</label><citation-alternatives><element-citation id="ec-CR166" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oskouie</surname><given-names>MN</given-names></name><name name-style="western"><surname>Aghili Moghaddam</surname><given-names>NS</given-names></name><name name-style="western"><surname>Butler</surname><given-names>AE</given-names></name><name name-style="western"><surname>Zamani</surname><given-names>P</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>A</given-names></name></person-group><article-title>Therapeutic use of curcumin-encapsulated and curcumin-primed exosomes</article-title><source>J Cell Physiol</source><year>2019</year><volume>234</volume><issue>6</issue><fpage>8182</fpage><lpage>8191</lpage><pub-id pub-id-type="doi">10.1002/jcp.27615</pub-id><pub-id pub-id-type="pmid">30317632</pub-id></element-citation><mixed-citation id="mc-CR166" publication-type="journal">Oskouie MN, Aghili Moghaddam NS, Butler AE, Zamani P, Sahebkar A. Therapeutic use of curcumin-encapsulated and curcumin-primed exosomes. J Cell Physiol. 2019;234(6):8182&#8211;91.<pub-id pub-id-type="pmid">30317632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcp.27615</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR167"><label>167.</label><citation-alternatives><element-citation id="ec-CR167" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimiz-Gebologlu</surname><given-names>I</given-names></name><name name-style="western"><surname>Oncel</surname><given-names>SS</given-names></name></person-group><article-title>Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake</article-title><source>J Controll Release</source><year>2022</year><volume>347</volume><fpage>533</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2022.05.027</pub-id><pub-id pub-id-type="pmid">35597405</pub-id></element-citation><mixed-citation id="mc-CR167" publication-type="journal">Kimiz-Gebologlu I, Oncel SS. Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J Controll Release. 2022;347:533&#8211;43.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jconrel.2022.05.027</pub-id><pub-id pub-id-type="pmid">35597405</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR168"><label>168.</label><citation-alternatives><element-citation id="ec-CR168" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>P</given-names></name><name name-style="western"><surname>Wei</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Ultrasound triggered topical delivery of Bmp7 mRNA for white fat browning induction via engineered smart exosomes</article-title><source>J Nanobiotechnology</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>402</fpage><pub-id pub-id-type="doi">10.1186/s12951-021-01145-3</pub-id><pub-id pub-id-type="pmid">34863187</pub-id><pub-id pub-id-type="pmcid">PMC8645082</pub-id></element-citation><mixed-citation id="mc-CR168" publication-type="journal">Guo Y, Wan Z, Zhao P, Wei M, Liu Y, Bu T, et al. Ultrasound triggered topical delivery of Bmp7 mRNA for white fat browning induction via engineered smart exosomes. J Nanobiotechnology. 2021;19(1):402.<pub-id pub-id-type="pmid">34863187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-021-01145-3</pub-id><pub-id pub-id-type="pmcid">PMC8645082</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR169"><label>169.</label><citation-alternatives><element-citation id="ec-CR169" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oku</surname><given-names>N</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>RC</given-names></name></person-group><article-title>Differential effects of alkali metal chlorides on formation of giant liposomes by freezing and thawing and by dialysis</article-title><source>Biochemistry</source><year>1983</year><volume>22</volume><issue>4</issue><fpage>855</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1021/bi00273a023</pub-id><pub-id pub-id-type="pmid">6682337</pub-id></element-citation><mixed-citation id="mc-CR169" publication-type="journal">Oku N, MacDonald RC. Differential effects of alkali metal chlorides on formation of giant liposomes by freezing and thawing and by dialysis. Biochemistry. 1983;22(4):855&#8211;63.<pub-id pub-id-type="pmid">6682337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bi00273a023</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR170"><label>170.</label><citation-alternatives><element-citation id="ec-CR170" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pick</surname><given-names>U</given-names></name></person-group><article-title>Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures</article-title><source>Arch Biochem Biophys</source><year>1981</year><volume>212</volume><issue>1</issue><fpage>186</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(81)90358-1</pub-id><pub-id pub-id-type="pmid">7197900</pub-id></element-citation><mixed-citation id="mc-CR170" publication-type="journal">Pick U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch Biochem Biophys. 1981;212(1):186&#8211;94.<pub-id pub-id-type="pmid">7197900</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-9861(81)90358-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR171"><label>171.</label><citation-alternatives><element-citation id="ec-CR171" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>YT</given-names></name><name name-style="western"><surname>Umezaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Sawada</surname><given-names>S</given-names></name><name name-style="western"><surname>Mukai</surname><given-names>S</given-names></name><name name-style="western"><surname>atsu, Sasaki Y, Harada N,</surname></name><etal/></person-group><article-title>Engineering hybrid exosomes by membrane fusion with liposomes</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><issue>1</issue><fpage>21933</fpage><pub-id pub-id-type="doi">10.1038/srep21933</pub-id><pub-id pub-id-type="pmid">26911358</pub-id><pub-id pub-id-type="pmcid">PMC4766490</pub-id></element-citation><mixed-citation id="mc-CR171" publication-type="journal">Sato YT, Umezaki K, Sawada S, Mukai S, atsu, Sasaki Y, Harada N, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6(1):21933.<pub-id pub-id-type="pmid">26911358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep21933</pub-id><pub-id pub-id-type="pmcid">PMC4766490</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR172"><label>172.</label><citation-alternatives><element-citation id="ec-CR172" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hettich</surname><given-names>BF</given-names></name><name name-style="western"><surname>Bader</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Leroux</surname><given-names>J</given-names></name></person-group><article-title>Encapsulation of hydrophilic compounds in small extracellular vesicles: loading capacity and impact on vesicle functions</article-title><source>Adv Healthc Mater</source><year>2022</year><volume>11</volume><issue>5</issue><fpage>2100047</fpage><pub-id pub-id-type="doi">10.1002/adhm.202100047</pub-id><pub-id pub-id-type="pmid">33951319</pub-id><pub-id pub-id-type="pmcid">PMC11469324</pub-id></element-citation><mixed-citation id="mc-CR172" publication-type="journal">Hettich BF, Bader JJ, Leroux J. Encapsulation of hydrophilic compounds in small extracellular vesicles: loading capacity and impact on vesicle functions. Adv Healthc Mater. 2022;11(5):2100047.<pub-id pub-id-type="pmid">33951319</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adhm.202100047</pub-id><pub-id pub-id-type="pmcid">PMC11469324</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR173"><label>173.</label><citation-alternatives><element-citation id="ec-CR173" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hajipour</surname><given-names>H</given-names></name><name name-style="western"><surname>Farzadi</surname><given-names>L</given-names></name><name name-style="western"><surname>Roshangar</surname><given-names>L</given-names></name><name name-style="western"><surname>Latifi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kahroba</surname><given-names>H</given-names></name><name name-style="western"><surname>Shahnazi</surname><given-names>V</given-names></name><etal/></person-group><article-title>A human chorionic gonadotropin (hCG) delivery platform using engineered uterine exosomes to improve endometrial receptivity</article-title><source>Life Sci</source><year>2021</year><volume>275</volume><fpage>119351</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2021.119351</pub-id><pub-id pub-id-type="pmid">33737084</pub-id></element-citation><mixed-citation id="mc-CR173" publication-type="journal">Hajipour H, Farzadi L, Roshangar L, Latifi Z, Kahroba H, Shahnazi V, et al. A human chorionic gonadotropin (hCG) delivery platform using engineered uterine exosomes to improve endometrial receptivity. Life Sci. 2021;275:119351.<pub-id pub-id-type="pmid">33737084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2021.119351</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR174"><label>174.</label><citation-alternatives><element-citation id="ec-CR174" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao-Ming Xi</surname><given-names>XMX</given-names></name><name name-style="western"><surname>Chen-Meng</surname><given-names>CM</given-names></name><name name-style="western"><surname>Shu-Jun Xia</surname><given-names>SJX</given-names></name><name name-style="western"><surname>Rong Lu</surname><given-names>RL</given-names></name></person-group><article-title>Drug loading techniques for exosome-based drug delivery systems</article-title><source>Pharmazie</source><year>2021</year><volume>76</volume><issue>2/3</issue><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">33714281</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1691/ph.2021.0128</pub-id></element-citation><mixed-citation id="mc-CR174" publication-type="journal">Xiao-Ming Xi XMX, Chen-Meng CM, Shu-Jun Xia SJX, Rong Lu RL. Drug loading techniques for exosome-based drug delivery systems. Pharmazie. 2021;76(2/3):61&#8211;7.<pub-id pub-id-type="pmid">33714281</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1691/ph.2021.0128</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR175"><label>175.</label><citation-alternatives><element-citation id="ec-CR175" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rayamajhi</surname><given-names>S</given-names></name><name name-style="western"><surname>Aryal</surname><given-names>S</given-names></name></person-group><article-title>Surface functionalization strategies of extracellular vesicles</article-title><source>J Mater Chem B</source><year>2020</year><volume>8</volume><issue>21</issue><fpage>4552</fpage><lpage>4569</lpage><pub-id pub-id-type="doi">10.1039/D0TB00744G</pub-id><pub-id pub-id-type="pmid">32377649</pub-id></element-citation><mixed-citation id="mc-CR175" publication-type="journal">Rayamajhi S, Aryal S. Surface functionalization strategies of extracellular vesicles. J Mater Chem B. 2020;8(21):4552&#8211;69.<pub-id pub-id-type="pmid">32377649</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d0tb00744g</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR176"><label>176.</label><citation-alternatives><element-citation id="ec-CR176" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>T</given-names></name><name name-style="western"><surname>Petrova</surname><given-names>K</given-names></name><name name-style="western"><surname>Payton</surname><given-names>N</given-names></name><name name-style="western"><surname>Persaud</surname><given-names>I</given-names></name><name name-style="western"><surname>Redzic</surname><given-names>J</given-names></name><name name-style="western"><surname>Gruner</surname><given-names>M</given-names></name><etal/></person-group><article-title>Surface functionalization of exosomes using click chemistry</article-title><source>Bioconjug Chem</source><year>2014</year><volume>25</volume><issue>10</issue><fpage>1777</fpage><lpage>1784</lpage><pub-id pub-id-type="doi">10.1021/bc500291r</pub-id><pub-id pub-id-type="pmid">25220352</pub-id><pub-id pub-id-type="pmcid">PMC4198107</pub-id></element-citation><mixed-citation id="mc-CR176" publication-type="journal">Smyth T, Petrova K, Payton N, Persaud I, Redzic J, Gruner M, et al. Surface functionalization of exosomes using click chemistry. Bioconjug Chem. 2014;25(10):1777&#8211;84.<pub-id pub-id-type="pmid">25220352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bc500291r</pub-id><pub-id pub-id-type="pmcid">PMC4198107</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR177"><label>177.</label><citation-alternatives><element-citation id="ec-CR177" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Katrekar</surname><given-names>D</given-names></name><name name-style="western"><surname>Mali</surname><given-names>P</given-names></name></person-group><article-title>RNA-guided adenosine deaminases: advances and challenges for therapeutic RNA editing</article-title><source>Biochemistry</source><year>2019</year><volume>58</volume><issue>15</issue><fpage>1947</fpage><lpage>1957</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.9b00046</pub-id><pub-id pub-id-type="pmid">30943016</pub-id></element-citation><mixed-citation id="mc-CR177" publication-type="journal">Chen G, Katrekar D, Mali P. RNA-guided adenosine deaminases: advances and challenges for therapeutic RNA editing. Biochemistry. 2019;58(15):1947&#8211;57.<pub-id pub-id-type="pmid">30943016</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.biochem.9b00046</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR178"><label>178.</label><citation-alternatives><element-citation id="ec-CR178" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>J</given-names></name><name name-style="western"><surname>Gu</surname><given-names>C</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Engineering of M2 macrophages-derived exosomes via click chemistry for spinal cord injury repair</article-title><source>Adv Healthc Mater.</source><year>2023</year><pub-id pub-id-type="doi">10.1002/adhm.202203391</pub-id><pub-id pub-id-type="pmid">36877863</pub-id></element-citation><mixed-citation id="mc-CR178" publication-type="journal">Zeng J, Gu C, Sun Y, Chen X. Engineering of M2 macrophages-derived exosomes via click chemistry for spinal cord injury repair. Adv Healthc Mater. 2023. 10.1002/adhm.202203391.<pub-id pub-id-type="pmid">36877863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adhm.202203391</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR179"><label>179.</label><citation-alternatives><element-citation id="ec-CR179" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hao</surname><given-names>D</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L</given-names></name><name name-style="western"><surname>Song</surname><given-names>H</given-names></name><name name-style="western"><surname>Duan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Carney</surname><given-names>R</given-names></name><etal/></person-group><article-title>Engineered extracellular vesicles with high collagen-binding affinity present superior <italic toggle="yes">in situ</italic> retention and therapeutic efficacy in tissue repair</article-title><source>Theranostics</source><year>2022</year><volume>12</volume><issue>13</issue><fpage>6021</fpage><lpage>6037</lpage><pub-id pub-id-type="doi">10.7150/thno.70448</pub-id><pub-id pub-id-type="pmid">35966577</pub-id><pub-id pub-id-type="pmcid">PMC9373818</pub-id></element-citation><mixed-citation id="mc-CR179" publication-type="journal">Hao D, Lu L, Song H, Duan Y, Chen J, Carney R, et al. Engineered extracellular vesicles with high collagen-binding affinity present superior <italic toggle="yes">in situ</italic> retention and therapeutic efficacy in tissue repair. Theranostics. 2022;12(13):6021&#8211;37.<pub-id pub-id-type="pmid">35966577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.70448</pub-id><pub-id pub-id-type="pmcid">PMC9373818</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR180"><label>180.</label><citation-alternatives><element-citation id="ec-CR180" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuang</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Du</surname><given-names>D</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name><name name-style="western"><surname>Deng</surname><given-names>M</given-names></name><name name-style="western"><surname>Long</surname><given-names>Q</given-names></name><etal/></person-group><article-title>SPION decorated exosome delivery of TNF-&#945; to cancer cell membranes through magnetism</article-title><source>Nanoscale</source><year>2020</year><volume>12</volume><issue>1</issue><fpage>173</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1039/C9NR05865F</pub-id><pub-id pub-id-type="pmid">31803890</pub-id></element-citation><mixed-citation id="mc-CR180" publication-type="journal">Zhuang M, Chen X, Du D, Shi J, Deng M, Long Q, et al. SPION decorated exosome delivery of TNF-&#945; to cancer cell membranes through magnetism. Nanoscale. 2020;12(1):173&#8211;88.<pub-id pub-id-type="pmid">31803890</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c9nr05865f</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR181"><label>181.</label><citation-alternatives><element-citation id="ec-CR181" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di</surname><given-names>H</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>E</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>General approach to engineering extracellular vesicles for biomedical analysis</article-title><source>Anal Chem</source><year>2019</year><volume>91</volume><issue>20</issue><fpage>12752</fpage><lpage>12759</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.9b02268</pub-id><pub-id pub-id-type="pmid">31529961</pub-id></element-citation><mixed-citation id="mc-CR181" publication-type="journal">Di H, Zeng E, Zhang P, Liu X, Zhang C, Yang J, et al. General approach to engineering extracellular vesicles for biomedical analysis. Anal Chem. 2019;91(20):12752&#8211;9.<pub-id pub-id-type="pmid">31529961</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.9b02268</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR182"><label>182.</label><citation-alternatives><element-citation id="ec-CR182" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamura</surname><given-names>R</given-names></name><name name-style="western"><surname>Uemoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Tabata</surname><given-names>Y</given-names></name></person-group><article-title>Augmented liver targeting of exosomes by surface modification with cationized pullulan</article-title><source>Acta Biomater</source><year>2017</year><volume>15</volume><issue>57</issue><fpage>274</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2017.05.013</pub-id><pub-id pub-id-type="pmid">28483695</pub-id></element-citation><mixed-citation id="mc-CR182" publication-type="journal">Tamura R, Uemoto S, Tabata Y. Augmented liver targeting of exosomes by surface modification with cationized pullulan. Acta Biomater. 2017;15(57):274&#8211;84.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2017.05.013</pub-id><pub-id pub-id-type="pmid">28483695</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR183"><label>183.</label><citation-alternatives><element-citation id="ec-CR183" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><name name-style="western"><surname>Ran</surname><given-names>N</given-names></name><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy</article-title><source>Sci Transl Med.</source><year>2018</year><volume>10</volume><issue>444</issue><fpage>eaat0195</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aat0195</pub-id><pub-id pub-id-type="pmid">29875202</pub-id></element-citation><mixed-citation id="mc-CR183" publication-type="journal">Gao X, Ran N, Dong X, Zuo B, Yang R, Zhou Q, et al. Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy. Sci Transl Med. 2018;10(444):eaat0195.<pub-id pub-id-type="pmid">29875202</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aat0195</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR184"><label>184.</label><citation-alternatives><element-citation id="ec-CR184" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sercombe</surname><given-names>L</given-names></name><name name-style="western"><surname>Veerati</surname><given-names>T</given-names></name><name name-style="western"><surname>Moheimani</surname><given-names>F</given-names></name><name name-style="western"><surname>Wu</surname><given-names>SY</given-names></name><name name-style="western"><surname>Sood</surname><given-names>AK</given-names></name><name name-style="western"><surname>Hua</surname><given-names>S</given-names></name></person-group><article-title>Advances and challenges of liposome assisted drug delivery</article-title><source>Front Pharmacol</source><year>2015</year><volume>6</volume><fpage>286</fpage><pub-id pub-id-type="doi">10.3389/fphar.2015.00286</pub-id><pub-id pub-id-type="pmid">26648870</pub-id><pub-id pub-id-type="pmcid">PMC4664963</pub-id></element-citation><mixed-citation id="mc-CR184" publication-type="journal">Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286.<pub-id pub-id-type="pmid">26648870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2015.00286</pub-id><pub-id pub-id-type="pmcid">PMC4664963</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR185"><label>185.</label><citation-alternatives><element-citation id="ec-CR185" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name></person-group><article-title>Bioinspired exosome-like therapeutics and delivery nanoplatforms</article-title><source>Biomaterials</source><year>2020</year><volume>2</volume><issue>242</issue><fpage>119925</fpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.119925</pub-id><pub-id pub-id-type="pmid">32151860</pub-id></element-citation><mixed-citation id="mc-CR185" publication-type="journal">Lu M, Huang Y. Bioinspired exosome-like therapeutics and delivery nanoplatforms. Biomaterials. 2020;2(242):119925.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2020.119925</pub-id><pub-id pub-id-type="pmid">32151860</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR186"><label>186.</label><citation-alternatives><element-citation id="ec-CR186" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment</article-title><source>Theranostics</source><year>2022</year><volume>12</volume><issue>11</issue><fpage>4866</fpage><lpage>4878</lpage><pub-id pub-id-type="doi">10.7150/thno.69368</pub-id><pub-id pub-id-type="pmid">35836795</pub-id><pub-id pub-id-type="pmcid">PMC9274754</pub-id></element-citation><mixed-citation id="mc-CR186" publication-type="journal">Liang Y, Xu X, Xu L, Iqbal Z, Ouyang K, Zhang H, et al. Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment. Theranostics. 2022;12(11):4866&#8211;78.<pub-id pub-id-type="pmid">35836795</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.69368</pub-id><pub-id pub-id-type="pmcid">PMC9274754</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR187"><label>187.</label><citation-alternatives><element-citation id="ec-CR187" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Virus-mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes</article-title><source>Adv Mater</source><year>2017</year><pub-id pub-id-type="doi">10.1002/adma.201605604</pub-id><pub-id pub-id-type="pmid">28165174</pub-id></element-citation><mixed-citation id="mc-CR187" publication-type="journal">Yang Y, Hong Y, Nam GH, Chung JH, Koh E, Kim IS. Virus-mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes. Adv Mater. 2017;29(13). 10.1002/adma.201605604.<pub-id pub-id-type="pmid">28165174</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adma.201605604</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR188"><label>188.</label><citation-alternatives><element-citation id="ec-CR188" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>G</given-names></name><name name-style="western"><surname>Ceilley</surname><given-names>R</given-names></name></person-group><article-title>Chronic wound healing: a review of current management and treatments</article-title><source>Adv Ther</source><year>2017</year><volume>34</volume><issue>3</issue><fpage>599</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1007/s12325-017-0478-y</pub-id><pub-id pub-id-type="pmid">28108895</pub-id><pub-id pub-id-type="pmcid">PMC5350204</pub-id></element-citation><mixed-citation id="mc-CR188" publication-type="journal">Han G, Ceilley R. Chronic wound healing: a review of current management and treatments. Adv Ther. 2017;34(3):599&#8211;610.<pub-id pub-id-type="pmid">28108895</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12325-017-0478-y</pub-id><pub-id pub-id-type="pmcid">PMC5350204</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR189"><label>189.</label><citation-alternatives><element-citation id="ec-CR189" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>AD</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>DA</given-names></name></person-group><article-title>Stem cell extracellular vesicles in skin repair</article-title><source>Bioeng Basel Switz</source><year>2018</year><volume>6</volume><issue>1</issue><fpage>E4</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/bioengineering6010004</pub-id><pub-id pub-id-type="pmcid">PMC6466099</pub-id><pub-id pub-id-type="pmid">30598033</pub-id></element-citation><mixed-citation id="mc-CR189" publication-type="journal">Ferreira AD, Gomes DA. Stem cell extracellular vesicles in skin repair. Bioeng Basel Switz. 2018;6(1):E4.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/bioengineering6010004</pub-id><pub-id pub-id-type="pmcid">PMC6466099</pub-id><pub-id pub-id-type="pmid">30598033</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR190"><label>190.</label><citation-alternatives><element-citation id="ec-CR190" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gushiken</surname><given-names>LFS</given-names></name><name name-style="western"><surname>Beserra</surname><given-names>FP</given-names></name><name name-style="western"><surname>Bastos</surname><given-names>JK</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Pellizzon</surname><given-names>CH</given-names></name></person-group><article-title>Cutaneous wound healing: an update from physiopathology to current therapies</article-title><source>Life</source><year>2021</year><volume>11</volume><issue>7</issue><fpage>665</fpage><pub-id pub-id-type="doi">10.3390/life11070665</pub-id><pub-id pub-id-type="pmid">34357037</pub-id><pub-id pub-id-type="pmcid">PMC8307436</pub-id></element-citation><mixed-citation id="mc-CR190" publication-type="journal">Gushiken LFS, Beserra FP, Bastos JK, Jackson CJ, Pellizzon CH. Cutaneous wound healing: an update from physiopathology to current therapies. Life. 2021;11(7):665.<pub-id pub-id-type="pmid">34357037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/life11070665</pub-id><pub-id pub-id-type="pmcid">PMC8307436</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR191"><label>191.</label><citation-alternatives><element-citation id="ec-CR191" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braund</surname><given-names>R</given-names></name><name name-style="western"><surname>Hook</surname><given-names>S</given-names></name><name name-style="western"><surname>Medlicott</surname><given-names>NJ</given-names></name></person-group><article-title>The role of topical growth factors in chronic wounds</article-title><source>Curr Drug Deliv</source><year>2007</year><volume>4</volume><issue>3</issue><fpage>195</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.2174/156720107781023857</pub-id><pub-id pub-id-type="pmid">17627493</pub-id></element-citation><mixed-citation id="mc-CR191" publication-type="journal">Braund R, Hook S, Medlicott NJ. The role of topical growth factors in chronic wounds. Curr Drug Deliv. 2007;4(3):195&#8211;204.<pub-id pub-id-type="pmid">17627493</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/156720107781023857</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR192"><label>192.</label><citation-alternatives><element-citation id="ec-CR192" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Margolis</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Kantor</surname><given-names>J</given-names></name><name name-style="western"><surname>Santanna</surname><given-names>J</given-names></name><name name-style="western"><surname>Strom</surname><given-names>BL</given-names></name><name name-style="western"><surname>Berlin</surname><given-names>JA</given-names></name></person-group><article-title>Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis</article-title><source>Arch Dermatol</source><year>2000</year><volume>136</volume><issue>12</issue><fpage>1531</fpage><lpage>1535</lpage><pub-id pub-id-type="doi">10.1001/archderm.136.12.1531</pub-id><pub-id pub-id-type="pmid">11115166</pub-id></element-citation><mixed-citation id="mc-CR192" publication-type="journal">Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol. 2000;136(12):1531&#8211;5.<pub-id pub-id-type="pmid">11115166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archderm.136.12.1531</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR193"><label>193.</label><citation-alternatives><element-citation id="ec-CR193" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Margolis</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Allen-Taylor</surname><given-names>L</given-names></name><name name-style="western"><surname>Hoffstad</surname><given-names>O</given-names></name><name name-style="western"><surname>Berlin</surname><given-names>JA</given-names></name></person-group><article-title>Healing diabetic neuropathic foot ulcers: are we getting better?</article-title><source>Diabet Med</source><year>2005</year><volume>22</volume><issue>2</issue><fpage>172</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2004.01375.x</pub-id><pub-id pub-id-type="pmid">15660734</pub-id></element-citation><mixed-citation id="mc-CR193" publication-type="journal">Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Healing diabetic neuropathic foot ulcers: are we getting better? Diabet Med. 2005;22(2):172&#8211;6.<pub-id pub-id-type="pmid">15660734</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1464-5491.2004.01375.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR194"><label>194.</label><citation-alternatives><element-citation id="ec-CR194" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>M</given-names></name><name name-style="western"><surname>Kosaric</surname><given-names>N</given-names></name><name name-style="western"><surname>Bonham</surname><given-names>CA</given-names></name><name name-style="western"><surname>Gurtner</surname><given-names>GC</given-names></name></person-group><article-title>Wound healing: a cellular perspective</article-title><source>Physiol Rev</source><year>2019</year><volume>99</volume><issue>1</issue><fpage>665</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1152/physrev.00067.2017</pub-id><pub-id pub-id-type="pmid">30475656</pub-id><pub-id pub-id-type="pmcid">PMC6442927</pub-id></element-citation><mixed-citation id="mc-CR194" publication-type="journal">Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound healing: a cellular perspective. Physiol Rev. 2019;99(1):665&#8211;706.<pub-id pub-id-type="pmid">30475656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/physrev.00067.2017</pub-id><pub-id pub-id-type="pmcid">PMC6442927</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR195"><label>195.</label><citation-alternatives><element-citation id="ec-CR195" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>R</given-names></name><etal/></person-group><article-title>Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><issue>1</issue><fpage>32993</fpage><pub-id pub-id-type="doi">10.1038/srep32993</pub-id><pub-id pub-id-type="pmid">27615560</pub-id><pub-id pub-id-type="pmcid">PMC5018733</pub-id></element-citation><mixed-citation id="mc-CR195" publication-type="journal">Hu L, Wang J, Zhou X, Xiong Z, Zhao J, Yu R, et al. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci Rep. 2016;6(1):32993.<pub-id pub-id-type="pmid">27615560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep32993</pub-id><pub-id pub-id-type="pmcid">PMC5018733</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR196"><label>196.</label><citation-alternatives><element-citation id="ec-CR196" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xunian</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kalluri</surname><given-names>R</given-names></name></person-group><article-title>Biology and therapeutic potential of mesenchymal stem cell-derived exosomes</article-title><source>Cancer Sci</source><year>2020</year><volume>111</volume><issue>9</issue><fpage>3100</fpage><lpage>3110</lpage><pub-id pub-id-type="doi">10.1111/cas.14563</pub-id><pub-id pub-id-type="pmid">32639675</pub-id><pub-id pub-id-type="pmcid">PMC7469857</pub-id></element-citation><mixed-citation id="mc-CR196" publication-type="journal">Xunian Z, Kalluri R. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes. Cancer Sci. 2020;111(9):3100&#8211;10.<pub-id pub-id-type="pmid">32639675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cas.14563</pub-id><pub-id pub-id-type="pmcid">PMC7469857</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR197"><label>197.</label><citation-alternatives><element-citation id="ec-CR197" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guillamat-Prats</surname><given-names>R</given-names></name></person-group><article-title>The role of MSC in wound healing, scarring and regeneration</article-title><source>Cells</source><year>2021</year><volume>10</volume><issue>7</issue><fpage>1729</fpage><pub-id pub-id-type="doi">10.3390/cells10071729</pub-id><pub-id pub-id-type="pmid">34359898</pub-id><pub-id pub-id-type="pmcid">PMC8305394</pub-id></element-citation><mixed-citation id="mc-CR197" publication-type="journal">Guillamat-Prats R. The role of MSC in wound healing, scarring and regeneration. Cells. 2021;10(7):1729.<pub-id pub-id-type="pmid">34359898</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells10071729</pub-id><pub-id pub-id-type="pmcid">PMC8305394</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR198"><label>198.</label><citation-alternatives><element-citation id="ec-CR198" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Traversa</surname><given-names>B</given-names></name><name name-style="western"><surname>Sussman</surname><given-names>G</given-names></name></person-group><article-title>The role of growth factors, cytokines and proteases in wound management</article-title><source>Prim Intent: Aust J Wound Manag</source><year>2001</year><volume>9</volume><fpage>161</fpage><lpage>167</lpage></element-citation><mixed-citation id="mc-CR198" publication-type="journal">Traversa B, Sussman G. The role of growth factors, cytokines and proteases in wound management. Prim Intent: Aust J Wound Manag. 2001;9:161&#8211;7.</mixed-citation></citation-alternatives></ref><ref id="CR199"><label>199.</label><citation-alternatives><element-citation id="ec-CR199" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santoro</surname><given-names>MM</given-names></name><name name-style="western"><surname>Gaudino</surname><given-names>G</given-names></name></person-group><article-title>Cellular and molecular facets of keratinocyte reepithelization during wound healing</article-title><source>Exp Cell Res</source><year>2005</year><volume>304</volume><issue>1</issue><fpage>274</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2004.10.033</pub-id><pub-id pub-id-type="pmid">15707592</pub-id></element-citation><mixed-citation id="mc-CR199" publication-type="journal">Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res. 2005;304(1):274&#8211;86.<pub-id pub-id-type="pmid">15707592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yexcr.2004.10.033</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR200"><label>200.</label><citation-alternatives><element-citation id="ec-CR200" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiritsy</surname><given-names>CP</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>AB</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>SE</given-names></name></person-group><article-title>Role of growth factors in cutaneous wound healing: a review</article-title><source>Crit Rev Oral Biol Med Off Publ Am Assoc Oral Biol</source><year>1993</year><volume>4</volume><issue>5</issue><fpage>729</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1177/10454411930040050401</pub-id><pub-id pub-id-type="pmid">8292715</pub-id></element-citation><mixed-citation id="mc-CR200" publication-type="journal">Kiritsy CP, Lynch AB, Lynch SE. Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol Med Off Publ Am Assoc Oral Biol. 1993;4(5):729&#8211;60.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/10454411930040050401</pub-id><pub-id pub-id-type="pmid">8292715</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR201"><label>201.</label><citation-alternatives><element-citation id="ec-CR201" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diegelmann</surname><given-names>RF</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>IK</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>AM</given-names></name></person-group><article-title>The role of macrophages in wound repair: a review</article-title><source>Plast Reconstr Surg</source><year>1981</year><volume>68</volume><issue>1</issue><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1097/00006534-198107000-00025</pub-id><pub-id pub-id-type="pmid">7017779</pub-id></element-citation><mixed-citation id="mc-CR201" publication-type="journal">Diegelmann RF, Cohen IK, Kaplan AM. The role of macrophages in wound repair: a review. Plast Reconstr Surg. 1981;68(1):107&#8211;13.<pub-id pub-id-type="pmid">7017779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00006534-198107000-00025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR202"><label>202.</label><citation-alternatives><element-citation id="ec-CR202" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>XM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qi</surname><given-names>ZQ</given-names></name></person-group><article-title>Enhanced wound healing and hemostasis with exosome-loaded gelatin sponges from human umbilical cord mesenchymal stem cells</article-title><source>World J Stem Cells</source><year>2023</year><volume>15</volume><issue>9</issue><fpage>947</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.4252/wjsc.v15.i9.947</pub-id><pub-id pub-id-type="pmid">37900941</pub-id><pub-id pub-id-type="pmcid">PMC10600743</pub-id></element-citation><mixed-citation id="mc-CR202" publication-type="journal">Hu XM, Wang CC, Xiao Y, Jiang P, Liu Y, Qi ZQ. Enhanced wound healing and hemostasis with exosome-loaded gelatin sponges from human umbilical cord mesenchymal stem cells. World J Stem Cells. 2023;15(9):947&#8211;59.<pub-id pub-id-type="pmid">37900941</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4252/wjsc.v15.i9.947</pub-id><pub-id pub-id-type="pmcid">PMC10600743</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR203"><label>203.</label><citation-alternatives><element-citation id="ec-CR203" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eming</surname><given-names>SA</given-names></name><name name-style="western"><surname>Krieg</surname><given-names>T</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>JM</given-names></name></person-group><article-title>Inflammation in wound repair: molecular and cellular mechanisms</article-title><source>J Invest Dermatol</source><year>2007</year><volume>127</volume><issue>3</issue><fpage>514</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1038/sj.jid.5700701</pub-id><pub-id pub-id-type="pmid">17299434</pub-id></element-citation><mixed-citation id="mc-CR203" publication-type="journal">Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127(3):514&#8211;25.<pub-id pub-id-type="pmid">17299434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.jid.5700701</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR204"><label>204.</label><citation-alternatives><element-citation id="ec-CR204" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Land&#233;n</surname><given-names>NX</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>St&#229;hle</surname><given-names>M</given-names></name></person-group><article-title>Transition from inflammation to proliferation: a critical step during wound healing</article-title><source>Cell Mol Life Sci CMLS</source><year>2016</year><volume>73</volume><issue>20</issue><fpage>3861</fpage><lpage>3885</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2268-0</pub-id><pub-id pub-id-type="pmid">27180275</pub-id><pub-id pub-id-type="pmcid">PMC5021733</pub-id></element-citation><mixed-citation id="mc-CR204" publication-type="journal">Land&#233;n NX, Li D, St&#229;hle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci CMLS. 2016;73(20):3861&#8211;85.<pub-id pub-id-type="pmid">27180275</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00018-016-2268-0</pub-id><pub-id pub-id-type="pmcid">PMC5021733</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR205"><label>205.</label><citation-alternatives><element-citation id="ec-CR205" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blazquez</surname><given-names>R</given-names></name><name name-style="western"><surname>Sanchez-Margallo</surname><given-names>FM</given-names></name><name name-style="western"><surname>De La Rosa</surname><given-names>O</given-names></name><name name-style="western"><surname>Dalemans</surname><given-names>W</given-names></name><name name-style="western"><surname>&#195;lvarez</surname><given-names>V</given-names></name><name name-style="western"><surname>Tarazona</surname><given-names>R</given-names></name><etal/></person-group><article-title>Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells</article-title><source>Front Immunol.</source><year>2014</year><volume>5</volume><fpage>556</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00556</pub-id><pub-id pub-id-type="pmid">25414703</pub-id><pub-id pub-id-type="pmcid">PMC4220146</pub-id></element-citation><mixed-citation id="mc-CR205" publication-type="journal">Blazquez R, Sanchez-Margallo FM, De La Rosa O, Dalemans W, &#195;lvarez V, Tarazona R, et al. Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells. Front Immunol. 2014;5:556.<pub-id pub-id-type="pmid">25414703</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2014.00556</pub-id><pub-id pub-id-type="pmcid">PMC4220146</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR206"><label>206.</label><citation-alternatives><element-citation id="ec-CR206" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X</given-names></name><name name-style="western"><surname>Lian</surname><given-names>W</given-names></name><name name-style="western"><surname>Shi</surname><given-names>R</given-names></name><name name-style="western"><surname>Han</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model</article-title><source>Exp Mol Med</source><year>2018</year><volume>50</volume><issue>4</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/s12276-018-0058-5</pub-id><pub-id pub-id-type="pmid">29651102</pub-id><pub-id pub-id-type="pmcid">PMC5938041</pub-id></element-citation><mixed-citation id="mc-CR206" publication-type="journal">Li X, Xie X, Lian W, Shi R, Han S, Zhang H, et al. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Exp Mol Med. 2018;50(4):1&#8211;14.<pub-id pub-id-type="pmid">29651102</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s12276-018-0058-5</pub-id><pub-id pub-id-type="pmcid">PMC5938041</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR207"><label>207.</label><citation-alternatives><element-citation id="ec-CR207" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Xia</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>R</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fan</surname><given-names>J</given-names></name><name name-style="western"><surname>Shu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization</article-title><source>Stem Cell Res Ther</source><year>2020</year><volume>11</volume><issue>1</issue><fpage>424</fpage><pub-id pub-id-type="doi">10.1186/s13287-020-01937-8</pub-id><pub-id pub-id-type="pmid">32993783</pub-id><pub-id pub-id-type="pmcid">PMC7522905</pub-id></element-citation><mixed-citation id="mc-CR207" publication-type="journal">Wang J, Xia J, Huang R, Hu Y, Fan J, Shu Q, et al. Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization. Stem Cell Res Ther. 2020;11(1):424.<pub-id pub-id-type="pmid">32993783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-020-01937-8</pub-id><pub-id pub-id-type="pmcid">PMC7522905</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR208"><label>208.</label><citation-alternatives><element-citation id="ec-CR208" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M</given-names></name><name name-style="western"><surname>Xie</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Ye</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway</article-title><source>Stem Cell Res Ther</source><year>2020</year><volume>11</volume><issue>1</issue><fpage>259</fpage><pub-id pub-id-type="doi">10.1186/s13287-020-01756-x</pub-id><pub-id pub-id-type="pmid">32600435</pub-id><pub-id pub-id-type="pmcid">PMC7322868</pub-id></element-citation><mixed-citation id="mc-CR208" publication-type="journal">Liu W, Yu M, Xie D, Wang L, Ye C, Zhu Q, et al. Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020;11(1):259.<pub-id pub-id-type="pmid">32600435</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-020-01756-x</pub-id><pub-id pub-id-type="pmcid">PMC7322868</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR209"><label>209.</label><citation-alternatives><element-citation id="ec-CR209" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Lu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Human exosomes accelerate cutaneous wound healing by promoting collagen synthesis in a diabetic mouse model</article-title><source>Stem Cells Dev</source><year>2021</year><volume>30</volume><issue>18</issue><fpage>922</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1089/scd.2021.0100</pub-id><pub-id pub-id-type="pmid">34167333</pub-id></element-citation><mixed-citation id="mc-CR209" publication-type="journal">Zhao B, Zhang X, Zhang Y, Lu Y, Zhang W, Lu S, et al. Human exosomes accelerate cutaneous wound healing by promoting collagen synthesis in a diabetic mouse model. Stem Cells Dev. 2021;30(18):922&#8211;33.<pub-id pub-id-type="pmid">34167333</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/scd.2021.0100</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR210"><label>210.</label><citation-alternatives><element-citation id="ec-CR210" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalirfardouei</surname><given-names>R</given-names></name><name name-style="western"><surname>Jamialahmadi</surname><given-names>K</given-names></name><name name-style="western"><surname>Jafarian</surname><given-names>AH</given-names></name><name name-style="western"><surname>Mahdipour</surname><given-names>E</given-names></name></person-group><article-title>Promising effects of exosomes isolated from menstrual blood-derived mesenchymal stem cell on wound-healing process in diabetic mouse model</article-title><source>J Tissue Eng Regen Med</source><year>2019</year><volume>13</volume><issue>4</issue><fpage>555</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1002/term.2799</pub-id><pub-id pub-id-type="pmid">30656863</pub-id></element-citation><mixed-citation id="mc-CR210" publication-type="journal">Dalirfardouei R, Jamialahmadi K, Jafarian AH, Mahdipour E. Promising effects of exosomes isolated from menstrual blood-derived mesenchymal stem cell on wound-healing process in diabetic mouse model. J Tissue Eng Regen Med. 2019;13(4):555&#8211;68.<pub-id pub-id-type="pmid">30656863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/term.2799</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR211"><label>211.</label><citation-alternatives><element-citation id="ec-CR211" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hao</surname><given-names>PC</given-names></name><name name-style="western"><surname>Burnouf</surname><given-names>T</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>CW</given-names></name><name name-style="western"><surname>Jheng</surname><given-names>PR</given-names></name><name name-style="western"><surname>Szunerits</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Enhanced diabetic wound healing using platelet-derived extracellular vesicles and reduced graphene oxide in polymer-coordinated hydrogels</article-title><source>J Nanobiotechnology</source><year>2023</year><volume>21</volume><issue>1</issue><fpage>318</fpage><pub-id pub-id-type="doi">10.1186/s12951-023-02068-x</pub-id><pub-id pub-id-type="pmid">37667248</pub-id><pub-id pub-id-type="pmcid">PMC10478311</pub-id></element-citation><mixed-citation id="mc-CR211" publication-type="journal">Hao PC, Burnouf T, Chiang CW, Jheng PR, Szunerits S, Yang JC, et al. Enhanced diabetic wound healing using platelet-derived extracellular vesicles and reduced graphene oxide in polymer-coordinated hydrogels. J Nanobiotechnology. 2023;21(1):318.<pub-id pub-id-type="pmid">37667248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-023-02068-x</pub-id><pub-id pub-id-type="pmcid">PMC10478311</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR212"><label>212.</label><citation-alternatives><element-citation id="ec-CR212" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ha</surname><given-names>DH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>HH</given-names></name><name name-style="western"><surname>Park</surname><given-names>GH</given-names></name><name name-style="western"><surname>Yang</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration</article-title><source>Cells</source><year>2020</year><volume>9</volume><issue>5</issue><fpage>E1157</fpage><pub-id pub-id-type="doi">10.3390/cells9051157</pub-id><pub-id pub-id-type="pmcid">PMC7290908</pub-id><pub-id pub-id-type="pmid">32392899</pub-id></element-citation><mixed-citation id="mc-CR212" publication-type="journal">Ha DH, Kim HK, Lee J, Kwon HH, Park GH, Yang SH, et al. Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration. Cells. 2020;9(5):E1157.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells9051157</pub-id><pub-id pub-id-type="pmcid">PMC7290908</pub-id><pub-id pub-id-type="pmid">32392899</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR213"><label>213.</label><citation-alternatives><element-citation id="ec-CR213" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorg</surname><given-names>H</given-names></name><name name-style="western"><surname>Tilkorn</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Hager</surname><given-names>S</given-names></name><name name-style="western"><surname>Hauser</surname><given-names>J</given-names></name><name name-style="western"><surname>Mirastschijski</surname><given-names>U</given-names></name></person-group><article-title>Skin wound healing: an update on the current knowledge and concepts</article-title><source>Eur Surg Res Eur Chir Forsch Rech Chir Eur</source><year>2017</year><volume>58</volume><issue>1&#8211;2</issue><fpage>81</fpage><lpage>94</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000454919</pub-id><pub-id pub-id-type="pmid">27974711</pub-id></element-citation><mixed-citation id="mc-CR213" publication-type="journal">Sorg H, Tilkorn DJ, Hager S, Hauser J, Mirastschijski U. Skin wound healing: an update on the current knowledge and concepts. Eur Surg Res Eur Chir Forsch Rech Chir Eur. 2017;58(1&#8211;2):81&#8211;94.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000454919</pub-id><pub-id pub-id-type="pmid">27974711</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR214"><label>214.</label><citation-alternatives><element-citation id="ec-CR214" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pomatto</surname><given-names>M</given-names></name><name name-style="western"><surname>Gai</surname><given-names>C</given-names></name><name name-style="western"><surname>Negro</surname><given-names>F</given-names></name><name name-style="western"><surname>Cedrino</surname><given-names>M</given-names></name><name name-style="western"><surname>Grange</surname><given-names>C</given-names></name><name name-style="western"><surname>Ceccotti</surname><given-names>E</given-names></name><etal/></person-group><article-title>Differential therapeutic effect of extracellular vesicles derived by bone marrow and adipose mesenchymal stem cells on wound healing of diabetic ulcers and correlation to their cargoes</article-title><source>Int J Mol Sci</source><year>2021</year><volume>22</volume><issue>8</issue><fpage>3851</fpage><pub-id pub-id-type="doi">10.3390/ijms22083851</pub-id><pub-id pub-id-type="pmid">33917759</pub-id><pub-id pub-id-type="pmcid">PMC8068154</pub-id></element-citation><mixed-citation id="mc-CR214" publication-type="journal">Pomatto M, Gai C, Negro F, Cedrino M, Grange C, Ceccotti E, et al. Differential therapeutic effect of extracellular vesicles derived by bone marrow and adipose mesenchymal stem cells on wound healing of diabetic ulcers and correlation to their cargoes. Int J Mol Sci. 2021;22(8):3851.<pub-id pub-id-type="pmid">33917759</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22083851</pub-id><pub-id pub-id-type="pmcid">PMC8068154</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR215"><label>215.</label><citation-alternatives><element-citation id="ec-CR215" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tao</surname><given-names>R</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xue</surname><given-names>H</given-names></name><name name-style="western"><surname>Hu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis</article-title><source>J Nanobiotechnology</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>150</fpage><pub-id pub-id-type="doi">10.1186/s12951-021-00894-5</pub-id><pub-id pub-id-type="pmid">34020670</pub-id><pub-id pub-id-type="pmcid">PMC8139165</pub-id></element-citation><mixed-citation id="mc-CR215" publication-type="journal">Hu Y, Tao R, Chen L, Xiong Y, Xue H, Hu L, et al. Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis. J Nanobiotechnology. 2021;19(1):150.<pub-id pub-id-type="pmid">34020670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-021-00894-5</pub-id><pub-id pub-id-type="pmcid">PMC8139165</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR216"><label>216.</label><citation-alternatives><element-citation id="ec-CR216" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shabbir</surname><given-names>A</given-names></name><name name-style="western"><surname>Cox</surname><given-names>A</given-names></name><name name-style="western"><surname>Rodriguez-Menocal</surname><given-names>L</given-names></name><name name-style="western"><surname>Salgado</surname><given-names>M</given-names></name><name name-style="western"><surname>Badiavas</surname><given-names>EV</given-names></name></person-group><article-title>Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis In vitro</article-title><source>Stem Cells Dev</source><year>2015</year><volume>24</volume><issue>14</issue><fpage>1635</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.1089/scd.2014.0316</pub-id><pub-id pub-id-type="pmid">25867197</pub-id><pub-id pub-id-type="pmcid">PMC4499790</pub-id></element-citation><mixed-citation id="mc-CR216" publication-type="journal">Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Badiavas EV. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis In vitro. Stem Cells Dev. 2015;24(14):1635&#8211;47.<pub-id pub-id-type="pmid">25867197</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/scd.2014.0316</pub-id><pub-id pub-id-type="pmcid">PMC4499790</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR217"><label>217.</label><citation-alternatives><element-citation id="ec-CR217" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bian</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Ma</surname><given-names>K</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Regenerative and protective effects of dMSC-sEVs on high-glucose-induced senescent fibroblasts by suppressing RAGE pathway and activating smad pathway</article-title><source>Stem Cell Res Ther</source><year>2020</year><volume>11</volume><issue>1</issue><fpage>166</fpage><pub-id pub-id-type="doi">10.1186/s13287-020-01681-z</pub-id><pub-id pub-id-type="pmid">32349787</pub-id><pub-id pub-id-type="pmcid">PMC7191792</pub-id></element-citation><mixed-citation id="mc-CR217" publication-type="journal">Bian X, Li B, Yang J, Ma K, Sun M, Zhang C, et al. Regenerative and protective effects of dMSC-sEVs on high-glucose-induced senescent fibroblasts by suppressing RAGE pathway and activating smad pathway. Stem Cell Res Ther. 2020;11(1):166.<pub-id pub-id-type="pmid">32349787</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-020-01681-z</pub-id><pub-id pub-id-type="pmcid">PMC7191792</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR218"><label>218.</label><citation-alternatives><element-citation id="ec-CR218" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>F</given-names></name><name name-style="western"><surname>Gu</surname><given-names>L</given-names></name><name name-style="western"><surname>Ji</surname><given-names>P</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Adipose mesenchymal stem cell exosomes promote wound healing through accelerated keratinocyte migration and proliferation by activating the AKT/HIF-1&#945; axis</article-title><source>J Mol Histol</source><year>2020</year><volume>51</volume><issue>4</issue><fpage>375</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1007/s10735-020-09887-4</pub-id><pub-id pub-id-type="pmid">32556903</pub-id></element-citation><mixed-citation id="mc-CR218" publication-type="journal">Zhang Y, Han F, Gu L, Ji P, Yang X, Liu M, et al. Adipose mesenchymal stem cell exosomes promote wound healing through accelerated keratinocyte migration and proliferation by activating the AKT/HIF-1&#945; axis. J Mol Histol. 2020;51(4):375&#8211;83.<pub-id pub-id-type="pmid">32556903</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10735-020-09887-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR219"><label>219.</label><citation-alternatives><element-citation id="ec-CR219" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>T</given-names></name><name name-style="western"><surname>Fu</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pan</surname><given-names>M</given-names></name></person-group><article-title>Adipose mesenchymal stem cell-derived exosomes promote cell proliferation, migration, and inhibit cell apoptosis via wnt/&#946;-catenin signaling in cutaneous wound healing</article-title><source>J Cell Biochem</source><year>2019</year><volume>120</volume><issue>6</issue><fpage>10847</fpage><lpage>10854</lpage><pub-id pub-id-type="doi">10.1002/jcb.28376</pub-id><pub-id pub-id-type="pmid">30681184</pub-id></element-citation><mixed-citation id="mc-CR219" publication-type="journal">Ma T, Fu B, Yang X, Xiao Y, Pan M. Adipose mesenchymal stem cell-derived exosomes promote cell proliferation, migration, and inhibit cell apoptosis via wnt/&#946;-catenin signaling in cutaneous wound healing. J Cell Biochem. 2019;120(6):10847&#8211;54.<pub-id pub-id-type="pmid">30681184</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcb.28376</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR220"><label>220.</label><citation-alternatives><element-citation id="ec-CR220" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>G</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>MSC-derived exosomes attenuate cell death through suppressing AIF nucleus translocation and enhance cutaneous wound healing</article-title><source>Stem Cell Res Ther</source><year>2020</year><volume>11</volume><issue>1</issue><fpage>174</fpage><pub-id pub-id-type="doi">10.1186/s13287-020-01616-8</pub-id><pub-id pub-id-type="pmid">32393338</pub-id><pub-id pub-id-type="pmcid">PMC7212595</pub-id></element-citation><mixed-citation id="mc-CR220" publication-type="journal">Zhao G, Liu F, Liu Z, Zuo K, Wang B, Zhang Y, et al. MSC-derived exosomes attenuate cell death through suppressing AIF nucleus translocation and enhance cutaneous wound healing. Stem Cell Res Ther. 2020;11(1):174.<pub-id pub-id-type="pmid">32393338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-020-01616-8</pub-id><pub-id pub-id-type="pmcid">PMC7212595</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR221"><label>221.</label><citation-alternatives><element-citation id="ec-CR221" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Gong</surname><given-names>H</given-names></name><name name-style="western"><surname>Qi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Fetal dermal mesenchymal stem cell-derived exosomes accelerate cutaneous wound healing by activating notch signaling</article-title><source>Stem Cells Int</source><year>2019</year><volume>10</volume><issue>2019</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/2402916</pub-id><pub-id pub-id-type="pmcid">PMC6590601</pub-id><pub-id pub-id-type="pmid">31281370</pub-id></element-citation><mixed-citation id="mc-CR221" publication-type="journal">Wang X, Jiao Y, Pan Y, Zhang L, Gong H, Qi Y, et al. Fetal dermal mesenchymal stem cell-derived exosomes accelerate cutaneous wound healing by activating notch signaling. Stem Cells Int. 2019;10(2019):1&#8211;11.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/2402916</pub-id><pub-id pub-id-type="pmcid">PMC6590601</pub-id><pub-id pub-id-type="pmid">31281370</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR222"><label>222.</label><citation-alternatives><element-citation id="ec-CR222" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broughton</surname><given-names>G</given-names></name><name name-style="western"><surname>Janis</surname><given-names>JE</given-names></name><name name-style="western"><surname>Attinger</surname><given-names>CE</given-names></name></person-group><article-title>The basic science of wound healing</article-title><source>Plast Reconstr Surg</source><year>2006</year><volume>117</volume><issue>SUPPLEMENT</issue><fpage>12S</fpage><lpage>34S</lpage><pub-id pub-id-type="doi">10.1097/01.prs.0000225430.42531.c2</pub-id><pub-id pub-id-type="pmid">16799372</pub-id></element-citation><mixed-citation id="mc-CR222" publication-type="journal">Broughton G, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006;117(SUPPLEMENT):12S-34S.<pub-id pub-id-type="pmid">16799372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.prs.0000225430.42531.c2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR223"><label>223.</label><citation-alternatives><element-citation id="ec-CR223" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCarty</surname><given-names>SM</given-names></name><name name-style="western"><surname>Percival</surname><given-names>SL</given-names></name></person-group><article-title>Proteases and delayed wound healing</article-title><source>Adv Wound Care</source><year>2013</year><volume>2</volume><issue>8</issue><fpage>438</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1089/wound.2012.0370</pub-id><pub-id pub-id-type="pmcid">PMC3842891</pub-id><pub-id pub-id-type="pmid">24688830</pub-id></element-citation><mixed-citation id="mc-CR223" publication-type="journal">McCarty SM, Percival SL. Proteases and delayed wound healing. Adv Wound Care. 2013;2(8):438&#8211;47.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/wound.2012.0370</pub-id><pub-id pub-id-type="pmcid">PMC3842891</pub-id><pub-id pub-id-type="pmid">24688830</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR224"><label>224.</label><citation-alternatives><element-citation id="ec-CR224" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>auf dem Keller</surname><given-names>U</given-names></name><name name-style="western"><surname>Sabino</surname><given-names>F</given-names></name></person-group><article-title>Matrix metalloproteinases in impaired wound healing</article-title><source>Met Med.</source><year>2015</year><volume>2</volume><fpage>1</fpage></element-citation><mixed-citation id="mc-CR224" publication-type="journal">auf dem Keller U, Sabino F. Matrix metalloproteinases in impaired wound healing. Met Med. 2015;2:1.</mixed-citation></citation-alternatives></ref><ref id="CR225"><label>225.</label><citation-alternatives><element-citation id="ec-CR225" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gong</surname><given-names>A</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shi</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><etal/></person-group><article-title>HucMSC exosome-delivered 14-3-3&#950; orchestrates self-control of the wnt response via modulation of YAP during cutaneous regeneration</article-title><source>Stem Cells</source><year>2016</year><volume>34</volume><issue>10</issue><fpage>2485</fpage><lpage>2500</lpage><pub-id pub-id-type="doi">10.1002/stem.2432</pub-id><pub-id pub-id-type="pmid">27334574</pub-id></element-citation><mixed-citation id="mc-CR225" publication-type="journal">Zhang B, Shi Y, Gong A, Pan Z, Shi H, Yang H, et al. HucMSC exosome-delivered 14-3-3&#950; orchestrates self-control of the wnt response via modulation of YAP during cutaneous regeneration. Stem Cells. 2016;34(10):2485&#8211;500.<pub-id pub-id-type="pmid">27334574</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/stem.2432</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR226"><label>226.</label><citation-alternatives><element-citation id="ec-CR226" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Hu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Shehada</surname><given-names>HMA</given-names></name><etal/></person-group><article-title>Exosomes secreted by human adipose mesenchymal stem cells promote scarless cutaneous repair by regulating extracellular matrix remodelling</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>13321</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-12919-x</pub-id><pub-id pub-id-type="pmid">29042658</pub-id><pub-id pub-id-type="pmcid">PMC5645460</pub-id></element-citation><mixed-citation id="mc-CR226" publication-type="journal">Wang L, Hu L, Zhou X, Xiong Z, Zhang C, Shehada HMA, et al. Exosomes secreted by human adipose mesenchymal stem cells promote scarless cutaneous repair by regulating extracellular matrix remodelling. Sci Rep. 2017;7(1):13321.<pub-id pub-id-type="pmid">29042658</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-017-12919-x</pub-id><pub-id pub-id-type="pmcid">PMC5645460</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR227"><label>227.</label><citation-alternatives><element-citation id="ec-CR227" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>P</given-names></name><name name-style="western"><surname>Sui</surname><given-names>BD</given-names></name><name name-style="western"><surname>Liu</surname><given-names>N</given-names></name><name name-style="western"><surname>Lv</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>CX</given-names></name><name name-style="western"><surname>Lu</surname><given-names>YB</given-names></name><etal/></person-group><article-title>Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application</article-title><source>Aging Cell</source><year>2017</year><volume>16</volume><issue>5</issue><fpage>1083</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1111/acel.12635</pub-id><pub-id pub-id-type="pmid">28677234</pub-id><pub-id pub-id-type="pmcid">PMC5595695</pub-id></element-citation><mixed-citation id="mc-CR227" publication-type="journal">Zhao P, Sui BD, Liu N, Lv YJ, Zheng CX, Lu YB, et al. Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application. Aging Cell. 2017;16(5):1083&#8211;93.<pub-id pub-id-type="pmid">28677234</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/acel.12635</pub-id><pub-id pub-id-type="pmcid">PMC5595695</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR228"><label>228.</label><citation-alternatives><element-citation id="ec-CR228" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>SC</given-names></name><name name-style="western"><surname>Guo</surname><given-names>SC</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Ke</surname><given-names>QF</given-names></name><name name-style="western"><surname>Guo</surname><given-names>YP</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>CQ</given-names></name></person-group><article-title>Chitosan wound dressings incorporating exosomes derived from MicroRNA-126-overexpressing synovium mesenchymal stem cells provide sustained release of exosomes and heal full-thickness skin defects in a diabetic rat model</article-title><source>Stem Cells Transl Med</source><year>2017</year><volume>6</volume><issue>3</issue><fpage>736</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.5966/sctm.2016-0275</pub-id><pub-id pub-id-type="pmid">28297576</pub-id><pub-id pub-id-type="pmcid">PMC5442792</pub-id></element-citation><mixed-citation id="mc-CR228" publication-type="journal">Tao SC, Guo SC, Li M, Ke QF, Guo YP, Zhang CQ. Chitosan wound dressings incorporating exosomes derived from MicroRNA-126-overexpressing synovium mesenchymal stem cells provide sustained release of exosomes and heal full-thickness skin defects in a diabetic rat model. Stem Cells Transl Med. 2017;6(3):736&#8211;47.<pub-id pub-id-type="pmid">28297576</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5966/sctm.2016-0275</pub-id><pub-id pub-id-type="pmcid">PMC5442792</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR229"><label>229.</label><citation-alternatives><element-citation id="ec-CR229" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Hu</surname><given-names>W</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Ma</surname><given-names>K</given-names></name><etal/></person-group><article-title>MiR146a-loaded engineered exosomes released from silk fibroin patch promote diabetic wound healing by targeting IRAK1</article-title><source>Signal Transduct Target Ther</source><year>2023</year><volume>8</volume><issue>1</issue><fpage>62</fpage><pub-id pub-id-type="doi">10.1038/s41392-022-01263-w</pub-id><pub-id pub-id-type="pmid">36775818</pub-id><pub-id pub-id-type="pmcid">PMC9922687</pub-id></element-citation><mixed-citation id="mc-CR229" publication-type="journal">Li Q, Hu W, Huang Q, Yang J, Li B, Ma K, et al. MiR146a-loaded engineered exosomes released from silk fibroin patch promote diabetic wound healing by targeting IRAK1. Signal Transduct Target Ther. 2023;8(1):62.<pub-id pub-id-type="pmid">36775818</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-022-01263-w</pub-id><pub-id pub-id-type="pmcid">PMC9922687</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR230"><label>230.</label><citation-alternatives><element-citation id="ec-CR230" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Exposure to blue light stimulates the proangiogenic capability of exosomes derived from human umbilical cord mesenchymal stem cells</article-title><source>Stem Cell Res Ther</source><year>2019</year><volume>10</volume><issue>1</issue><fpage>358</fpage><pub-id pub-id-type="doi">10.1186/s13287-019-1472-x</pub-id><pub-id pub-id-type="pmid">31779691</pub-id><pub-id pub-id-type="pmcid">PMC6883639</pub-id></element-citation><mixed-citation id="mc-CR230" publication-type="journal">Yang K, Li D, Wang M, Xu Z, Chen X, Liu Q, et al. Exposure to blue light stimulates the proangiogenic capability of exosomes derived from human umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2019;10(1):358.<pub-id pub-id-type="pmid">31779691</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-019-1472-x</pub-id><pub-id pub-id-type="pmcid">PMC6883639</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR231"><label>231.</label><citation-alternatives><element-citation id="ec-CR231" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>D</given-names></name><name name-style="western"><surname>Kang</surname><given-names>L</given-names></name><name name-style="western"><surname>Tian</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Exosomes derived from bone mesenchymal stem cells with the stimulation of Fe3O4 nanoparticles and static magnetic field enhance wound healing through upregulated miR-21-5p</article-title><source>Int J Nanomedicine</source><year>2020</year><volume>15</volume><fpage>7979</fpage><lpage>7993</lpage><pub-id pub-id-type="doi">10.2147/IJN.S275650</pub-id><pub-id pub-id-type="pmid">33116513</pub-id><pub-id pub-id-type="pmcid">PMC7585514</pub-id></element-citation><mixed-citation id="mc-CR231" publication-type="journal">Wu D, Kang L, Tian J, Wu Y, Liu J, Li Z, Wu X, Huang Y, Gao B, Wang H, et al. Exosomes derived from bone mesenchymal stem cells with the stimulation of Fe3O4 nanoparticles and static magnetic field enhance wound healing through upregulated miR-21-5p. Int J Nanomedicine. 2020;15:7979&#8211;93.<pub-id pub-id-type="pmid">33116513</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S275650</pub-id><pub-id pub-id-type="pmcid">PMC7585514</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR232"><label>232.</label><citation-alternatives><element-citation id="ec-CR232" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>N</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Tang</surname><given-names>T</given-names></name><name name-style="western"><surname>Xu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Hypoxia-pretreated ADSC-derived exosome-embedded hydrogels promote angiogenesis and accelerate diabetic wound healing</article-title><source>Acta Biomater</source><year>2023</year><volume>157</volume><fpage>175</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2022.11.057</pub-id><pub-id pub-id-type="pmid">36503078</pub-id></element-citation><mixed-citation id="mc-CR232" publication-type="journal">Hu N, Cai Z, Jiang X, Wang C, Tang T, Xu T, et al. Hypoxia-pretreated ADSC-derived exosome-embedded hydrogels promote angiogenesis and accelerate diabetic wound healing. Acta Biomater. 2023;157:175&#8211;86.<pub-id pub-id-type="pmid">36503078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2022.11.057</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR233"><label>233.</label><citation-alternatives><element-citation id="ec-CR233" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patil</surname><given-names>SM</given-names></name><name name-style="western"><surname>Sawant</surname><given-names>SS</given-names></name><name name-style="western"><surname>Kunda</surname><given-names>NK</given-names></name></person-group><article-title>Exosomes as drug delivery systems: a brief overview and progress update</article-title><source>Eur J Pharm Biopharm</source><year>2020</year><volume>154</volume><fpage>259</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2020.07.026</pub-id><pub-id pub-id-type="pmid">32717385</pub-id></element-citation><mixed-citation id="mc-CR233" publication-type="journal">Patil SM, Sawant SS, Kunda NK. Exosomes as drug delivery systems: a brief overview and progress update. Eur J Pharm Biopharm. 2020;154:259&#8211;69.<pub-id pub-id-type="pmid">32717385</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejpb.2020.07.026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR234"><label>234.</label><citation-alternatives><element-citation id="ec-CR234" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulz-Siegmund</surname><given-names>M</given-names></name><name name-style="western"><surname>Aigner</surname><given-names>A</given-names></name></person-group><article-title>Nucleic acid delivery with extracellular vesicles</article-title><source>Adv Drug Deliv Rev</source><year>2021</year><volume>173</volume><fpage>89</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2021.03.005</pub-id><pub-id pub-id-type="pmid">33746014</pub-id></element-citation><mixed-citation id="mc-CR234" publication-type="journal">Schulz-Siegmund M, Aigner A. Nucleic acid delivery with extracellular vesicles. Adv Drug Deliv Rev. 2021;173:89&#8211;111.<pub-id pub-id-type="pmid">33746014</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addr.2021.03.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR235"><label>235.</label><citation-alternatives><element-citation id="ec-CR235" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>H</given-names></name><name name-style="western"><surname>Nanda</surname><given-names>HS</given-names></name><name name-style="western"><surname>Peng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Exosomes, a new star for targeted delivery</article-title><source>Front Cell Dev Biol</source><year>2021</year><pub-id pub-id-type="doi">10.3389/fcell.2021.751079</pub-id><pub-id pub-id-type="pmid">34692704</pub-id><pub-id pub-id-type="pmcid">PMC8531489</pub-id></element-citation><mixed-citation id="mc-CR235" publication-type="journal">Chen H, Wang L, Zeng X, Schwarz H, Nanda HS, Peng X, et al. Exosomes, a new star for targeted delivery. Front Cell Dev Biol. 2021. 10.3389/fcell.2021.751079.<pub-id pub-id-type="pmid">34692704</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcell.2021.751079</pub-id><pub-id pub-id-type="pmcid">PMC8531489</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR236"><label>236.</label><citation-alternatives><element-citation id="ec-CR236" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>A</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>X</given-names></name><name name-style="western"><surname>Sabbah</surname><given-names>M</given-names></name><name name-style="western"><surname>Boroumand</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>TCT</given-names></name><etal/></person-group><article-title>TGF-&#946; loaded exosome enhances ischemic wound healing <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic></article-title><source>Theranostics</source><year>2021</year><volume>11</volume><issue>13</issue><fpage>6616</fpage><lpage>6631</lpage><pub-id pub-id-type="doi">10.7150/thno.57701</pub-id><pub-id pub-id-type="pmid">33995680</pub-id><pub-id pub-id-type="pmcid">PMC8120220</pub-id></element-citation><mixed-citation id="mc-CR236" publication-type="journal">Shi A, Li J, Qiu X, Sabbah M, Boroumand S, Huang TCT, et al. TGF-&#946; loaded exosome enhances ischemic wound healing <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>. Theranostics. 2021;11(13):6616&#8211;31.<pub-id pub-id-type="pmid">33995680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.57701</pub-id><pub-id pub-id-type="pmcid">PMC8120220</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR237"><label>237.</label><citation-alternatives><element-citation id="ec-CR237" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>M</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis</article-title><source>Drug Deliv</source><year>2022</year><volume>29</volume><issue>1</issue><fpage>214</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1080/10717544.2021.2023699</pub-id><pub-id pub-id-type="pmid">34985397</pub-id><pub-id pub-id-type="pmcid">PMC8741248</pub-id></element-citation><mixed-citation id="mc-CR237" publication-type="journal">Yan C, Chen J, Wang C, Yuan M, Kang Y, Wu Z, et al. Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis. Drug Deliv. 2022;29(1):214&#8211;28.<pub-id pub-id-type="pmid">34985397</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10717544.2021.2023699</pub-id><pub-id pub-id-type="pmcid">PMC8741248</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR238"><label>238.</label><citation-alternatives><element-citation id="ec-CR238" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lv</surname><given-names>Q</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing</article-title><source>Mol Pharm</source><year>2020</year><volume>17</volume><issue>5</issue><fpage>1723</fpage><lpage>1733</lpage><pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.0c00177</pub-id><pub-id pub-id-type="pmid">32233440</pub-id></element-citation><mixed-citation id="mc-CR238" publication-type="journal">Lv Q, Deng J, Chen Y, Wang Y, Liu B, Liu J. Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing. Mol Pharm. 2020;17(5):1723&#8211;33.<pub-id pub-id-type="pmid">32233440</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.0c00177</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR239"><label>239.</label><citation-alternatives><element-citation id="ec-CR239" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>QH</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><name name-style="western"><surname>Wan</surname><given-names>GQ</given-names></name><name name-style="western"><surname>Hu</surname><given-names>YG</given-names></name><name name-style="western"><surname>Li</surname><given-names>XL</given-names></name></person-group><article-title>Engineered BMSCs-derived exosomal miR-542-3p promotes cutaneous wound healing</article-title><source>Endocr Metab Immune Disord Drug Targets</source><year>2023</year><volume>23</volume><issue>3</issue><fpage>336</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.2174/1871530322666220523151713</pub-id><pub-id pub-id-type="pmid">35616673</pub-id></element-citation><mixed-citation id="mc-CR239" publication-type="journal">Xiong QH, Zhao L, Wan GQ, Hu YG, Li XL. Engineered BMSCs-derived exosomal miR-542-3p promotes cutaneous wound healing. Endocr Metab Immune Disord Drug Targets. 2023;23(3):336&#8211;46.<pub-id pub-id-type="pmid">35616673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1871530322666220523151713</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR240"><label>240.</label><citation-alternatives><element-citation id="ec-CR240" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheikh</surname><given-names>IM</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>OA</given-names></name><name name-style="western"><surname>Adam</surname><given-names>SM</given-names></name><name name-style="western"><surname>Ali</surname><given-names>AI</given-names></name><name name-style="western"><surname>Ogedegbe</surname><given-names>OJ</given-names></name><name name-style="western"><surname>Tabowei</surname><given-names>G</given-names></name><etal/></person-group><article-title>Association of pioglitazone with major adverse cardiovascular events, all-cause mortality, and heart failure hospitalizations: a systematic review</article-title><source>Cureus</source><year>2023</year><volume>15</volume><issue>10</issue><fpage>e46911</fpage><pub-id pub-id-type="pmid">37954768</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.46911</pub-id><pub-id pub-id-type="pmcid">PMC10639032</pub-id></element-citation><mixed-citation id="mc-CR240" publication-type="journal">Sheikh IM, Hassan OA, Adam SM, Ali AI, Ogedegbe OJ, Tabowei G, et al. Association of pioglitazone with major adverse cardiovascular events, all-cause mortality, and heart failure hospitalizations: a systematic review. Cureus. 2023;15(10):e46911.<pub-id pub-id-type="pmid">37954768</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.46911</pub-id><pub-id pub-id-type="pmcid">PMC10639032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR241"><label>241.</label><citation-alternatives><element-citation id="ec-CR241" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mihai</surname><given-names>MM</given-names></name><name name-style="western"><surname>Dima</surname><given-names>MB</given-names></name><name name-style="western"><surname>Dima</surname><given-names>B</given-names></name><name name-style="western"><surname>Holban</surname><given-names>AM</given-names></name></person-group><article-title>Nanomaterials for wound healing and infection control</article-title><source>Materials</source><year>2019</year><volume>12</volume><issue>13</issue><fpage>2176</fpage><pub-id pub-id-type="doi">10.3390/ma12132176</pub-id><pub-id pub-id-type="pmid">31284587</pub-id><pub-id pub-id-type="pmcid">PMC6650835</pub-id></element-citation><mixed-citation id="mc-CR241" publication-type="journal">Mihai MM, Dima MB, Dima B, Holban AM. Nanomaterials for wound healing and infection control. Materials. 2019;12(13):2176.<pub-id pub-id-type="pmid">31284587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ma12132176</pub-id><pub-id pub-id-type="pmcid">PMC6650835</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR242"><label>242.</label><citation-alternatives><element-citation id="ec-CR242" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khorasani</surname><given-names>MT</given-names></name><name name-style="western"><surname>Joorabloo</surname><given-names>A</given-names></name><name name-style="western"><surname>Adeli</surname><given-names>H</given-names></name><name name-style="western"><surname>Milan</surname><given-names>PB</given-names></name><name name-style="western"><surname>Amoupour</surname><given-names>M</given-names></name></person-group><article-title>Enhanced antimicrobial and full-thickness wound healing efficiency of hydrogels loaded with heparinized ZnO nanoparticles: In vitro and in vivo evaluation</article-title><source>Int J Biol Macromol</source><year>2021</year><volume>166</volume><fpage>200</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.10.142</pub-id><pub-id pub-id-type="pmid">33190822</pub-id></element-citation><mixed-citation id="mc-CR242" publication-type="journal">Khorasani MT, Joorabloo A, Adeli H, Milan PB, Amoupour M. Enhanced antimicrobial and full-thickness wound healing efficiency of hydrogels loaded with heparinized ZnO nanoparticles: In vitro and in vivo evaluation. Int J Biol Macromol. 2021;166:200&#8211;12.<pub-id pub-id-type="pmid">33190822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijbiomac.2020.10.142</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR243"><label>243.</label><citation-alternatives><element-citation id="ec-CR243" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joorabloo</surname><given-names>A</given-names></name><name name-style="western"><surname>Khorasani</surname><given-names>MT</given-names></name><name name-style="western"><surname>Adeli</surname><given-names>H</given-names></name><name name-style="western"><surname>Brouki Milan</surname><given-names>P</given-names></name><name name-style="western"><surname>Amoupour</surname><given-names>M</given-names></name></person-group><article-title>Using artificial neural network for design and development of PVA/chitosan/starch/heparinized nZnO hydrogels for enhanced wound healing</article-title><source>J Ind Eng Chem</source><year>2022</year><volume>108</volume><fpage>88</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.jiec.2021.12.027</pub-id></element-citation><mixed-citation id="mc-CR243" publication-type="journal">Joorabloo A, Khorasani MT, Adeli H, Brouki Milan P, Amoupour M. Using artificial neural network for design and development of PVA/chitosan/starch/heparinized nZnO hydrogels for enhanced wound healing. J Ind Eng Chem. 2022;108:88&#8211;100.</mixed-citation></citation-alternatives></ref><ref id="CR244"><label>244.</label><citation-alternatives><element-citation id="ec-CR244" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Magnetic targeting enhances the cutaneous wound healing effects of human mesenchymal stem cell-derived iron oxide exosomes</article-title><source>J Nanobiotechnology</source><year>2020</year><volume>18</volume><issue>1</issue><fpage>113</fpage><pub-id pub-id-type="doi">10.1186/s12951-020-00670-x</pub-id><pub-id pub-id-type="pmid">32799868</pub-id><pub-id pub-id-type="pmcid">PMC7429707</pub-id></element-citation><mixed-citation id="mc-CR244" publication-type="journal">Li X, Wang Y, Shi L, Li B, Li J, Wei Z, et al. Magnetic targeting enhances the cutaneous wound healing effects of human mesenchymal stem cell-derived iron oxide exosomes. J Nanobiotechnology. 2020;18(1):113.<pub-id pub-id-type="pmid">32799868</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-020-00670-x</pub-id><pub-id pub-id-type="pmcid">PMC7429707</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR245"><label>245.</label><citation-alternatives><element-citation id="ec-CR245" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>Z</given-names></name><name name-style="western"><surname>Bai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Na</surname><given-names>J</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A moisturizing chitosan-silk fibroin dressing with silver nanoparticles-adsorbed exosomes for repairing infected wounds</article-title><source>J Mater Chem B</source><year>2020</year><volume>8</volume><issue>32</issue><fpage>7197</fpage><lpage>7212</lpage><pub-id pub-id-type="doi">10.1039/D0TB01100B</pub-id><pub-id pub-id-type="pmid">32633312</pub-id></element-citation><mixed-citation id="mc-CR245" publication-type="journal">Qian Z, Bai Y, Zhou J, Li L, Na J, Fan Y, et al. A moisturizing chitosan-silk fibroin dressing with silver nanoparticles-adsorbed exosomes for repairing infected wounds. J Mater Chem B. 2020;8(32):7197&#8211;212.<pub-id pub-id-type="pmid">32633312</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d0tb01100b</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR246"><label>246.</label><citation-alternatives><element-citation id="ec-CR246" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name><name name-style="western"><surname>Wu</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Song</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ye</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mohammadniaei</surname><given-names>M</given-names></name><etal/></person-group><article-title>An optimally designed engineering exosome-reductive COF integrated nanoagent for synergistically enhanced diabetic fester wound healing</article-title><source>Small</source><year>2022</year><volume>18</volume><issue>26</issue><fpage>2200895</fpage><pub-id pub-id-type="doi">10.1002/smll.202200895</pub-id><pub-id pub-id-type="pmid">35638464</pub-id></element-citation><mixed-citation id="mc-CR246" publication-type="journal">Sun B, Wu F, Wang X, Song Q, Ye Z, Mohammadniaei M, et al. An optimally designed engineering exosome-reductive COF integrated nanoagent for synergistically enhanced diabetic fester wound healing. Small. 2022;18(26):2200895.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/smll.202200895</pub-id><pub-id pub-id-type="pmid">35638464</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR247"><label>247.</label><citation-alternatives><element-citation id="ec-CR247" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X</given-names></name></person-group><article-title>Engineered NF-&#954;B siRNA-encapsulating exosomes as a modality for therapy of skin lesions</article-title><source>Front Immunol</source><year>2023</year><volume>8</volume><issue>14</issue><fpage>1109381</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2023.1109381</pub-id><pub-id pub-id-type="pmcid">PMC9945116</pub-id><pub-id pub-id-type="pmid">36845116</pub-id></element-citation><mixed-citation id="mc-CR247" publication-type="journal">Lu W, Zhang J, Wu Y, Sun W, Jiang Z, Luo X. Engineered NF-&#954;B siRNA-encapsulating exosomes as a modality for therapy of skin lesions. Front Immunol. 2023;8(14):1109381.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2023.1109381</pub-id><pub-id pub-id-type="pmcid">PMC9945116</pub-id><pub-id pub-id-type="pmid">36845116</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR248"><label>248.</label><citation-alternatives><element-citation id="ec-CR248" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ge</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H</given-names></name><name name-style="western"><surname>Tao</surname><given-names>E</given-names></name><name name-style="western"><surname>Xia</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><etal/></person-group><article-title>Engineered exosomes derived from miR-132-overexpresssing adipose stem cells promoted diabetic wound healing and skin reconstruction</article-title><source>Front Bioeng Biotechnol</source><year>2023</year><volume>1</volume><issue>11</issue><fpage>1129538</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2023.1129538</pub-id><pub-id pub-id-type="pmcid">PMC10014603</pub-id><pub-id pub-id-type="pmid">36937759</pub-id></element-citation><mixed-citation id="mc-CR248" publication-type="journal">Ge L, Wang K, Lin H, Tao E, Xia W, Wang F, et al. Engineered exosomes derived from miR-132-overexpresssing adipose stem cells promoted diabetic wound healing and skin reconstruction. Front Bioeng Biotechnol. 2023;1(11):1129538.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fbioe.2023.1129538</pub-id><pub-id pub-id-type="pmcid">PMC10014603</pub-id><pub-id pub-id-type="pmid">36937759</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR249"><label>249.</label><citation-alternatives><element-citation id="ec-CR249" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kooijmans</surname><given-names>SAA</given-names></name><name name-style="western"><surname>De Jong</surname><given-names>OG</given-names></name><name name-style="western"><surname>Schiffelers</surname><given-names>RM</given-names></name></person-group><article-title>Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design</article-title><source>Adv Drug Deliv Rev</source><year>2021</year><volume>173</volume><fpage>252</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2021.03.017</pub-id><pub-id pub-id-type="pmid">33798644</pub-id></element-citation><mixed-citation id="mc-CR249" publication-type="journal">Kooijmans SAA, De Jong OG, Schiffelers RM. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design. Adv Drug Deliv Rev. 2021;173:252&#8211;78.<pub-id pub-id-type="pmid">33798644</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addr.2021.03.017</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR250"><label>250.</label><citation-alternatives><element-citation id="ec-CR250" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>L</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ren</surname><given-names>T</given-names></name><etal/></person-group><article-title>Antioxidant-engineered milk-derived extracellular vesicles for accelerating wound healing via regulation of the PI3K-AKT signaling pathway</article-title><source>Adv Healthc Mater</source><year>2023</year><volume>12</volume><issue>32</issue><fpage>2301865</fpage><pub-id pub-id-type="doi">10.1002/adhm.202301865</pub-id><pub-id pub-id-type="pmid">37660257</pub-id></element-citation><mixed-citation id="mc-CR250" publication-type="journal">Fan L, Ma X, Liu B, Yang Y, Yang Y, Ren T, et al. Antioxidant-engineered milk-derived extracellular vesicles for accelerating wound healing via regulation of the PI3K-AKT signaling pathway. Adv Healthc Mater. 2023;12(32):2301865.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adhm.202301865</pub-id><pub-id pub-id-type="pmid">37660257</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR251"><label>251.</label><citation-alternatives><element-citation id="ec-CR251" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gondaliya</surname><given-names>P</given-names></name><name name-style="western"><surname>Sayyed</surname><given-names>AA</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>P</given-names></name><name name-style="western"><surname>Mali</surname><given-names>M</given-names></name><name name-style="western"><surname>Arya</surname><given-names>N</given-names></name><name name-style="western"><surname>Khairnar</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mesenchymal stem cell-derived exosomes loaded with miR-155 inhibitor ameliorate diabetic wound healing</article-title><source>Mol Pharm</source><year>2022</year><volume>19</volume><issue>5</issue><fpage>1294</fpage><lpage>1308</lpage><pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.1c00669</pub-id><pub-id pub-id-type="pmid">35294195</pub-id></element-citation><mixed-citation id="mc-CR251" publication-type="journal">Gondaliya P, Sayyed AA, Bhat P, Mali M, Arya N, Khairnar A, et al. Mesenchymal stem cell-derived exosomes loaded with miR-155 inhibitor ameliorate diabetic wound healing. Mol Pharm. 2022;19(5):1294&#8211;308.<pub-id pub-id-type="pmid">35294195</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.1c00669</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR252"><label>252.</label><citation-alternatives><element-citation id="ec-CR252" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Falanga</surname><given-names>V</given-names></name><name name-style="western"><surname>Isseroff</surname><given-names>RR</given-names></name><name name-style="western"><surname>Soulika</surname><given-names>AM</given-names></name><name name-style="western"><surname>Romanelli</surname><given-names>M</given-names></name><name name-style="western"><surname>Margolis</surname><given-names>D</given-names></name><name name-style="western"><surname>Kapp</surname><given-names>S</given-names></name><etal/></person-group><article-title>Chronic wounds</article-title><source>Nat Rev Dis Primer</source><year>2022</year><volume>8</volume><issue>1</issue><fpage>50</fpage><pub-id pub-id-type="doi">10.1038/s41572-022-00377-3</pub-id><pub-id pub-id-type="pmcid">PMC10352385</pub-id><pub-id pub-id-type="pmid">35864102</pub-id></element-citation><mixed-citation id="mc-CR252" publication-type="journal">Falanga V, Isseroff RR, Soulika AM, Romanelli M, Margolis D, Kapp S, et al. Chronic wounds. Nat Rev Dis Primer. 2022;8(1):50.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41572-022-00377-3</pub-id><pub-id pub-id-type="pmcid">PMC10352385</pub-id><pub-id pub-id-type="pmid">35864102</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR253"><label>253.</label><citation-alternatives><element-citation id="ec-CR253" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jibing</surname><given-names>C</given-names></name><name name-style="western"><surname>Weiping</surname><given-names>L</given-names></name><name name-style="western"><surname>Yuwei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bingzheng</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhiran</surname><given-names>X</given-names></name></person-group><article-title>Exosomal microRNA-based therapies for skin diseases</article-title><source>Regen Ther</source><year>2024</year><volume>25</volume><fpage>101</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.reth.2023.12.005</pub-id><pub-id pub-id-type="pmid">38178928</pub-id><pub-id pub-id-type="pmcid">PMC10765304</pub-id></element-citation><mixed-citation id="mc-CR253" publication-type="journal">Jibing C, Weiping L, Yuwei Y, Bingzheng F, Zhiran X. Exosomal microRNA-based therapies for skin diseases. Regen Ther. 2024;25:101&#8211;12.<pub-id pub-id-type="pmid">38178928</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.reth.2023.12.005</pub-id><pub-id pub-id-type="pmcid">PMC10765304</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR254"><label>254.</label><citation-alternatives><element-citation id="ec-CR254" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mony</surname><given-names>MP</given-names></name><name name-style="western"><surname>Harmon</surname><given-names>KA</given-names></name><name name-style="western"><surname>Hess</surname><given-names>R</given-names></name><name name-style="western"><surname>Dorafshar</surname><given-names>AH</given-names></name><name name-style="western"><surname>Shafikhani</surname><given-names>SH</given-names></name></person-group><article-title>An updated review of hypertrophic scarring</article-title><source>Cells</source><year>2023</year><volume>12</volume><issue>5</issue><fpage>678</fpage><pub-id pub-id-type="doi">10.3390/cells12050678</pub-id><pub-id pub-id-type="pmid">36899815</pub-id><pub-id pub-id-type="pmcid">PMC10000648</pub-id></element-citation><mixed-citation id="mc-CR254" publication-type="journal">Mony MP, Harmon KA, Hess R, Dorafshar AH, Shafikhani SH. An updated review of hypertrophic scarring. Cells. 2023;12(5):678.<pub-id pub-id-type="pmid">36899815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells12050678</pub-id><pub-id pub-id-type="pmcid">PMC10000648</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR255"><label>255.</label><citation-alternatives><element-citation id="ec-CR255" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>S</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Cui</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>MiR-141-3p-functionalized exosomes loaded in dissolvable microneedle arrays for hypertrophic scar treatment</article-title><source>Small</source><year>2024</year><volume>20</volume><issue>8</issue><fpage>2305374</fpage><pub-id pub-id-type="doi">10.1002/smll.202305374</pub-id><pub-id pub-id-type="pmid">37724002</pub-id></element-citation><mixed-citation id="mc-CR255" publication-type="journal">Meng S, Wei Q, Chen S, Liu X, Cui S, Huang Q, et al. MiR-141-3p-functionalized exosomes loaded in dissolvable microneedle arrays for hypertrophic scar treatment. Small. 2024;20(8):2305374.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/smll.202305374</pub-id><pub-id pub-id-type="pmid">37724002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR256"><label>256.</label><citation-alternatives><element-citation id="ec-CR256" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>R</given-names></name><name name-style="western"><surname>Dai</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name></person-group><article-title>Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-&#946;2/Smad3 signaling</article-title><source>Mol Med Rep</source><year>2021</year><volume>24</volume><issue>5</issue><fpage>758</fpage><pub-id pub-id-type="doi">10.3892/mmr.2021.12398</pub-id><pub-id pub-id-type="pmid">34476508</pub-id><pub-id pub-id-type="pmcid">PMC8436211</pub-id></element-citation><mixed-citation id="mc-CR256" publication-type="journal">Yuan R, Dai X, Li Y, Li C, Liu L. Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-&#946;2/Smad3 signaling. Mol Med Rep. 2021;24(5):758.<pub-id pub-id-type="pmid">34476508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2021.12398</pub-id><pub-id pub-id-type="pmcid">PMC8436211</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR257"><label>257.</label><citation-alternatives><element-citation id="ec-CR257" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Song</surname><given-names>H</given-names></name><etal/></person-group><article-title>Exosomes derived from TSG-6 modified mesenchymal stromal cells attenuate scar formation during wound healing</article-title><source>Biochimie</source><year>2020</year><volume>177</volume><fpage>40</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2020.08.003</pub-id><pub-id pub-id-type="pmid">32800897</pub-id></element-citation><mixed-citation id="mc-CR257" publication-type="journal">Jiang L, Zhang Y, Liu T, Wang X, Wang H, Song H, et al. Exosomes derived from TSG-6 modified mesenchymal stromal cells attenuate scar formation during wound healing. Biochimie. 2020;177:40&#8211;9.<pub-id pub-id-type="pmid">32800897</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biochi.2020.08.003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR258"><label>258.</label><citation-alternatives><element-citation id="ec-CR258" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>LC</given-names></name><etal/></person-group><article-title>All feet on deck: the role of podiatry during the COVID-19 pandemic: preventing hospitalizations in an overburdened health-care system, reducing amputation and death in people with diabetes</article-title><source>J Am Podiatr Med Assoc</source><year>2023</year><volume>113</volume><issue>2</issue><fpage>20-051</fpage><pub-id pub-id-type="doi">10.7547/20-051</pub-id><pub-id pub-id-type="pmid">32208983</pub-id></element-citation><mixed-citation id="mc-CR258" publication-type="journal">Rogers LC, Lavery LA, Joseph WS, Armstrong DG. All feet on deck: the role of podiatry during the COVID-19 pandemic: preventing hospitalizations in an overburdened health-care system, reducing amputation and death in people with diabetes. J Am Podiatr Med Assoc. 2023;113(2):20-051. 10.7547/20-051.<pub-id pub-id-type="pmid">32208983</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7547/20-051</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR259"><label>259.</label><citation-alternatives><element-citation id="ec-CR259" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanchette</surname><given-names>V</given-names></name><name name-style="western"><surname>Brousseau-Foley</surname><given-names>M</given-names></name><name name-style="western"><surname>Cloutier</surname><given-names>L</given-names></name></person-group><article-title>Effect of contact with podiatry in a team approach context on diabetic foot ulcer and lower extremity amputation: systematic review and meta-analysis</article-title><source>J Foot Ankle Res</source><year>2020</year><volume>13</volume><issue>1</issue><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/s13047-020-0380-8</pub-id><pub-id pub-id-type="pmid">32192509</pub-id><pub-id pub-id-type="pmcid">PMC7083052</pub-id></element-citation><mixed-citation id="mc-CR259" publication-type="journal">Blanchette V, Brousseau-Foley M, Cloutier L. Effect of contact with podiatry in a team approach context on diabetic foot ulcer and lower extremity amputation: systematic review and meta-analysis. J Foot Ankle Res. 2020;13(1):15.<pub-id pub-id-type="pmid">32192509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13047-020-0380-8</pub-id><pub-id pub-id-type="pmcid">PMC7083052</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR260"><label>260.</label><citation-alternatives><element-citation id="ec-CR260" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsson</surname><given-names>M</given-names></name><name name-style="western"><surname>J&#228;rbrink</surname><given-names>K</given-names></name><name name-style="western"><surname>Divakar</surname><given-names>U</given-names></name><name name-style="western"><surname>Bajpai</surname><given-names>R</given-names></name><name name-style="western"><surname>Upton</surname><given-names>Z</given-names></name><name name-style="western"><surname>Schmidtchen</surname><given-names>A</given-names></name><etal/></person-group><article-title>The humanistic and economic burden of chronic wounds: a systematic review</article-title><source>Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc</source><year>2019</year><volume>27</volume><issue>1</issue><fpage>114</fpage><lpage>125</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/wrr.12683</pub-id><pub-id pub-id-type="pmid">30362646</pub-id></element-citation><mixed-citation id="mc-CR260" publication-type="journal">Olsson M, J&#228;rbrink K, Divakar U, Bajpai R, Upton Z, Schmidtchen A, et al. The humanistic and economic burden of chronic wounds: a systematic review. Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc. 2019;27(1):114&#8211;25.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/wrr.12683</pub-id><pub-id pub-id-type="pmid">30362646</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR261"><label>261.</label><citation-alternatives><element-citation id="ec-CR261" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sen</surname><given-names>CK</given-names></name></person-group><article-title>Human wound and its burden: updated 2022 compendium of estimates</article-title><source>Adv Wound Care</source><year>2023</year><volume>12</volume><issue>12</issue><fpage>657</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1089/wound.2023.0150</pub-id><pub-id pub-id-type="pmcid">PMC10615092</pub-id><pub-id pub-id-type="pmid">37756368</pub-id></element-citation><mixed-citation id="mc-CR261" publication-type="journal">Sen CK. Human wound and its burden: updated 2022 compendium of estimates. Adv Wound Care. 2023;12(12):657&#8211;70.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/wound.2023.0150</pub-id><pub-id pub-id-type="pmcid">PMC10615092</pub-id><pub-id pub-id-type="pmid">37756368</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR262"><label>262.</label><citation-alternatives><element-citation id="ec-CR262" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Powers</surname><given-names>JG</given-names></name><name name-style="western"><surname>Higham</surname><given-names>C</given-names></name><name name-style="western"><surname>Broussard</surname><given-names>K</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>TJ</given-names></name></person-group><article-title>Wound healing and treating wounds: chronic wound care and management</article-title><source>J Am Acad Dermatol</source><year>2016</year><volume>74</volume><issue>4</issue><fpage>607</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2015.08.070</pub-id><pub-id pub-id-type="pmid">26979353</pub-id></element-citation><mixed-citation id="mc-CR262" publication-type="journal">Powers JG, Higham C, Broussard K, Phillips TJ. Wound healing and treating wounds: chronic wound care and management. J Am Acad Dermatol. 2016;74(4):607&#8211;25.<pub-id pub-id-type="pmid">26979353</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaad.2015.08.070</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR263"><label>263.</label><citation-alternatives><element-citation id="ec-CR263" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Gibb</surname><given-names>M</given-names></name><name name-style="western"><surname>Graves</surname><given-names>N</given-names></name><name name-style="western"><surname>Finlayson</surname><given-names>K</given-names></name><name name-style="western"><surname>Pacella</surname><given-names>RE</given-names></name></person-group><article-title>Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in australia</article-title><source>BMC Health Serv Res</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>421</fpage><pub-id pub-id-type="doi">10.1186/s12913-018-3234-3</pub-id><pub-id pub-id-type="pmid">29880046</pub-id><pub-id pub-id-type="pmcid">PMC5992639</pub-id></element-citation><mixed-citation id="mc-CR263" publication-type="journal">Cheng Q, Gibb M, Graves N, Finlayson K, Pacella RE. Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in australia. BMC Health Serv Res. 2018;18(1):421.<pub-id pub-id-type="pmid">29880046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12913-018-3234-3</pub-id><pub-id pub-id-type="pmcid">PMC5992639</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR264"><label>264.</label><citation-alternatives><element-citation id="ec-CR264" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razavi</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Sharafshadehi</surname><given-names>SA</given-names></name><name name-style="western"><surname>Yousefi</surname><given-names>MH</given-names></name><name name-style="western"><surname>Javaheri</surname><given-names>F</given-names></name><name name-style="western"><surname>Barghani</surname><given-names>MRR</given-names></name><name name-style="western"><surname>Afkhami</surname><given-names>H</given-names></name><etal/></person-group><article-title>Application of novel strategies in chronic wound management with focusing on pressure ulcers: new perspective</article-title><source>Arch Dermatol Res</source><year>2025</year><volume>317</volume><issue>1</issue><fpage>320</fpage><pub-id pub-id-type="doi">10.1007/s00403-024-03790-8</pub-id><pub-id pub-id-type="pmid">39888392</pub-id></element-citation><mixed-citation id="mc-CR264" publication-type="journal">Razavi ZS, Sharafshadehi SA, Yousefi MH, Javaheri F, Barghani MRR, Afkhami H, et al. Application of novel strategies in chronic wound management with focusing on pressure ulcers: new perspective. Arch Dermatol Res. 2025;317(1):320.<pub-id pub-id-type="pmid">39888392</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00403-024-03790-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR265"><label>265.</label><citation-alternatives><element-citation id="ec-CR265" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Selection of appropriate wound dressing for various Wounds</article-title><source>Front Bioeng Biotechnol.</source><year>2020</year><pub-id pub-id-type="doi">10.3389/fbioe.2020.00182</pub-id><pub-id pub-id-type="pmid">32266224</pub-id><pub-id pub-id-type="pmcid">PMC7096556</pub-id></element-citation><mixed-citation id="mc-CR265" publication-type="journal">Shi C, Wang C, Liu H, Li Q, Li R, Zhang Y, et al. Selection of appropriate wound dressing for various Wounds. Front Bioeng Biotechnol. 2020. 10.3389/fbioe.2020.00182.<pub-id pub-id-type="pmid">32266224</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fbioe.2020.00182</pub-id><pub-id pub-id-type="pmcid">PMC7096556</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR266"><label>266.</label><citation-alternatives><element-citation id="ec-CR266" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Homaeigohar</surname><given-names>S</given-names></name><name name-style="western"><surname>Boccaccini</surname><given-names>AR</given-names></name></person-group><article-title>Antibacterial biohybrid nanofibers for wound dressings</article-title><source>Acta Biomater</source><year>2020</year><volume>15</volume><issue>107</issue><fpage>25</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2020.02.022</pub-id><pub-id pub-id-type="pmid">32084600</pub-id></element-citation><mixed-citation id="mc-CR266" publication-type="journal">Homaeigohar S, Boccaccini AR. Antibacterial biohybrid nanofibers for wound dressings. Acta Biomater. 2020;15(107):25&#8211;49.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2020.02.022</pub-id><pub-id pub-id-type="pmid">32084600</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR267"><label>267.</label><citation-alternatives><element-citation id="ec-CR267" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Liang</surname><given-names>WH</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liang</surname><given-names>HR</given-names></name><name name-style="western"><surname>Chen</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Li</surname><given-names>YM</given-names></name><etal/></person-group><article-title>Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis</article-title><source>Eur Respir J</source><year>2020</year><volume>55</volume><issue>5</issue><fpage>2000547</fpage><pub-id pub-id-type="doi">10.1183/13993003.00547-2020</pub-id><pub-id pub-id-type="pmid">32217650</pub-id><pub-id pub-id-type="pmcid">PMC7098485</pub-id></element-citation><mixed-citation id="mc-CR267" publication-type="journal">Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.<pub-id pub-id-type="pmid">32217650</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.00547-2020</pub-id><pub-id pub-id-type="pmcid">PMC7098485</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR268"><label>268.</label><citation-alternatives><element-citation id="ec-CR268" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emami</surname><given-names>A</given-names></name><name name-style="western"><surname>Javanmardi</surname><given-names>F</given-names></name><name name-style="western"><surname>Pirbonyeh</surname><given-names>N</given-names></name><name name-style="western"><surname>Akbari</surname><given-names>A</given-names></name></person-group><article-title>Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis</article-title><source>Arch Acad Emerg Med</source><year>2020</year><volume>8</volume><issue>1</issue><fpage>e35</fpage><pub-id pub-id-type="pmid">32232218</pub-id><pub-id pub-id-type="pmcid">PMC7096724</pub-id></element-citation><mixed-citation id="mc-CR268" publication-type="journal">Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35.<pub-id pub-id-type="pmid">32232218</pub-id><pub-id pub-id-type="pmcid">PMC7096724</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR269"><label>269.</label><citation-alternatives><element-citation id="ec-CR269" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casciato</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Yancovitz</surname><given-names>S</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>J</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>S</given-names></name><name name-style="western"><surname>Bischoff</surname><given-names>A</given-names></name><name name-style="western"><surname>Ayres</surname><given-names>S</given-names></name><etal/></person-group><article-title>Diabetes-related major and minor amputation risk increased during the COVID-19 pandemic</article-title><source>J Am Podiatr Med Assoc</source><year>2020</year><volume>3</volume><fpage>20</fpage><lpage>224</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.7547/20-224</pub-id><pub-id pub-id-type="pmid">33146723</pub-id></element-citation><mixed-citation id="mc-CR269" publication-type="journal">Casciato DJ, Yancovitz S, Thompson J, Anderson S, Bischoff A, Ayres S, et al. Diabetes-related major and minor amputation risk increased during the COVID-19 pandemic. J Am Podiatr Med Assoc. 2020;3:20&#8211;224.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7547/20-224</pub-id><pub-id pub-id-type="pmid">33146723</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR270"><label>270.</label><citation-alternatives><element-citation id="ec-CR270" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corbett</surname><given-names>LQ</given-names></name></person-group><article-title>Wound care nursing: professional issues and opportunities</article-title><source>Adv Wound Care</source><year>2012</year><volume>1</volume><issue>5</issue><fpage>189</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1089/wound.2011.0329</pub-id><pub-id pub-id-type="pmcid">PMC3839022</pub-id><pub-id pub-id-type="pmid">24527304</pub-id></element-citation><mixed-citation id="mc-CR270" publication-type="journal">Corbett LQ. Wound care nursing: professional issues and opportunities. Adv Wound Care. 2012;1(5):189&#8211;93.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/wound.2011.0329</pub-id><pub-id pub-id-type="pmcid">PMC3839022</pub-id><pub-id pub-id-type="pmid">24527304</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR271"><label>271.</label><citation-alternatives><element-citation id="ec-CR271" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sen</surname><given-names>CK</given-names></name></person-group><article-title>Human wound and its burden: updated 2020 compendium of estimates</article-title><source>Adv Wound Care</source><year>2021</year><volume>10</volume><issue>5</issue><fpage>281</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1089/wound.2021.0026</pub-id><pub-id pub-id-type="pmcid">PMC8024242</pub-id><pub-id pub-id-type="pmid">33733885</pub-id></element-citation><mixed-citation id="mc-CR271" publication-type="journal">Sen CK. Human wound and its burden: updated 2020 compendium of estimates. Adv Wound Care. 2021;10(5):281&#8211;92.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/wound.2021.0026</pub-id><pub-id pub-id-type="pmcid">PMC8024242</pub-id><pub-id pub-id-type="pmid">33733885</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR272"><label>272.</label><mixed-citation publication-type="other">Nelson EA, Bell-Syer SE. Compression for preventing recurrence of venous ulcers. Cochrane Wounds Group, editor. Cochrane Database Syst Rev [Internet]. 2014 Sep 9 [cited 2024 Jan 12];2014 (9). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002303.pub3/full<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD002303.pub3</pub-id><pub-id pub-id-type="pmcid">PMC7138196</pub-id><pub-id pub-id-type="pmid">25203307</pub-id></mixed-citation></ref><ref id="CR273"><label>273.</label><citation-alternatives><element-citation id="ec-CR273" publication-type="journal"><person-group person-group-type="author"><collab>Team V</collab><name name-style="western"><surname>Chandler</surname><given-names>PG</given-names></name><name name-style="western"><surname>Weller</surname><given-names>CD</given-names></name></person-group><article-title>Adjuvant therapies in venous leg ulcer management: a scoping review</article-title><source>Wound Repair Regen</source><year>2019</year><volume>27</volume><issue>5</issue><fpage>562</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1111/wrr.12724</pub-id><pub-id pub-id-type="pmid">31025794</pub-id></element-citation><mixed-citation id="mc-CR273" publication-type="journal">Team V, Chandler PG, Weller CD. Adjuvant therapies in venous leg ulcer management: a scoping review. Wound Repair Regen. 2019;27(5):562&#8211;90.<pub-id pub-id-type="pmid">31025794</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/wrr.12724</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR274"><label>274.</label><citation-alternatives><element-citation id="ec-CR274" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mo&#347;cicka</surname><given-names>P</given-names></name><name name-style="western"><surname>Szewczyk</surname><given-names>M</given-names></name><name name-style="western"><surname>Cwajda-Bia&#322;asik</surname><given-names>J</given-names></name><name name-style="western"><surname>Jawie&#324;</surname><given-names>A</given-names></name></person-group><article-title>The role of compression therapy in the treatment of venous leg ulcers</article-title><source>Adv Clin Exp Med</source><year>2018</year><volume>28</volume><issue>6</issue><fpage>847</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.17219/acem/78768</pub-id><pub-id pub-id-type="pmid">30085435</pub-id></element-citation><mixed-citation id="mc-CR274" publication-type="journal">Mo&#347;cicka P, Szewczyk M, Cwajda-Bia&#322;asik J, Jawie&#324; A. The role of compression therapy in the treatment of venous leg ulcers. Adv Clin Exp Med. 2018;28(6):847&#8211;52.<pub-id pub-id-type="doi" assigning-authority="pmc">10.17219/acem/78768</pub-id><pub-id pub-id-type="pmid">30085435</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR275"><label>275.</label><citation-alternatives><element-citation id="ec-CR275" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monika</surname><given-names>P</given-names></name><name name-style="western"><surname>Chandraprabha</surname><given-names>MN</given-names></name><name name-style="western"><surname>Rangarajan</surname><given-names>A</given-names></name><name name-style="western"><surname>Waiker</surname><given-names>PV</given-names></name><name name-style="western"><surname>Chidambara Murthy</surname><given-names>KN</given-names></name></person-group><article-title>Challenges in healing wound: role of complementary and alternative medicine</article-title><source>Front Nutr</source><year>2022</year><volume>20</volume><issue>8</issue><fpage>791899</fpage><pub-id pub-id-type="doi">10.3389/fnut.2021.791899</pub-id><pub-id pub-id-type="pmcid">PMC8811258</pub-id><pub-id pub-id-type="pmid">35127787</pub-id></element-citation><mixed-citation id="mc-CR275" publication-type="journal">Monika P, Chandraprabha MN, Rangarajan A, Waiker PV, Chidambara Murthy KN. Challenges in healing wound: role of complementary and alternative medicine. Front Nutr. 2022;20(8):791899.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnut.2021.791899</pub-id><pub-id pub-id-type="pmcid">PMC8811258</pub-id><pub-id pub-id-type="pmid">35127787</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR276"><label>276.</label><citation-alternatives><element-citation id="ec-CR276" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misra</surname><given-names>A</given-names></name><name name-style="western"><surname>Nanchahal</surname><given-names>J</given-names></name></person-group><article-title>Use of gauze soaked in povidone iodine for dressing acute open wounds</article-title><source>Plast Reconstr Surg</source><year>2003</year><volume>111</volume><issue>6</issue><fpage>2105</fpage><lpage>2107</lpage><pub-id pub-id-type="pmid">12711982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.PRS.0000057076.71217.B2</pub-id></element-citation><mixed-citation id="mc-CR276" publication-type="journal">Misra A, Nanchahal J. Use of gauze soaked in povidone iodine for dressing acute open wounds. Plast Reconstr Surg. 2003;111(6):2105&#8211;7.<pub-id pub-id-type="pmid">12711982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.PRS.0000057076.71217.B2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR277"><label>277.</label><citation-alternatives><element-citation id="ec-CR277" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hudspith</surname><given-names>J</given-names></name><name name-style="western"><surname>Rayatt</surname><given-names>S</given-names></name></person-group><article-title>First aid and treatment of minor burns</article-title><source>BMJ</source><year>2004</year><volume>328</volume><issue>7454</issue><fpage>1487</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.1136/bmj.328.7454.1487</pub-id><pub-id pub-id-type="pmid">15205294</pub-id><pub-id pub-id-type="pmcid">PMC428524</pub-id></element-citation><mixed-citation id="mc-CR277" publication-type="journal">Hudspith J, Rayatt S. First aid and treatment of minor burns. BMJ. 2004;328(7454):1487&#8211;9.<pub-id pub-id-type="pmid">15205294</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.328.7454.1487</pub-id><pub-id pub-id-type="pmcid">PMC428524</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR278"><label>278.</label><citation-alternatives><element-citation id="ec-CR278" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiklander</surname><given-names>OPB</given-names></name><name name-style="western"><surname>Nordin</surname><given-names>JZ</given-names></name><name name-style="western"><surname>O&#8217;Loughlin</surname><given-names>A</given-names></name><name name-style="western"><surname>Gustafsson</surname><given-names>Y</given-names></name><name name-style="western"><surname>Corso</surname><given-names>G</given-names></name><name name-style="western"><surname>M&#228;ger</surname><given-names>I</given-names></name><etal/></person-group><article-title>Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting</article-title><source>J Extracell Vesicles</source><year>2015</year><volume>4</volume><issue>1</issue><fpage>26316</fpage><pub-id pub-id-type="doi">10.3402/jev.v4.26316</pub-id><pub-id pub-id-type="pmid">25899407</pub-id><pub-id pub-id-type="pmcid">PMC4405624</pub-id></element-citation><mixed-citation id="mc-CR278" publication-type="journal">Wiklander OPB, Nordin JZ, O&#8217;Loughlin A, Gustafsson Y, Corso G, M&#228;ger I, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4(1):26316.<pub-id pub-id-type="pmid">25899407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3402/jev.v4.26316</pub-id><pub-id pub-id-type="pmcid">PMC4405624</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR279"><label>279.</label><citation-alternatives><element-citation id="ec-CR279" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schiffelers</surname><given-names>RM</given-names></name><name name-style="western"><surname>Bakker-Woudenberg</surname><given-names>IAJM</given-names></name><name name-style="western"><surname>Storm</surname><given-names>G</given-names></name></person-group><article-title>Localization of sterically stabilized liposomes in experimental rat klebsiella pneumoniae pneumonia: dependence on circulation kinetics and presence of poly (ethylene)glycol coating</article-title><source>Biochim Biophys Acta BBA - Biomembr</source><year>2000</year><volume>1468</volume><issue>1&#8211;2</issue><fpage>253</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/S0005-2736(00)00265-0</pub-id><pub-id pub-id-type="pmid">11018669</pub-id></element-citation><mixed-citation id="mc-CR279" publication-type="journal">Schiffelers RM, Bakker-Woudenberg IAJM, Storm G. Localization of sterically stabilized liposomes in experimental rat klebsiella pneumoniae pneumonia: dependence on circulation kinetics and presence of poly (ethylene)glycol coating. Biochim Biophys Acta BBA - Biomembr. 2000;1468(1&#8211;2):253&#8211;61.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0005-2736(00)00265-0</pub-id><pub-id pub-id-type="pmid">11018669</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR280"><label>280.</label><citation-alternatives><element-citation id="ec-CR280" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saunderson</surname><given-names>SC</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>AC</given-names></name><name name-style="western"><surname>Crocker</surname><given-names>PR</given-names></name><name name-style="western"><surname>McLellan</surname><given-names>AD</given-names></name></person-group><article-title>CD169 mediates the capture of exosomes in spleen and lymph node</article-title><source>Blood</source><year>2014</year><volume>123</volume><issue>2</issue><fpage>208</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-03-489732</pub-id><pub-id pub-id-type="pmid">24255917</pub-id><pub-id pub-id-type="pmcid">PMC3888287</pub-id></element-citation><mixed-citation id="mc-CR280" publication-type="journal">Saunderson SC, Dunn AC, Crocker PR, McLellan AD. CD169 mediates the capture of exosomes in spleen and lymph node. Blood. 2014;123(2):208&#8211;16.<pub-id pub-id-type="pmid">24255917</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2013-03-489732</pub-id><pub-id pub-id-type="pmcid">PMC3888287</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR281"><label>281.</label><citation-alternatives><element-citation id="ec-CR281" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Fang</surname><given-names>F</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Extracellular vesicles as bioactive nanotherapeutics: an emerging paradigm for regenerative medicine</article-title><source>Theranostics</source><year>2022</year><volume>12</volume><issue>11</issue><fpage>4879</fpage><lpage>4903</lpage><pub-id pub-id-type="doi">10.7150/thno.72812</pub-id><pub-id pub-id-type="pmid">35836815</pub-id><pub-id pub-id-type="pmcid">PMC9274746</pub-id></element-citation><mixed-citation id="mc-CR281" publication-type="journal">Li M, Fang F, Sun M, Zhang Y, Hu M, Zhang J. Extracellular vesicles as bioactive nanotherapeutics: an emerging paradigm for regenerative medicine. Theranostics. 2022;12(11):4879&#8211;903.<pub-id pub-id-type="pmid">35836815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.72812</pub-id><pub-id pub-id-type="pmcid">PMC9274746</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR282"><label>282.</label><citation-alternatives><element-citation id="ec-CR282" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lener</surname><given-names>T</given-names></name><name name-style="western"><surname>Gimona</surname><given-names>M</given-names></name><name name-style="western"><surname>Aigner</surname><given-names>L</given-names></name><name name-style="western"><surname>B&#246;rger</surname><given-names>V</given-names></name><name name-style="western"><surname>Buzas</surname><given-names>E</given-names></name><name name-style="western"><surname>Camussi</surname><given-names>G</given-names></name><etal/></person-group><article-title>Applying extracellular vesicles based therapeutics in clinical trials&#8212;an ISEV position paper</article-title><source>J Extracell Vesicles</source><year>2015</year><volume>4</volume><issue>1</issue><fpage>30087</fpage><pub-id pub-id-type="doi">10.3402/jev.v4.30087</pub-id><pub-id pub-id-type="pmid">26725829</pub-id><pub-id pub-id-type="pmcid">PMC4698466</pub-id></element-citation><mixed-citation id="mc-CR282" publication-type="journal">Lener T, Gimona M, Aigner L, B&#246;rger V, Buzas E, Camussi G, et al. Applying extracellular vesicles based therapeutics in clinical trials&#8212;an ISEV position paper. J Extracell Vesicles. 2015;4(1):30087.<pub-id pub-id-type="pmid">26725829</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3402/jev.v4.30087</pub-id><pub-id pub-id-type="pmcid">PMC4698466</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR283"><label>283.</label><citation-alternatives><element-citation id="ec-CR283" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><name name-style="western"><surname>Hochberg</surname><given-names>FH</given-names></name><name name-style="western"><surname>Jones</surname><given-names>PS</given-names></name></person-group><article-title>Extracellular vesicles: the growth as diagnostics and therapeutics; a survey</article-title><source>J Extracell Vesicles</source><year>2018</year><volume>7</volume><issue>1</issue><fpage>1438720</fpage><pub-id pub-id-type="doi">10.1080/20013078.2018.1438720</pub-id><pub-id pub-id-type="pmid">29511461</pub-id><pub-id pub-id-type="pmcid">PMC5827771</pub-id></element-citation><mixed-citation id="mc-CR283" publication-type="journal">Roy S, Hochberg FH, Jones PS. Extracellular vesicles: the growth as diagnostics and therapeutics; a survey. J Extracell Vesicles. 2018;7(1):1438720.<pub-id pub-id-type="pmid">29511461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/20013078.2018.1438720</pub-id><pub-id pub-id-type="pmcid">PMC5827771</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR284"><label>284.</label><citation-alternatives><element-citation id="ec-CR284" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verma</surname><given-names>KD</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>F</given-names></name><name name-style="western"><surname>Mejia</surname><given-names>M</given-names></name><name name-style="western"><surname>Chalasani</surname><given-names>M</given-names></name><name name-style="western"><surname>Marcus</surname><given-names>KA</given-names></name></person-group><article-title>Food and drug administration perspective: advancing product development for non-healing chronic wounds</article-title><source>Wound Repair Regen</source><year>2022</year><volume>30</volume><issue>3</issue><fpage>299</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1111/wrr.13008</pub-id><pub-id pub-id-type="pmid">35385594</pub-id><pub-id pub-id-type="pmcid">PMC9081155</pub-id></element-citation><mixed-citation id="mc-CR284" publication-type="journal">Verma KD, Lewis F, Mejia M, Chalasani M, Marcus KA. Food and drug administration perspective: advancing product development for non-healing chronic wounds. Wound Repair Regen. 2022;30(3):299&#8211;302.<pub-id pub-id-type="pmid">35385594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/wrr.13008</pub-id><pub-id pub-id-type="pmcid">PMC9081155</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR285"><label>285.</label><citation-alternatives><element-citation id="ec-CR285" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Tu</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wen</surname><given-names>H</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name></person-group><article-title>Exosomal IRF1-loaded rat adipose-derived stem cell sheet contributes to wound healing in the diabetic foot ulcers</article-title><source>Mol Med</source><year>2023</year><volume>29</volume><issue>1</issue><fpage>60</fpage><pub-id pub-id-type="doi">10.1186/s10020-023-00617-6</pub-id><pub-id pub-id-type="pmid">37098476</pub-id><pub-id pub-id-type="pmcid">PMC10131451</pub-id></element-citation><mixed-citation id="mc-CR285" publication-type="journal">Wu M, Tu J, Huang J, Wen H, Zeng Y, Lu Y. Exosomal IRF1-loaded rat adipose-derived stem cell sheet contributes to wound healing in the diabetic foot ulcers. Mol Med. 2023;29(1):60.<pub-id pub-id-type="pmid">37098476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s10020-023-00617-6</pub-id><pub-id pub-id-type="pmcid">PMC10131451</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR286"><label>286.</label><citation-alternatives><element-citation id="ec-CR286" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Fu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zou</surname><given-names>H</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ye</surname><given-names>L</given-names></name><etal/></person-group><article-title>Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair</article-title><source>J Nanobiotechnology</source><year>2023</year><volume>21</volume><issue>1</issue><fpage>176</fpage><pub-id pub-id-type="doi">10.1186/s12951-023-01886-3</pub-id><pub-id pub-id-type="pmid">37269014</pub-id><pub-id pub-id-type="pmcid">PMC10236791</pub-id></element-citation><mixed-citation id="mc-CR286" publication-type="journal">Zhao X, Fu L, Zou H, He Y, Pan Y, Ye L, et al. Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair. J Nanobiotechnology. 2023;21(1):176.<pub-id pub-id-type="pmid">37269014</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-023-01886-3</pub-id><pub-id pub-id-type="pmcid">PMC10236791</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR287"><label>287.</label><citation-alternatives><element-citation id="ec-CR287" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>M</given-names></name><name name-style="western"><surname>Yi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Exosomes derived from E2F1-/- adipose-derived stem cells promote skin wound healing via miR-130b-5p/TGFBR3 axis</article-title><source>Int J Nanomedicine</source><year>2023</year><volume>18</volume><fpage>6275</fpage><lpage>6292</lpage><pub-id pub-id-type="doi">10.2147/IJN.S431725</pub-id><pub-id pub-id-type="pmid">37941530</pub-id><pub-id pub-id-type="pmcid">PMC10629453</pub-id></element-citation><mixed-citation id="mc-CR287" publication-type="journal">Yu H, Wu Y, Zhang B, Xiong M, Yi Y, Zhang Q, et al. Exosomes derived from E2F1-/- adipose-derived stem cells promote skin wound healing via miR-130b-5p/TGFBR3 axis. Int J Nanomedicine. 2023;18:6275&#8211;92.<pub-id pub-id-type="pmid">37941530</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S431725</pub-id><pub-id pub-id-type="pmcid">PMC10629453</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR288"><label>288.</label><citation-alternatives><element-citation id="ec-CR288" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heo</surname><given-names>JS</given-names></name></person-group><article-title>Selenium-stimulated exosomes enhance wound healing by modulating inflammation and angiogenesis</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><issue>19</issue><fpage>11543</fpage><pub-id pub-id-type="doi">10.3390/ijms231911543</pub-id><pub-id pub-id-type="pmid">36232844</pub-id><pub-id pub-id-type="pmcid">PMC9570007</pub-id></element-citation><mixed-citation id="mc-CR288" publication-type="journal">Heo JS. Selenium-stimulated exosomes enhance wound healing by modulating inflammation and angiogenesis. Int J Mol Sci. 2022;23(19):11543.<pub-id pub-id-type="pmid">36232844</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms231911543</pub-id><pub-id pub-id-type="pmcid">PMC9570007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR289"><label>289.</label><citation-alternatives><element-citation id="ec-CR289" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ju</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Ji</surname><given-names>P</given-names></name><etal/></person-group><article-title>miR-100&#8211;5p promotes epidermal stem cell proliferation through targeting MTMR3 to activate PIP3/AKT and ERK signaling pathways</article-title><source>Stem Cells Int.</source><year>2022</year><volume>2022</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/1474273</pub-id><pub-id pub-id-type="pmcid">PMC9421352</pub-id><pub-id pub-id-type="pmid">36045954</pub-id></element-citation><mixed-citation id="mc-CR289" publication-type="journal">Liu Z, Yang Y, Ju J, Zhang G, Zhang P, Ji P, et al. miR-100&#8211;5p promotes epidermal stem cell proliferation through targeting MTMR3 to activate PIP3/AKT and ERK signaling pathways. Stem Cells Int. 2022;2022:1&#8211;16.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/1474273</pub-id><pub-id pub-id-type="pmcid">PMC9421352</pub-id><pub-id pub-id-type="pmid">36045954</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR290"><label>290.</label><citation-alternatives><element-citation id="ec-CR290" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M</given-names></name><name name-style="western"><surname>Yin</surname><given-names>W</given-names></name><name name-style="western"><surname>Liang</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>A</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Development of a novel RNAi therapy: engineered miR-31 exosomes promoted the healing of diabetic wounds</article-title><source>Bioact Mater</source><year>2021</year><volume>6</volume><issue>9</issue><fpage>2841</fpage><lpage>2853</lpage><pub-id pub-id-type="pmid">33718666</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioactmat.2021.02.007</pub-id><pub-id pub-id-type="pmcid">PMC7905076</pub-id></element-citation><mixed-citation id="mc-CR290" publication-type="journal">Huang J, Yu M, Yin W, Liang B, Li A, Li J, et al. Development of a novel RNAi therapy: engineered miR-31 exosomes promoted the healing of diabetic wounds. Bioact Mater. 2021;6(9):2841&#8211;53.<pub-id pub-id-type="pmid">33718666</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioactmat.2021.02.007</pub-id><pub-id pub-id-type="pmcid">PMC7905076</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR291"><label>291.</label><citation-alternatives><element-citation id="ec-CR291" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>XF</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZX</given-names></name><name name-style="western"><surname>Huang</surname><given-names>KP</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YW</given-names></name><name name-style="western"><surname>Wang</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Hypoxic ucMSC-secreted exosomal miR-125b promotes endothelial cell survival and migration during wound healing by targeting TP53INP1</article-title><source>Mol Ther - Nucleic Acids</source><year>2021</year><volume>26</volume><fpage>347</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/j.omtn.2021.07.014</pub-id><pub-id pub-id-type="pmid">34513314</pub-id><pub-id pub-id-type="pmcid">PMC8416974</pub-id></element-citation><mixed-citation id="mc-CR291" publication-type="journal">Zhang XF, Wang T, Wang ZX, Huang KP, Zhang YW, Wang GL, et al. Hypoxic ucMSC-secreted exosomal miR-125b promotes endothelial cell survival and migration during wound healing by targeting TP53INP1. Mol Ther - Nucleic Acids. 2021;26:347&#8211;59.<pub-id pub-id-type="pmid">34513314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.omtn.2021.07.014</pub-id><pub-id pub-id-type="pmcid">PMC8416974</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>